
<html lang="en"     class="pb-page"  data-request-id="2ed539b6-4b60-4dfd-aa17-7a7c5133d610"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.8b00783;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design" /></meta><meta name="dc.Creator" content="Frank  Narjes" /></meta><meta name="dc.Creator" content="Yafeng  Xue" /></meta><meta name="dc.Creator" content="Stefan  von Berg" /></meta><meta name="dc.Creator" content="Jesper  Malmberg" /></meta><meta name="dc.Creator" content="Antonio  Llinas" /></meta><meta name="dc.Creator" content="Roine I.  Olsson" /></meta><meta name="dc.Creator" content="Johan  Jirholt" /></meta><meta name="dc.Creator" content="Hanna  Grindebacke" /></meta><meta name="dc.Creator" content="Agnes  Leffler" /></meta><meta name="dc.Creator" content="Nafizal  Hossain" /></meta><meta name="dc.Creator" content="Matti  Lepistö" /></meta><meta name="dc.Creator" content="Linda  Thunberg" /></meta><meta name="dc.Creator" content="Hanna  Leek" /></meta><meta name="dc.Creator" content="Anna  Aagaard" /></meta><meta name="dc.Creator" content="Jane  McPheat" /></meta><meta name="dc.Creator" content="Eva L.  Hansson" /></meta><meta name="dc.Creator" content="Elisabeth  Bäck" /></meta><meta name="dc.Creator" content="Stefan  Tångefjord" /></meta><meta name="dc.Creator" content="Rongfeng  Chen" /></meta><meta name="dc.Creator" content="Yao  Xiong" /></meta><meta name="dc.Creator" content="Ge  Hongbin" /></meta><meta name="dc.Creator" content="Thomas G.  Hansson" /></meta><meta name="dc.Description" content="Retinoic acid receptor related orphan receptor γt (RORγt), has been identified as the master regulator of TH17-cell function and development, making it an attractive target for the treatment of aut..." /></meta><meta name="Description" content="Retinoic acid receptor related orphan receptor γt (RORγt), has been identified as the master regulator of TH17-cell function and development, making it an attractive target for the treatment of aut..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 10, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00783" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00783" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00783" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00783" /></link>
        
    
    

<title>Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00783" /></meta><meta property="og:title" content="Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0023.jpeg" /></meta><meta property="og:description" content="Retinoic acid receptor related orphan receptor γt (RORγt), has been identified as the master regulator of TH17-cell function and development, making it an attractive target for the treatment of autoimmune diseases by a small-molecule approach. Herein, we describe our investigations on a series of 4-aryl-thienyl acetamides, which were guided by insights from X-ray cocrystal structures. Efforts in targeting the cofactor-recruitment site from the 4-aryl group on the thiophene led to a series of potent binders with nanomolar activity in a primary human-TH17-cell assay. The observation of a DMSO molecule binding in a subpocket outside the LBD inspired the introduction of an acetamide into the benzylic position of these compounds. Hereby, a hydrogen-bond interaction of the introduced acetamide oxygen with the backbone amide of Glu379 was established. This greatly enhanced the cellular activity of previously weakly cell-active compounds. The best compounds combined potent inhibition of IL-17 release with favorable PK in rodents, with compound 32 representing a promising starting point for future investigations." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00783"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00783">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00783&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00783&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00783&amp;href=/doi/10.1021/acs.jmedchem.8b00783" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7796-7813</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00765" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00790" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Frank Narjes</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frank Narjes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#cea8bcafa0a5e0a0afbca4abbd8eafbdbabcafb4aba0abadafe0ada1a3"><span class="__cf_email__" data-cfemail="6c0a1e0d020742020d1e06091f2c0d1f181e0d160902090f0d420f0301">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Narjes">Frank Narjes</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3104-7771" title="Orcid link">http://orcid.org/0000-0002-3104-7771</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yafeng Xue</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yafeng Xue</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structure, Biophysics & FBLG, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yafeng++Xue">Yafeng Xue</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefan von Berg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan von Berg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++von+Berg">Stefan von Berg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jesper Malmberg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jesper Malmberg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jesper++Malmberg">Jesper Malmberg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonio Llinas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio Llinas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">DMPK, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Llinas">Antonio Llinas</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4620-9363" title="Orcid link">http://orcid.org/0000-0003-4620-9363</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roine I. Olsson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roine I. Olsson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roine+I.++Olsson">Roine I. Olsson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Johan Jirholt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Johan Jirholt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioscience, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Johan++Jirholt">Johan Jirholt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hanna Grindebacke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hanna Grindebacke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioscience, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hanna++Grindebacke">Hanna Grindebacke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Agnes Leffler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Agnes Leffler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioscience, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Agnes++Leffler">Agnes Leffler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nafizal Hossain</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nafizal Hossain</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nafizal++Hossain">Nafizal Hossain</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matti Lepistö</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matti Lepistö</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matti++Lepist%C3%B6">Matti Lepistö</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Linda Thunberg</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Linda Thunberg</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Early Product Development, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Linda++Thunberg">Linda Thunberg</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hanna Leek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hanna Leek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Early Product Development, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hanna++Leek">Hanna Leek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anna Aagaard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anna Aagaard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structure, Biophysics & FBLG, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Aagaard">Anna Aagaard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jane McPheat</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jane McPheat</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mechanistic Biology and Profiling, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jane++McPheat">Jane McPheat</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eva L. Hansson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eva L. Hansson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mechanistic Biology and Profiling, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eva+L.++Hansson">Eva L. Hansson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elisabeth Bäck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elisabeth Bäck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mechanistic Biology and Profiling, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elisabeth++B%C3%A4ck">Elisabeth Bäck</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefan Tångefjord</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan Tångefjord</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structure, Biophysics & FBLG, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++T%C3%A5ngefjord">Stefan Tångefjord</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rongfeng Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rongfeng Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaron Beijing Company, Ltd., Taihe Road, BDA, Beijing 100176, PR China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rongfeng++Chen">Rongfeng Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yao Xiong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yao Xiong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaron Beijing Company, Ltd., Taihe Road, BDA, Beijing 100176, PR China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yao++Xiong">Yao Xiong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ge Hongbin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ge Hongbin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaron Beijing Company, Ltd., Taihe Road, BDA, Beijing 100176, PR China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ge++Hongbin">Ge Hongbin</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Thomas G. Hansson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas G. Hansson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+G.++Hansson">Thomas G. Hansson</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00783&amp;href=/doi/10.1021%2Facs.jmedchem.8b00783" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7796–7813</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 10, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 May 2018</li><li><span class="item_label"><b>Published</b> online</span>10 August 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 September 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00783" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00783</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7796%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFrank%2BNarjes%252C%2BYafeng%2BXue%252C%2BStefan%2Bvon%2BBerg%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D17%26contentID%3Dacs.jmedchem.8b00783%26title%3DPotent%2Band%2BOrally%2BBioavailable%2BInverse%2BAgonists%2Bof%2BROR%25CE%25B3t%2BResulting%2Bfrom%2BStructure-Based%2BDesign%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7813%26publicationDate%3DSeptember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00783"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1979</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00783" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Narjes&quot;},{&quot;first_name&quot;:&quot;Yafeng&quot;,&quot;last_name&quot;:&quot;Xue&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;von Berg&quot;},{&quot;first_name&quot;:&quot;Jesper&quot;,&quot;last_name&quot;:&quot;Malmberg&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Llinas&quot;},{&quot;first_name&quot;:&quot;Roine&quot;,&quot;last_name&quot;:&quot;I. Olsson&quot;},{&quot;first_name&quot;:&quot;Johan&quot;,&quot;last_name&quot;:&quot;Jirholt&quot;},{&quot;first_name&quot;:&quot;Hanna&quot;,&quot;last_name&quot;:&quot;Grindebacke&quot;},{&quot;first_name&quot;:&quot;Agnes&quot;,&quot;last_name&quot;:&quot;Leffler&quot;},{&quot;first_name&quot;:&quot;Nafizal&quot;,&quot;last_name&quot;:&quot;Hossain&quot;},{&quot;first_name&quot;:&quot;Matti&quot;,&quot;last_name&quot;:&quot;Lepistö&quot;},{&quot;first_name&quot;:&quot;Linda&quot;,&quot;last_name&quot;:&quot;Thunberg&quot;},{&quot;first_name&quot;:&quot;Hanna&quot;,&quot;last_name&quot;:&quot;Leek&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Aagaard&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;McPheat&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;L. Hansson&quot;},{&quot;first_name&quot;:&quot;Elisabeth&quot;,&quot;last_name&quot;:&quot;Bäck&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Tångefjord&quot;},{&quot;first_name&quot;:&quot;Rongfeng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Yao&quot;,&quot;last_name&quot;:&quot;Xiong&quot;},{&quot;first_name&quot;:&quot;Ge&quot;,&quot;last_name&quot;:&quot;Hongbin&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;G. Hansson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;7796-7813&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00783&quot;},&quot;abstract&quot;:&quot;Retinoic acid receptor related orphan receptor γt (RORγt), has been identified as the master regulator of TH17-cell function and development, making it an attractive target for the treatment of autoimmune diseases by a small-molecule approach. Herein, we describe our investigations on a series of 4-aryl-thienyl acetamides, which were guided by insights from X-ray cocrystal structures. Efforts in targeting the cofactor-recruitment site from the 4-aryl group on the thiophene led to a series of potent binders with nanomolar activity in a primary human-TH17-cell assay. The observation of a DMSO molecule binding in a subpocket outside the LBD inspired the introduction of an acetamide into the benzylic position of these compounds. Hereby, a hydrogen-bond interaction of the introduced acetamide oxygen with the backbone amide of Glu379 was established. This greatly enhanced the cellular activity of previously weakly cell-active compounds. The best compounds combined potent inhibition of IL-17 release with favorable P&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00783&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00783" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00783&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00783" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00783&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00783" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00783&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00783&amp;href=/doi/10.1021/acs.jmedchem.8b00783" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00783" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00783" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00783%26sid%3Dliteratum%253Aachs%26pmid%3D30095900%26genre%3Darticle%26aulast%3DNarjes%26date%3D2018%26atitle%3DPotent%2Band%2BOrally%2BBioavailable%2BInverse%2BAgonists%2Bof%2BROR%25CE%25B3t%2BResulting%2Bfrom%2BStructure-Based%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D17%26spage%3D7796%26epage%3D7813%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/jmcmar.2018.61.issue-17/20180913/jmcmar.2018.61.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Retinoic acid receptor related orphan receptor γt (RORγt), has been identified as the master regulator of T<sub>H</sub>17-cell function and development, making it an attractive target for the treatment of autoimmune diseases by a small-molecule approach. Herein, we describe our investigations on a series of 4-aryl-thienyl acetamides, which were guided by insights from X-ray cocrystal structures. Efforts in targeting the cofactor-recruitment site from the 4-aryl group on the thiophene led to a series of potent binders with nanomolar activity in a primary human-T<sub>H</sub>17-cell assay. The observation of a DMSO molecule binding in a subpocket outside the LBD inspired the introduction of an acetamide into the benzylic position of these compounds. Hereby, a hydrogen-bond interaction of the introduced acetamide oxygen with the backbone amide of Glu379 was established. This greatly enhanced the cellular activity of previously weakly cell-active compounds. The best compounds combined potent inhibition of IL-17 release with favorable PK in rodents, with compound <b>32</b> representing a promising starting point for future investigations.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14285" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14285" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The nuclear receptor retinoic acid receptor related orphan receptor γ (RORγ, NR1F3, or RORc) exists in two isoforms, with one isoform (RORγ or RORc1) widely expressed in a variety of tissues, and the expression of the second isoform (RORγt or RORc2) restricted to the thymus and cells of the immune system.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> RORγt is the key transcription factor for the function and development of CD4<sup>+</sup> T-helper 17 (T<sub>H</sub>17) cells and related IL-17-producing immune cells, such as innate lymphoid 3 cells and γδ T cells.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> T<sub>H</sub>17 cells are characterized by the production of the cytokines IL-17A, IL-17F, and IL-22 and play a key role in host defense against extracellular pathogens.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Dysregulation of the T<sub>H</sub>17 pathway has been implicated in the pathology of a variety of autoimmune disorders, such as psoriasis, Crohn’s disease, multiple sclerosis, and rheumatoid arthritis.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11 ref12">(7−12)</a> Antibodies targeting IL-17; its receptor, IL-17RA; or the cytokines involved in the inflammatory pathway, such as IL-23, have shown clinical efficacy in treating psoriasis and related autoimmune disorders.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13−16)</a></div><div class="NLM_p">Nuclear receptors are ligand-inducible transcription factors, whose function can be modulated by the binding of small molecules to the ligand-binding domain (LBD) of the receptor, thereby inducing conformational changes to the cofactor-recruitment binding site and ultimately affecting gene transcription.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> RORγt has been shown to be active in the absence of ligands, but sterol derivatives were described to affect receptor function and to control T<sub>H</sub>17 differentiation.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20−23)</a> The crystal structures of two sterol derivatives, agonist 25-hydroxychesterol and inverse agonist digoxin, provided insights into the molecular mechanisms leading to the different functional effects.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a></div><div class="NLM_p">Efforts to discover orally bioavailable inverse agonists of RORγt, as an alternative to antibody treatment, have generated a variety of different structural classes.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26−29)</a> Compounds affecting the receptor by binding to the LBD are not expected to exhibit isoform selectivity, because the two isoforms of RORγ differ only at their N-termini and share the same DNA- and ligand-binding domains.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40">(30−40)</a> Recent clinical candidates from these efforts include GNE-3500,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> GSK805,<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> GSK2981278,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and VTP-43742<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). GSK2981278, whose structure has not been disclosed, was developed for the topical treatment of psoriasis but failed to show efficacy in a Phase 1 study,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> whereas Vitae Pharmaceuticals recently reported positive results for VTP-43742 from a Phase 2a study for the same indication. Oral administration over 4 weeks was found to be safe and efficacious, resulting in a 24% reduction in the psoriasis-area severity index.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selection of published inverse agonists of RORγt.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We recently disclosed a series of benzoxazepine-based modulators, which we eventually abandoned because of the metabolic instability of the compounds.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The hit-identification approaches we conducted to find new starting points included X-ray-based fragment screening,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and the characterization of compounds from the literature. Among these were derivatives <b>1</b> and <b>2</b>, previously described by scientists from GSK.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a></div><div class="NLM_p">Both compounds were potent binders in a radioligand-binding assay (SPA) and behaved as inverse agonists in a FRET assay, showing functional suppression of the recruitment of a coactivator peptide derived from steroid-receptor coactivator 1 (SRC1) to RORγt LBD. The activity of <b>2</b> observed in the FRET assay was about 10-fold lower compared with that in the binding assay, which we ascribed to the conditions of the FRET assay, placing a limit on the lowest IC<sub>50</sub> that can be determined at around 0.02 μM. They efficiently suppressed IL-17A production from primary human T<sub>H</sub>17 cells, with thiophene <b>2</b> being 30-fold more potent. Compound <b>2</b> is highly lipophilic, and its pharmacokinetic properties in mouse were characterized by high plasma clearance and low oral bioavailability.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compound <b>3</b> was prepared as part of an early effort to understand the SAR and reduce lipophilicity. It was about 60-fold less active in the SPA assay, but we were intrigued by the observation that despite the lack of the benzoate moiety, <b>3</b> behaved as an inverse agonist in the FRET assay. Even though <b>3</b> exhibited submicromolar binding potency and efficacy in the FRET assay, it was not able to suppress IL-17 release from primary human T<sub>H</sub>17 cells.</div><div class="NLM_p last">In this paper we describe our SAR efforts around <b>3</b>, which were guided by insights from X-ray crystal structures on the binding modes of compounds as the series evolved. These resulted in a class of compounds that efficiently suppressed IL-17 production in primary human cells and had favorable PK properties in rodent species.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We succeeded in soaking compound <b>1</b> into the apo-crystals of RORγt LBD tethered to an SRC2-derived peptide, representing the agonist state of the receptor (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref24 ref39'); return false;" href="javascript:void(0);" class="ref ref24 ref39">(24,39)</a> Recently, the cocrystal structures of <b>1</b> and of a closely related agonist were published.<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50−52)</a> Despite the different crystallization conditions, the key interactions of the compounds inside the ligand-binding domain are very similar. These include the hydrogen-bond interactions of the sulfone oxygens with Arg367 and Gln286 and of the amide moiety with the backbone carbonyl of Phe377. The amide bond is coplanar with the thiazole ring, with a stabilizing 1,5-O···S interaction.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The meta-chloro substituent of the 4-aryl residue points to Ser404 (3.5 Å), and the side chain of Met365 has moved significantly (about 3.5 Å) with respect to the apo-structure.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) X-ray structure of <b>1</b> (green) binding inside RORγt LBD (gray; 2.30 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI5">5NI5</a>). Compound <b>1</b> and key residues of RORγt LBD are shown as sticks. (b) Overlay of <b>1</b> (green) and 25-hydroxycholesterol (25-HC, gray), showing the interaction of 25-HC with the water molecule (dotted sphere) and the Tyr–His lock.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An overlay with 25-hydroxycholesterol (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b) shows that the benzoyl group at the 5-position of the thiazole fills the hydrophobic pocket near helix 12 only partially and does not interact with the so-called Tyr–His lock, composed of His479 on helix 11 and Tyr502 on helix 12. These two residues form part of the activation-function-2 domain (AF2), the interaction site for coregulatory proteins. We observed a conserved water near Trp317 and the His–Tyr lock, which, in the structure with the agonist, 25-hydroxycholesterol, interacts with the 25-hydroxy group and stabilizes the agonist conformation.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Stabilization of the AF2 domain by hydrophobic interactions was suggested as an explanation for the agonism of thiazole amides and keto amides.<a onclick="showRef(event, 'ref50 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref52">(50,52)</a> For the inverse agonism of <b>1</b>, a water-trapping mechanism was proposed, whereby the release of the water molecule trapped at the AF2 domain in the hydrophobic environment is energetically favorable, leading to destabilization of helix 12.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div class="NLM_p">The X-ray structures described above were not published when we started our work, but the results in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> pointed to a key role of the lipophilic benzoyl group for potency and activity in the cell assay. Assuming that the binding mode of <b>3</b> would closely resemble that of <b>1</b>, we hypothesized that it should be possible to combine cell potency and druglike properties by using the appropriate substituents appended to the thiophene-linked aryl group of <b>3</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Profile of Compounds <b>1</b>–<b>3</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> SPA<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> [μM]</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> FRET<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> [μM] (% eff)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> IL-17 cell<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> [μM] (% eff)</th><th class="colsep0 rowsep0" align="center">log <i>D</i><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">clogP</th><th class="colsep0 rowsep0" align="center">LLE<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">0.009</td><td class="colsep0 rowsep0" align="center">0.022 (−87)</td><td class="colsep0 rowsep0" align="center">0.18 (−75)</td><td class="colsep0 rowsep0" align="center">>4.2</td><td class="colsep0 rowsep0" align="center">5.5</td><td class="colsep0 rowsep0" align="center">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center">0.002</td><td class="colsep0 rowsep0" align="center">0.023 (−82)</td><td class="colsep0 rowsep0" align="center">0.006 (−85)</td><td class="colsep0 rowsep0" align="center">4.5</td><td class="colsep0 rowsep0" align="center">6.0</td><td class="colsep0 rowsep0" align="center">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">0.11</td><td class="colsep0 rowsep0" align="center">0.18 (−96)</td><td class="colsep0 rowsep0" align="center">>3</td><td class="colsep0 rowsep0" align="center">>4.1</td><td class="colsep0 rowsep0" align="center">4.0</td><td class="colsep0 rowsep0" align="center">3.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Displacement of tritiated ligand from human RORγt LBD (geometric mean of <i>n</i> ≥ 2).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Inhibition or activation of the recruitment of the SRC1-derived coactivator peptide (NCOA1, 677–700 aa) to human RORγt LBD (geometric mean of <i>n</i> ≥ 2). Negative percent-efficacy (% eff) values denote inverse agonism.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Inhibition of IL-17 production from human primary T<sub>H</sub>17 cells (geometric mean of <i>n</i> ≥ 3). Negative values of percent efficacy signify inhibition of IL-17 production.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Distribution coefficient between 1-octanol and aqueous phosphate buffer at pH 7.4.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Ligand lipophilic efficiency defined as SPA pIC<sub>50</sub> – clogP.</p></div></div></div><div class="NLM_p">A focused library of compounds around the aryl substituent in the 4-position of the thiophene was prepared (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Addition of a cyano group in the 5-position of the 4-aryl group of <b>3</b> resulted in a 2-fold gain in potency. Moving the chlorine to the 2-position gave equipotent compound <b>5</b>, which exhibited a lower partition coefficient compared with that of <b>4</b>, whereas compound <b>6</b>, with a cyano group into the 4-position, was less active. Trisubstituted derivative <b>7</b>, bearing a methoxy group in place of the chlorine, gained another 2-fold increase in potency. Removal of the fluorine was tolerated, leading to <b>8</b>, with improved lipophilic ligand efficiency (LLE) compared with that of <b>3</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Initial SAR around the 4-Aryl Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0014.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0015.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Displacement of tritiated ligand from human RORγt LBD (geometric mean of <i>n</i> ≥ 2).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Inhibition or activation of the recruitment of the SRC1-derived coactivator peptide (NCOA1, 677–700 aa) to human RORγt LBD (geometric mean of <i>n</i> ≥ 2). Negative percent-efficacy (% eff) values denote inverse agonism; positive values denote agonism and were determined at a single concentration.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Distribution coefficient between 1-octanol and aqueous phosphate buffer at pH 7.4.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Ligand lipophilic efficiency defined as SPA pIC<sub>50</sub> – log <i>D</i>.</p></div></div><div></div></div><div class="NLM_p">Another set of interesting data was provided by the ortho-substituted pyridyl analogues, <b>9</b> and <b>10</b>. Methoxy derivative <b>9</b> exhibited diminished binding activity with respect to <b>3</b> but maintained functional activity. A bulkier benzyl ether, as in <b>10</b>, led to a 20-fold gain in binding affinity; however, <b>10</b> behaved as an agonist in the FRET assay, efficiently enhancing recruitment of the coactivator peptide. This indicated that our initial hypothesis of being able to modulate receptor function by proper substitution from the aryl group was at least partly correct. Attempts to further increase the polarity of <b>9</b>, as in pyrimidine <b>11</b>, resulted in a significant loss in potency. Compound <b>12</b> combined the potency-enhancing nitrile moiety with the methoxy group and gave results similar to <b>8</b>.</div><div class="NLM_p">Concurrent with the optimization of the aryl group, we also explored the possibility of lowering the lipophilicity by introducing changes to the aryl sulfone moiety. We considered groups that could maintain some of the interactions in the arginine-rich region. A sulfoxide and especially a sulfoximine moiety fulfilled these requirements,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> but the corresponding compounds, <b>13</b> and <b>14</b>, lost activity by 40- and 10-fold in the SPA assay, respectively, whereas in the FRET assay, 10- and 4-fold losses were observed (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). A methylsulfonamide, as in <b>15</b>, did not offer any reduction in lipophilicity but maintained potency with respect to <b>12</b>. Replacing the phenyl sulfone aromatic ring with a sulfonylated piperidine, as in <b>16</b>, also led to a considerable loss of activity, which we believe to be due to the different geometries of the saturated ring compared with those of the aromatic ring.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR around the Sulfonyl Head Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0016.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0017.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Displacement of tritiated ligand from human RORγt LBD (geometric mean of <i>n</i> ≥ 2).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Inhibition or activation of the recruitment of the SRC1-derived coactivator peptide (NCOA1, 677–700 aa) to human RORγt LBD (geometric mean of <i>n</i> ≥ 2). Negative percent-efficacy (% eff) values denote inverse agonism; positive values denote agonism and were determined at a single concentration.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Distribution coefficient between 1-octanol and aqueous phosphate buffer at pH 7.4.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Ligand lipophilic efficiency defined as SPA pIC<sub>50</sub> – log <i>D</i>.</p></div></div><div></div></div><div class="NLM_p">To better understand the tight SAR around the sulfone moiety, we performed a solvent analysis of the apo and complex structures with <b>1</b> using 3D-RISM.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The results indicated the presence of several water molecules in this arginine subpocket. Four of these were hydrophobic (unstable) and were replaced by the ethyl group, whereas two hydrophilic (stable) water molecules were each replaced by one of the oxygen atoms of the sulfone upon binding of the ligand (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Accordingly, the two oxygen atoms retain favorable polar interactions with the protein. As a result, the ethyl sulfone group seemed to provide the best configuration to replace the different solvent positions and the best binding affinity of the ligand. This would also explain the loss of potency for sulfoxide <b>13</b> and sulfoximine <b>14</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Solvent analysis of RORγt LBD in complex with <b>1</b> using 3D-RISM. The arylsulfone group of <b>1</b> and key residues of RORγt LBD are shown as sticks. Solvent positions in the apo-pocket are shown as spheres (hydrophobic, unstable waters are in orange, and hydrophilic, stable ones are in cyan).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We tested some of the more active compounds for their ability to inhibit IL-17A production in primary human T<sub>H</sub>17 cells (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). We found that all compounds were inactive at concentrations of up to 3.3 μM, apart from <b>7</b> and <b>10</b>. In line with their behavior in the functional FRET assay, inverse agonist <b>7</b> inhibited IL-17A production with an IC<sub>50</sub> of about 0.7 μM, whereas agonist <b>10</b> enhanced it to 38% over the baseline of the cell assay at a concentration of 3.3 μM. We noticed some effects on cell viability in the Cell-Titer-Glo read-outs for both compounds at 3 μM. This made the interpretation of the cell data problematic, as there was less than a 10-fold difference between the IC<sub>50</sub> values observed for the suppression of IL-17A production and toxicity. On the basis of good binding potency and functional activity in the FRET assay, we were expecting to see a more profound response on IL-17 production, and investigated if the lack of activity was due to issues related to cell permeability or efflux. Results from the Caco2-assay indicated that compared with <b>2</b>, all of our inverse agonists showed improved permeability. Compound recovery was only 40–50%, which was due to their relatively high lipophilicities (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), low solubilities, and high affinities for plasma proteins. This can lead to unspecific binding or precipitation, making data interpretation difficult. Compounds <b>7</b>, <b>8</b>, and <b>12</b> had similar permeabilities and moderate efflux, whereas sulfonamide <b>15</b> demonstrated lower permeability and higher efflux. We also measured the intrinsic permeabilities of these compounds in an assay where Caco2 cells were incubated with a cocktail of compounds inhibiting the most common transporters present in the cell, including PgP.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The intrinsic permeability values for all inverse agonists, apart from <b>2</b>, were high, indicating that these compounds should be able to reach the interiors of the cells. On the basis of the data, low permeability and efflux do not explain the lack of cell potency. Our conclusion is that binding and cofactor-recruitment assays using the truncated form of the receptor in a simplified system are not always predictive of the more complex biology of inhibition of IL-17 production in T<sub>H</sub>17 cells, where RORγ is in its native state and interacting with its endogenous ligands and cofactors.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cell-Assay Activity and Physicochemical Data for Selected Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> IL-17 cell<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> [μM] (% eff)</th><th class="colsep0 rowsep0" align="center">CTG<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> [μM] (% eff)</th><th class="colsep0 rowsep0" align="center">Caco2<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> <i>P</i><sub>app</sub> AtB/BtA/efflux [1 × 10<sup>–6</sup> cm/s]</th><th class="colsep0 rowsep0" align="center">Caco2<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> intrinsic <i>P</i><sub>0</sub> [1 × 10<sup>–6</sup> cm/s]</th><th class="colsep0 rowsep0" align="center">hPPB<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> [% free]</th><th class="colsep0 rowsep0" align="center">solubility<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a> [μM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center">0.006 ± 0.0003 (−85)</td><td class="colsep0 rowsep0" align="center">>3 (40%)</td><td class="colsep0 rowsep0" align="center"><0.001/0.6/>324 52% rec</td><td class="colsep0 rowsep0" align="center"><0.5</td><td class="colsep0 rowsep0" align="center"><0.2</td><td class="colsep0 rowsep0" align="center"><0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">0.7 ± 0.5 (−57)</td><td class="colsep0 rowsep0" align="center">>3 (60%)</td><td class="colsep0 rowsep0" align="center">1.8/7.1/3.9 41% rec</td><td class="colsep0 rowsep0" align="center">37</td><td class="colsep0 rowsep0" align="center">0.17</td><td class="colsep0 rowsep0" align="center"><0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">>3.3</td><td class="colsep0 rowsep0" align="center">—</td><td class="colsep0 rowsep0" align="center">1.6/12/7.6 41% rec</td><td class="colsep0 rowsep0" align="center">79</td><td class="colsep0 rowsep0" align="center">0.10</td><td class="colsep0 rowsep0" align="center">0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">+38% at 3.3 μM</td><td class="colsep0 rowsep0" align="center">>3 (30%)</td><td class="colsep0 rowsep0" align="center">—</td><td class="colsep0 rowsep0" align="center">—</td><td class="colsep0 rowsep0" align="center">0.03</td><td class="colsep0 rowsep0" align="center">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="center">>3.3</td><td class="colsep0 rowsep0" align="center">—</td><td class="colsep0 rowsep0" align="center">2.6/17.1/5.8 44% rec</td><td class="colsep0 rowsep0" align="center">65</td><td class="colsep0 rowsep0" align="center">0.09</td><td class="colsep0 rowsep0" align="center">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="center">>3.3</td><td class="colsep0 rowsep0" align="center">—</td><td class="colsep0 rowsep0" align="center">0.65/26/40 55% rec</td><td class="colsep0 rowsep0" align="center">67</td><td class="colsep0 rowsep0" align="center"><0.1</td><td class="colsep0 rowsep0" align="center">0.34</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of IL-17 production from human primary T<sub>H</sub>17 cells (geometric mean of <i>n</i> ≥ 3). Negative values of percent efficacy signify inhibition of IL-17 production; positive values signify potentiation under the assay conditions. Effects of the compounds on cell viability and proliferation were assessed in the same assay with Cell-Titer-Glo (CTG) measuring total ATP levels.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Permeability measured in Caco2 cells at pH = 7.4/7/4.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Permeability measured in Caco2 cells incubated at pH 6.5 with a cocktail of inhibitors of common transporters.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Binding to human plasma protein determined by equilibrium dialysis.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Determined from DMSO stock solutions in aqueous buffer at pH 7.4.</p></div></div></div><div class="NLM_p">We could obtain X-ray cocrystal structures of inverse agonist <b>8</b> and agonist <b>10</b> by soaking the compounds into the apo-crystals of RORγt LBD (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), proving that the compounds bind to the receptor and are genuine modulators of RORγt.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of (a) <b>1</b> and <b>8</b> (2.45 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI7">5NI7</a>) and (b) <b>8</b> and <b>10</b> (1.94 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI8">5NI8</a>) with key interactions to the RORγt LBD. Compounds <b>1</b> (green), <b>8</b> (cyan), and <b>10</b> (magenta) and key residues of RORγ LBD are shown as sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Both compounds showed an almost perfect overlap for the sulfone headgroup and core heterocycle. The same key interactions described above for <b>1</b> were established. For compound <b>8</b>, the nitrile on the aryl moiety pointed toward the side-chain oxygen of Ser404, indicative of a rather long hydrogen-bond interaction of 3.2 Å, which is similar to the meta-Cl of the 4-arylygroup of <b>1</b>. The 2-methoxy group is too short to interact with the AF2 domain, whereas the benzyl group in agonist <b>10</b> filled the pocket around the His–Tyr lock, replacing the conserved water observed in the structures of <b>1</b> and <b>8</b>. This hydrophobic interaction is thought to stabilize the agonist conformation of the AF2 domain, and similar observations were published recently for other RORγ agonists.<a onclick="showRef(event, 'ref39 ref50 ref52 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref39 ref50 ref52 ref57 ref58">(39,50,52,57,58)</a></div><div class="NLM_p">On the basis of the X-ray structure of <b>10</b>, we expected that increasing the size of the alkoxy group would eventually lead to a clash with the His–Tyr lock and therefore to inverse agonism. Increasing the size of the alkoxy substituent from methoxy, as in <b>9</b>, to ethoxy, as in <b>17</b>, and subsequently to phenoxy, as in <b>19</b>, resulted in an increase in binding affinity and a gradual switch in function from inverse agonism to agonism in the FRET assay (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), with <b>19</b> behaving like benzyl ether <b>10</b>. Pushing the phenyl group out further by chain elongation of <b>10</b> did not lead to inverse agonism, but derivatives <b>20</b> and <b>21</b> behaved as agonists. We hypothesized that the flexibility of these substituents allowed them to be accommodated in the binding pocket, avoiding the steric clash with the AF2 domain. Rigidifying the propyl linker of <b>21</b> with a double bond supported this hypothesis, as cinnamyl ether <b>22</b> was a potent inverse agonist in the FRET assay.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Compounds <b>9</b>, <b>10</b>, and <b>17</b>–<b>30</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0018.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> SPA<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> [μM]</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> FRET<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> [μM] (% eff)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> IL-17 cell<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a> [μM] (% eff)</th><th class="colsep0 rowsep0" align="center">CTG [μM] (% eff)</th><th class="colsep0 rowsep0" align="center">RH CL<sub>int</sub><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.41</td><td class="colsep0 rowsep0" align="center">0.11 (−82)</td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">OBn</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.020</td><td class="colsep0 rowsep0" align="center">+95% at 3.3 μM</td><td class="colsep0 rowsep0" align="center">+38% at 3.3 μM</td><td class="colsep0 rowsep0" align="center">>3 (30%)</td><td class="colsep0 rowsep0" align="center">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.15</td><td class="colsep0 rowsep0" align="center">0.08 (−72)</td><td class="colsep0 rowsep0" align="center">–47% at 1 μM</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">OPr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.059</td><td class="colsep0 rowsep0" align="center">–13% at 3.3 μM</td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="center">3 (40)</td><td class="colsep0 rowsep0" align="center">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">OPh</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.046</td><td class="colsep0 rowsep0" align="center">+42% at 3.3 μM</td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="center">3 (50)</td><td class="colsep0 rowsep0" align="center">196</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.029</td><td class="colsep0 rowsep0" align="center">+84% at 3.3 μM</td><td class="colsep0 rowsep0" align="center">+26% at 1 μM</td><td class="colsep0 rowsep0" align="center">3 (70)</td><td class="colsep0 rowsep0" align="center">125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.017</td><td class="colsep0 rowsep0" align="center">+17% at 3.3 μM</td><td class="colsep0 rowsep0" align="center">>3.3 μM</td><td class="colsep0 rowsep0" align="center">3 (30)</td><td class="colsep0 rowsep0" align="center">104</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH═CHPh</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.011</td><td class="colsep0 rowsep0" align="center">0.029 (−90%)</td><td class="colsep0 rowsep0" align="center">0.025 (−78)</td><td class="colsep0 rowsep0" align="center">3 (40)</td><td class="colsep0 rowsep0" align="center">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>Ph-4-CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.014</td><td class="colsep0 rowsep0" align="center">0.021 (−98)</td><td class="colsep0 rowsep0" align="center">0.035 (−92)</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>Ph-4-CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.01</td><td class="colsep0 rowsep0" align="center">0.03 (−57)</td><td class="colsep0 rowsep0" align="center">0.10 ± 0.08</td><td class="colsep0 rowsep0" align="center">>1 (50)</td><td class="colsep0 rowsep0" align="center">286</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>Ph-3-CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.019</td><td class="colsep0 rowsep0" align="center">+112% at 3.3 μM</td><td class="colsep0 rowsep0" align="center">+5% at 1 μM</td><td class="colsep0 rowsep0" align="center">0.3 (50)</td><td class="colsep0 rowsep0" align="center">281</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">OPh-4-CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.088</td><td class="colsep0 rowsep0" align="center">–18% at 3.3 μM</td><td class="colsep0 rowsep0" align="center">0.19 ± 0.13 (−79)</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>Ph-4-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.007</td><td class="colsep0 rowsep0" align="center">0.03 (−68)</td><td class="colsep0 rowsep0" align="center">0.025 ± 0.09 (−68)</td><td class="colsep0 rowsep0" align="center">3 (40%)</td><td class="colsep0 rowsep0" align="center">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">OPh-4-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.033</td><td class="colsep0 rowsep0" align="center">–19% at 3.3 μM</td><td class="colsep0 rowsep0" align="center">0.144 ± 0.12 (−65)</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.018</td><td class="colsep0 rowsep0" align="center">0.05 (−44)</td><td class="colsep0 rowsep0" align="center">0.10 ± 0.0 (−64%)</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="center">0.002</td><td class="colsep0 rowsep0" align="center">0.03 (−49%)</td><td class="colsep0 rowsep0" align="center">0.065 ± 0.03 (−66%)</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">7.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Displacement of tritiated ligand from human RORγt LBD (geometric mean of <i>n</i> ≥ 2).</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Inhibition or activation of the recruitment of the SRC1-derived coactivator peptide (NCOA1, 677–700 aa) to human RORγ LBD (geometric mean of <i>n</i> ≥ 2). Negative percent-efficacy (% eff) values denote inverse agonism; positive values denote agonism and were determined at a single concentration.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Inhibition of IL-17 production from human primary T<sub>H</sub>17 cells (geometric mean of <i>n</i> ≥ 3). Negative values of percent efficacy signify inhibition of IL-17 production; positive values signify potentiation under the assay conditions. Effects of the compounds on cell viability and proliferation were assessed in the same assay with Cell-Titer-Glo measuring total ATP levels; na, not active at 3.3 μM; nt, not tested.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Rat-hepatocyte metabolic intrinsic clearance (μL min<sup>–1</sup> (million cells)<sup>−1</sup>).</p></div></div></div><div class="NLM_p">Introduction of a substituent to the para-position of the benzyl group of <b>10</b> led to the expected change in the mode of action. Ester <b>23</b> as well as benzonitrile <b>24</b> behaved as inverse agonists. Moving the cyano residue to the meta-position of the phenyl ring as in <b>25</b> led to a switch to agonistic behavior in the FRET assay.</div><div class="NLM_p">Functional behavior in the FRET assay was mirrored in the cell assay, but the observed activity on IL-17A secretion was again obstructed by the effects on cell viability for several compounds. Exceptions were cinnamyl ether <b>22</b> and ester <b>23</b>, for which at least 100-fold windows between cell activity and toxicity were observed.</div><div class="NLM_p">Added lipophilicity, as in compounds <b>17</b>–<b>25</b>, which had measured log <i>D</i><sub>7.4</sub> values of around 4 or greater, came at the price of decreased metabolic stability, as the data from rat hepatocytes demonstrated. Removal of the metabolically labile methylene in benzyl ether <b>24</b> led to phenylether <b>26</b> with a lower log <i>D</i><sub>7.4</sub> value (3.6) and improved stability compared with that of either <b>19</b> or <b>24</b>. Compound <b>26</b> behaved as an inverse agonist in the cell assay, where it exhibited an IC<sub>50</sub> of 190 nM and no sign of cytotoxicity. Further SAR around the 4-phenyl substituent eventually identified the trifluoromethoxy group as an optimal group in the para-position. Benzylether <b>27</b> combined potent inhibition of IL-17A production with a 100-fold window over cytotoxicity and reasonable stability in rat hepatocytes. The corresponding phenylether, <b>28</b>, showed further improvement in metabolic stability. It behaved like a weak partial inverse agonist in the FRET assay, like <b>26</b>, and suppressed IL-17A secretion with an IC<sub>50</sub> of 144 nM in the cell assay with no effect on cell viability.</div><div class="NLM_p">We were also able to identify an inverse agonist with a short alkoxy side-chain by converting the ethoxy group of <b>17</b> to a bulkier trifluoroethoxy group. Compound <b>29</b> was a potent inhibitor of IL-17 production with no sign of cytotoxicity. Adding the nitrile group to the 5-position resulted in <b>30</b>, showing a 10-fold increase in binding potency, an improvement in metabolic stability, and a slight increase in cell potency. The maximum achievable inhibition in the cell assay reached a plateau at 66%, and most compounds in this series, apart from ester <b>23</b>, did not completely abolish IL-17A production.</div><div class="NLM_p">We succeeded in soaking agonist <b>25</b> into the apo-crystal (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), and the only difference with respect to <b>10</b> concerned the orientation of the benzyl moiety. In compound <b>25</b>, the phenyl ring was tilted in comparison with <b>10</b>, filling a space between helices 11 and 7 and stabilizing the agonist form. Structurally related inverse agonists, such as <b>23</b>, <b>24</b>, or <b>27</b> would be expected to push against the AF2-domain in either conformation, which was confirmed by the cocrystal structure of <b>23</b>, described below. The side chain of <b>30</b> is too short to interact directly with the helix 11–helix 12 interface, but it seemed to disturb the conserved water when we modeled it into the structure. Release of this water might destabilize the AF2 domain, as recently described for <b>1</b>.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Ligand interaction near the His–Tyr lock based on the structure of <b>25</b> (1.82 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NIB">5NIB</a>). Compounds <b>10</b> (magenta), <b>25</b> (yellow), and <b>30</b> (gray, modeled on the basis of <b>8</b>) and key residues of the His–Tyr lock of RORγt LBD are shown as sticks. The ligands are only shown partially for clarity. The conserved water position is shown as a dotted sphere in red, and the position of the CF3 in <b>30</b> is shown as dotted spheres in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cocrystal structure of <b>23</b> with the native RORγt construct in the absence of coactivator peptide<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> showed that the major interactions of <b>23</b> were the same as those illustrated for <b>10</b> and <b>25</b>, except for the benzoate ester group. In the agonist form, this group would clash with His479, as hypothesized above and indicated in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a. Consequently, part of helix 11 and the entirety of helix 12 are disordered and are missing from the electron density in the structure.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ligand interaction of compound <b>23</b> in RORγt LBD (2.37 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGQ">6FGQ</a>). (a) Overlay of agonists <b>10</b> (magenta) and <b>25</b> (yellow) with inverse agonist <b>23</b> (orange). Key residues of the His–Tyr lock of RORγt LBD are shown as sticks. The ligands are only shown partially for clarity. The conserved water position is shown as a dotted sphere in red. Helix 12 and part of helix 11 are disordered (indicated in the dashed circle) when compound <b>23</b> is bound. The putative steric clash between <b>23</b> and the side chain of His479 (based on <b>10</b> and <b>25</b>) is shown as a red star (∼1.4 Å in between). (b) Overlay of RORγt complexes with digoxin (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B0W">3B0W</a>, blue), <b>10</b> (magenta), and <b>23</b> (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An overlay with the inverse-agonist structure of digoxin showed a steric clash of ester <b>23</b> with His479, which in the digoxin structure is pulled in by the ligand, establishing a hydrogen-bond to one of its sugar hydroxy groups.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This in turn “pushes” away part of helix 11 and all downstream residues. Overall, <b>23</b> seems to achieve the inverse-agonist effect in a similar way but without pulling in His479. Although we were not able to obtain a structure, we believe that phenylethers <b>26</b> and <b>28</b> exert their modes of action by related mechanisms. In summary, cell-active agonists and two different types of inverse agonists can be obtained from the same template by the introduction of relatively minor structural changes to the alkoxy substituent. Similar results have been reported for a variety of diverse RORγ modulators.<a onclick="showRef(event, 'ref39 ref52 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref39 ref52 ref57 ref58 ref59">(39,52,57−59)</a></div><div class="NLM_p">At this point, we had identified compounds <b>27</b>–<b>30</b>, which demonstrated potent inhibition of IL-17A release in primary human cells and showed good metabolic stability. However, they were still rather lipophilic, and attempts to introduce further polarity had failed. Fortunately, we were able to capitalize on a finding from our X-ray fragment screen.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In a number of structures, we had noted the presence of a DMSO site, which was near a conserved water position. The binding of DMSO occurred in a subpocket (a channel or “entrance” to the pocket), and its oxygen atom formed a hydrogen bond with the backbone NH of Glu379 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). We saw this as an opportunity to endow our inhibitors with polar functionality. Modeling indicated that the carbonyl oxygen atom of an acetamide attached to the benzylic position of the phenylacetamide moiety would be able to mimic that interaction. We incorporated the acetamide into a set of compounds containing diverse 4-aryl residues and found that this change was tolerated in all compounds investigated, leading to similar activity in SPA and FRET assays with respect to the parent compounds (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). A reduction in lipophilicity was also achieved, accompanied by a higher stability in rat hepatocytes. To our surprise, we found that compounds <b>31</b> and <b>32</b>, the analogues of <b>12</b> and <b>7</b>, respectively, also acquired activity in the cell assay, efficiently suppressing IL-17 production without an effect on cell viability. Compound <b>32</b> was about one order of magnitude more active than <b>31</b>, with an IC<sub>50</sub> of 57 nM. The unsubstituted amine, <b>33</b>, was significantly less potent in the binding and cell assays, indicating that the acetyl residue in <b>32</b> had formed the desired interaction.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structure overlay of RORγt in complex with compound <b>8</b> and PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G45">5G45</a> (fragment-bound). (a) Stick view. Compound <b>8</b> is shown as sticks with carbons in cyan, and the bound fragment and DMSO are shown with carbons in blue (DMSO depicted as sticks and spheres). (b) Surface view to illustrate the channel (“entrance”) to the LBD. The tethered SRC2 peptide is shown as a gray helix.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Incorporation of an Acetamide Residue in 4-Aryl-thienyl Acetamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0019.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0020.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Displacement of tritiated ligand from human RORγt LBD (geometric mean of <i>n</i> ≥ 2).</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Inhibition or activation of the recruitment of the SRC1-derived coactivator peptide (NCOA1, 677–700 aa) to human RORγt LBD (geometric mean of <i>n</i> ≥ 2). Negative percent-efficacy (% eff) values denote inverse agonism; positive values denote agonism and were determined at the maximum tested concentration.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Inhibition of IL-17 production from human primary T<sub>H</sub>17 cells (geometric mean of <i>n</i> ≥ 3). Negative values of percent efficacy signify inhibition of IL-17 production; positive values signify potentiation under the assay conditions. Effects of the compounds on cell viability and proliferation were assessed in the same assay with Cell-Titer-Glo measuring total ATP levels.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">Rat-hepatocyte intrinsic clearance (μL min<sup>–1</sup> (million cells)<sup>−1</sup>).</p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last">Distribution coefficient between 1-octanol and aqueous phosphate buffer at pH 7.4.</p></div><div class="footnote" id="t6fn6"><sup><sup>f</sup></sup><p class="last">Ligand lipophilic efficiency defined as SPA pIC<sub>50</sub> – log <i>D</i>.</p></div></div><div></div></div><div class="NLM_p">This assumption was ultimately confirmed by a cocrystal structure, which defined the (<i>R</i>)-isomer of <b>32</b> as the bound species (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). The interactions formed inside RORγt LBD are very similar to those described for compound <b>8</b> (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), with the addition of a hydrogen bond formed between the carbonyl oxygen of the acetamide moiety and the NH of Glu379. As seen in the structure of <b>8</b>, the methoxy residue is too short and does not interact with the helix 11–helix 12 interface. There is also no conformational change of the receptor apparent upon binding of the acetamide with respect to <b>8</b>, and on the basis of this structure, we cannot explain the improvements in cell potency of <b>31</b> and <b>32</b>. Hydrogen bonding to Glu379 was also described recently for 6-substituted quinolines and bisaryl carboxamides.<a onclick="showRef(event, 'ref35 ref60'); return false;" href="javascript:void(0);" class="ref ref35 ref60">(35,60)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Comparison of the RORγt complex with <b>32</b> (1.84 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ESN">6ESN</a>, carbons in yellow) with the observed DMSO (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G45">5G45</a>, carbons in blue) site in the X-ray screen. (a) Position of DMSO as observed in the fragment structure. (b) Binding mode of <b>32</b> depicted in the same orientation. The newly introduced carbamate group superimposes well with the DMSO position and engages in an H-bond with the backbone NH of Glu379.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Unlike <b>31</b> and <b>32</b>, which bear simple aryl groups in the 4-positions of the thiophenes, acetamides <b>34</b>–<b>36</b>, with more elaborate benzyl or aryl ether linkages, did not show gains in cell potency with respect to that of their parents. Cell potency remained unaltered for <b>35</b> and <b>36</b>, whereas for <b>34</b>, a slight 3-fold loss in potency, compared with that of <b>26</b>, was observed. The acetamide substitution also did not seem to affect the function of the compounds, because benzyl ether <b>37</b> still behaved as an agonist.</div><div class="NLM_p">Compound <b>35</b> was separated into its enantiomers <b>38</b> and <b>39</b>, with the former being about 100-fold more active in the binding and FRET assays. On the basis of an X-ray structure of <b>32</b>, <b>38</b> was assigned the (<i>R</i>)-configuration, and <b>39</b> was assigned the (<i>S</i>). Surprisingly, the latter inhibited IL-17 release in the cell assay with the same potency as <b>38</b>. We hypothesized that the stereocenter might racemize under the assay conditions and investigated this for <b>38</b> and <b>39</b>. The compounds were stable at pH 5, 7.4, and 8 at 37 °C over 2 days, but racemized in the medium of the T<sub>H</sub>17 assay, explaining the activity observed for <b>39</b> (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). In view of these results, it cannot be excluded that some racemization occurs also under the conditions of other in vitro or in vivo assays, and this should be considered when using these compounds.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Racemization of <b>37</b> and <b>38</b> under Different Conditions</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="char" char=":" /></col><col align="char" char=":" /></col><col align="char" char=":" /></col><col align="char" char=":" /></col><col align="char" char=":" /></col><col align="char" char=":" /></col><col align="char" char=":" /></col><col align="char" char=":" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=":">pH 5<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=":">pH 7.4<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=":">pH 8<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=":">X-vivo<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">time [h]</th><th class="colsep0 rowsep0" align="center" char=":"><b>38</b></th><th class="colsep0 rowsep0" align="center" char=":"><b>39</b></th><th class="colsep0 rowsep0" align="center" char=":"><b>38</b></th><th class="colsep0 rowsep0" align="center" char=":"><b>39</b></th><th class="colsep0 rowsep0" align="center" char=":"><b>38</b></th><th class="colsep0 rowsep0" align="center" char=":"><b>39</b></th><th class="colsep0 rowsep0" align="center" char=":"><b>38</b></th><th class="colsep0 rowsep0" align="center" char=":"><b>39</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">1–9</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">24</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">60:40</td><td class="colsep0 rowsep0" align="char" char=":">80:20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">48</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">99:1</td><td class="colsep0 rowsep0" align="char" char=":">50:50</td><td class="colsep0 rowsep0" align="char" char=":">70:30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">96</td><td class="colsep0 rowsep0" align="char" char=":">nd</td><td class="colsep0 rowsep0" align="char" char=":">nd</td><td class="colsep0 rowsep0" align="char" char=":">nd</td><td class="colsep0 rowsep0" align="char" char=":">nd</td><td class="colsep0 rowsep0" align="char" char=":">nd</td><td class="colsep0 rowsep0" align="char" char=":">nd</td><td class="colsep0 rowsep0" align="char" char=":">50:50</td><td class="colsep0 rowsep0" align="char" char=":">55:45</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Buffer solution (10 mL) and DMSO (0.5 mL) were added to the compound (5 mg), and the resulting slurry was stirred at 37 °C. A sample of the slurry (20 μL) was taken at the indicated time points, diluted with methanol (80 μL), and analyzed by supercritical-fluid chromatography (SFC).</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">The compound (5 mg) was dissolved in the X-vivo medium (5 mL) and stirred at 37 °C. A sample of the solution (100 μL) was added to dichloromethane (1 mL) and shaken for 10 s. The organic layer was transferred to a vial, evaporated to about 100 μL and analyzed by SFC (Chiralpak AS column, 3 μm, 150 × 4.6 mm i.d.; mobile phase of 25% ethanol in carbon dioxide at 120 bar; temperature of 40 °C; flow rate of 3.5 mL/min; <i>R</i><sub>t1</sub> = 1.6 min and <i>R</i><sub>t2</sub> = 2.2 min).</p></div></div></div><div class="NLM_p">On the basis of their favorable cell potencies and metabolic stabilities in rat hepatocytes, we further profiled compound <b>28</b> and three matched pairs with and without the acetamide residue (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). The introduction of the acetamide residue raised the polar surface area by about 30 Å<sup>2</sup>, lowered the log <i>P</i>, and increased the ligand efficiency (see also <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Profiles of Selected Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0021.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0022.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn2"><div class="footnote" id="t8fn2"><sup><sup>a</sup></sup><p class="last">Ligand lipophilic efficiency defined as SPA pIC<sub>50</sub> – clogP.</p></div><div class="footnote" id="t8fn1"><sup><sup>b</sup></sup><p class="last">Time-resolved (TR)-FRET assay in agonist (ag) and inverse-agonist (inv-ag) modes using a peptide derived from PGC1α 130–154.</p></div><div class="footnote" id="t8fn3"><sup><sup>c</sup></sup><p class="last">Scintillation proximity binding assay (SPA).</p></div><div class="footnote" id="t8fn4"><sup><sup>d</sup></sup><p class="last">Determined from DMSO stock solutions in aqueous buffer at pH 7.4.</p></div><div class="footnote" id="t8fn5"><sup><sup>e</sup></sup><p class="last">Bindung to human plasma protein determined by equilibrium dialysis.</p></div><div class="footnote" id="t8fn6"><sup><sup>f</sup></sup><p class="last">Rat or human hepatocyte intrinsic clearance (μL min<sup>–1</sup> (million cells)<sup>−1</sup>).</p></div><div class="footnote" id="t8fn7"><sup><sup>g</sup></sup><p class="last">Permeability measured in Caco2 cells at pH = 7.4/7.4.</p></div><div class="footnote" id="t8fn8"><sup><sup>h</sup></sup><p class="last">Compounds dosed to male Han Wistar rats (<i>n</i> = 2): iv dose of 0.5 mg/kg (solution in 5% DMSO and 95% SBE-B-CD (30%, w/v) in water) and oral dose of 1 mg/kg (solution in 33% DMA, 33% TEG, and 34% water or suspension in 0.5% HPMC and 0.1% Tween in water).</p></div></div><div></div></div><div class="NLM_p">The compounds tested were not active on RORα in a time-resolved FRET assay conducted in agonist mode. When tested in inverse-agonist mode, compounds <b>30</b>, <b>32</b>, and <b>38</b> showed micromolar activity, with <b>36</b> being the most active with an IC<sub>50</sub> of 0.6 μM. No activity could be detected for <b>27</b>, <b>32</b>, <b>36</b>, and <b>38</b> in a RORβ-binding assay. Solubility was low for all analogues, except for <b>32</b>, in which the acetamide improved solubility significantly with respect to that of <b>7</b>. All compounds showed very high affinities for plasma proteins, and moderate stability in human hepatocytes. Relatively high activity on the hERG channel was noticed for <b>7</b> and <b>30</b> when tested at a fixed concentration of 11 μM, and it was decreased to acceptable levels in the corresponding acetamides <b>32</b> and <b>36</b>.</div><div class="NLM_p">All compounds, apart from <b>36</b>, were profiled for their pharmacokinetic behavior in Han Wistar rats (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). Plasma clearances for the non-acetamide-containing compounds, <b>7</b>, <b>27</b>, <b>28</b>, and <b>30</b>, decreased from high for the benzyl ether, <b>27</b> (46.5 mL/min/kg), to very low for <b>7</b> and <b>30</b> (<1 mL/min/kg), in line with the intrinsic clearances observed in rat hepatocytes.</div><div class="NLM_p last">Compounds in this series were quite lipophilic, with some of them reaching the upper limit of our log <i>D</i> assay, making it difficult to explore correlations based on the log <i>D</i> values. However, using a calculated log <i>P</i> value (clogP) a decent linear correlation (<i>r</i><sup>2</sup> = 0.8) was found between metabolic stability in rat and lipophilicity. The volumes of the distribution values were surprisingly low for compounds <b>7</b>, <b>30</b>, and <b>32</b>. For such lipophilic and neutral compounds, a volume of around 1 L/kg is expected. The reason for such low volumes of distribution are not known. Derivative <b>7</b> had the highest oral bioavailability of the compounds tested, whereas <b>27</b>, <b>28</b>, and <b>30</b> demonstrated encouraging oral bioavailability with fraction-absorbed (<i>F</i><sub>abs</sub>) values equal to or above 30%. Acetamide <b>32</b> exhibited lower clearance in rat and in human hepatocytes but also a significantly diminished oral bioavailability compared with that of <b>7</b>. The same was observed for the pair <b>27</b> and <b>38</b>. Introduction of the acetamide residue clearly had a positive impact on activity and stability, but the added polarity had a negative impact on the oral bioavailability. Caco2 data for the matched pair <b>7</b> and <b>32</b> indicate, that compared with its precursor (<b>7</b>), <b>32</b> displayed significant efflux, which could explain its decreased bioavailability.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In conclusion, we have obtained a series of inverse agonists of the nuclear receptor RORγt by starting from the X-ray cocrystal structure of thienyl acetamide <b>1</b>. Simplification of <b>2</b> led to <b>3</b> and <b>8</b>, both of which were not active in a primary human-T<sub>H</sub>17-cell assay, despite good binding potency and functional activity in the FRET assay of <b>8</b>. The SAR investigations concentrated on the aryl group in the 4-position of the thiophene and were guided by available X-ray cocrystal structures of modulators bound in RORγt LBD. Functional activity in the cell assay seemed to depend on how groups filled the volume toward the cofactor recruitment site. The insights gained from these X-ray cocrystal structures will therefore be useful for the design of novel RORγt modulators. Larger aromatic groups interacting directly with the helix 11–helix 12 interface, as in <b>27</b> and <b>28</b>, or smaller trifluoroethyl groups, as in <b>29</b> or <b>30</b>, proved to be effective in suppressing IL-17 production in the primary human cells. The compounds also exhibited good pharmacokinetic profiles in rats.</div><div class="NLM_p last">In several X-ray structures, we had observed a DMSO molecule establishing a hydrogen bond to the protein backbone. On the basis of this observation, we designed an acetamide residue into our molecules to mimic this interaction. This resulted in compounds, that were potent in the cell assay, had lower lipophilicity, and showed improved metabolic stability. However, the added polarity impacted negatively on permeability, resulting in lower oral bioavailability in rats. Fortunately, the acetamide substitution endowed weakly active molecules, such as <b>7</b>, with activity in the cell assay, leading to a reduction in molecular complexity compared with that of <b>2</b> or <b>27</b>. Compound <b>32</b>, devoid of the larger aromatic functional triggers, combined favorable cell potency with good metabolic stability, selectivity against the hERG channel and the related ROR isoforms, and encouraging oral bioavailability in rat. This key compound presented the starting point for further investigations in this series, leading ultimately to the discovery of AZD0284 (structure to be disclosed), which is currently in Phase Ib clinical trials for the treatment of psoriasis.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18841" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18841" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For the broader investigation of the SAR of the 4-thienyl aryl substituent, a library of compounds was prepared by Suzuki–Miyaura coupling using commercially available boronic acids with acetamide <b>43</b>, which in turn was readily available from the coupling of amine <b>41</b> with 4-sulfonyl-phenylacetic acid, <b>42a</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Compound <b>43</b> also served as a precursor for the preparation of two advanced intermediates, fluoropyridine <b>44</b> and boronic ester <b>45</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Diverse Aryl-Substituted 4-Thienyl Acetamides from Intermediate <b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA, DCM; (b) EDC, 4-DMAP, DCM, 53%; (c) ArB(OH)<sub>2</sub> or Arpin, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (4:1), 80 °C.</p></p></figure><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Aryl-Substituted 4-Thienyl Acetamides from Intermediates <b>44</b> and <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-(Fluoropyridin-3-yl)boronic acid, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (4:1), 100 °C, 64%. (b) ROH, KO<sup>t</sup>Bu, THF, 80 °C. (c) PdCl<sub>2</sub>(dppf), B<sub>2</sub>Pin<sub>2</sub>, KOAc, dioxane, 100 °C, 54%. (d) <b>46b</b>, <b>c</b>, or <b>d</b>; PdCl<sub>2</sub>(dppf); K<sub>2</sub>CO<sub>3</sub>; DME/H<sub>2</sub>O (5:1); 130 °C; microwave. (e) <b>46a</b>: 4-iodophenol, KO<sup>t</sup>Bu, THF, microwave 140 °C, 41%; <b>46c</b>: (4-trifluoromethoxy)phenyl)-methanol, NaH, DMF, 80 °C, 49%; <b>46d</b>: (4-trifluoromethoxy)phenol, NaH, DMF, 80 °C, 70%. (f) CuCN, <span class="smallcaps smallerCapital">l</span>-proline, DMF, 100 °C, 52%.</p></p></figure><div class="NLM_p">Coupling of <b>43</b> with 2-(fluoropyrid-3-yl)boronic acid or bis-pinacolato-diboron yielded advanced intermediates <b>44</b> and <b>45</b>, respectively. Treatment of <b>44</b> with the appropriate alcohol under basic conditions furnished compounds <b>18</b>–<b>25</b> and <b>29</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The boronic ester, <b>45</b>, was coupled with halopyridines <b>46b</b>–<b>d</b> under palladium-catalyzed Suzuki-reaction conditions to provide compounds <b>26</b>–<b>28</b>.</div><div class="NLM_p">Several compounds were prepared by the coupling of 4-aryl-2-aminothiophens to the right-hand phenylacetic acid moiety, which is exemplified for compound <b>30</b> in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The synthesis of compounds <b>11</b> and <b>13</b>–<b>16</b> followed similar routes and is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf" class="ext-link">Supporting Information</a>. The preparation of building block <b>48a</b> followed the synthetic routes laid out in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Removal of the Boc protecting group from <b>48a</b> could be done with either TFA or with TBSOTf. When we used TBSOTf, less decomposition of the resulting aminothiophene, <b>49a</b>, was observed, and then <b>49a</b> was used directly in the coupling step to give <b>30</b>.</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PdCl<sub>2</sub>(dppf), B<sub>2</sub>Pin<sub>2</sub>, KOAc, dioxane, 70 °C, 64%; (b) PdCl<sub>2</sub>(dppf), <b>46e</b>, NaHCO<sub>3</sub>, dioxane/H<sub>2</sub>O, 90 °C, 81%; (c) TBSOTf, DCM, 0 °C to RT; (d) <b>42a</b>, EDC, DMAP, DCM, RT, 93%; (e) CF<sub>3</sub>CH<sub>2</sub>OH, KO<sup>t</sup>Bu, THF, RT, 93%.</p></p></figure><div class="NLM_p">The preparation of compounds bearing the acetamide side-chain and their respective building blocks is laid out in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> for analogues <b>32</b> and <b>35</b>. The phenylglycine derivative, <b>42b</b>, was prepared in five steps from 2-oxo-acetate <b>50</b>, and was subsequently coupled to aminothiophene <b>49b</b> or <b>49c</b>, to give, after protective-group manipulation, the compounds <b>32</b> and <b>35</b>. The synthesis of derivatives <b>31</b>, <b>34</b>, <b>36</b>, and <b>37</b> follows this sequence and is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf" class="ext-link">Supporting Information</a>. Enantiomers (+)-<b>38</b> and (−)-<b>39</b> were obtained by chiral SFC resolution.</div><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Acetamides <b>32</b>, <b>35</b>, <b>38</b>, and <b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>m</i>-CPBA, DCM 0 °C to RT, 88%; H<sub>2</sub>NOH·HCl, EtOH, 80 °C, quantitative. (b) Pd/C (10% Pd), H<sub>2</sub>, EtOH, RT; Boc<sub>2</sub>O, TEA, DCM, 57%; LiOH, THF, H<sub>2</sub>O, RT, 86%. (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O 130 °C, microwave, 66%. (d) PdCl<sub>2</sub>(dppf), <b>46c</b>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (4:1), 100 °C, 80%. (e) TBSOTf, DCM, 0 °C to RT. (f) <b>53a</b>: <b>42b</b>, <b>49b</b>, EDC, HOBt, DIPEA, DCM, RT, 65%; <b>53b</b>: <b>42b</b>, <b>49c</b>, TBTU, Et<sub>3</sub>N EDC, DCM, RT, 59%. (g) <b>32</b>: TBSOTf, DCM, RT, then DCM, AcCl, Et<sub>3</sub>N, 51%; <b>35</b>: HCl in dioxane, then py, Ac<sub>2</sub>O, RT, 67%. (h) Chiral supercritical-fluid chromatography (SFC), 30% <i>i</i>-PrOH in CO<sub>2</sub> (120 bar): <b>38</b> (42%), <b>39</b> (44%).</p></p></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Analytical Information</h3><div class="NLM_p last">NMR spectra were recorded on a Bruker Avance, Avance II, or Avance III spectrometer at a proton frequency of 300, 400, 500, or 600 MHz. The central peaks of chloroform-δ (H 7.26 ppm), CD<sub>3</sub>OD (H 3.30 ppm), or DMSO-<i>d</i><sub>6</sub> (H 2.49 ppm) were used as internal references. LC/MS experiments were performed using a Waters Acquity system combined with a Waters Xevo Q-ToF Mass or a Shimadzu 2010EV UPLC system in ESI mode. Preparative HPLC was performed with a Waters FractionLynx system with integrated MS detection and equipped with Prep C18 OBD 5 μm, 19 × 150 mm columns from X-Bridge or Sunfire. Alternatively, Gilson GX-281 with integrated UV detection was used, equipped with Kromasil C8 10 μm (either 20 × 250 mm i.d. or 50 × 250 mm i.d.). Preparative SCF was performed with a Waters Prep100 SCF system with integrated MS detection, equipped with Waters Viridis 2-EP or Phenomenex Luna Hilic, 30 × 250 mm, 5 μm. Eluent gradients of eluent A (CO<sub>2</sub>, 100 g/min, 120 bar, 40 °C, and MeOH/NH<sub>3</sub>, 20 mM, or MeOH, 5% formic acid) or eluent B (MeOH) were applied. Unless otherwise stated, starting materials were commercially available or previously described in the literature. All solvents and commercial reagents were of laboratory grade and were used as received unless otherwise stated.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis and Characterization of Compounds</h3><div class="NLM_p last">Described here is the chemical synthesis of representative examples <b>4</b>, <b>7</b>, <b>12</b>, <b>22</b>, <b>26</b>–<b>30</b>, <b>32</b>, <b>33</b>, <b>35</b>, <b>38</b>, and <b>39</b>. The synthesis and characterization of all other compounds and intermediates are available in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf" class="ext-link">Supporting Information</a>. The purities of the synthesized compounds were determined by LC/MS analysis. All compounds for biological testing were ≥95% pure.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-[4-(3-Chloro-5-cyano-phenyl)-2-thienyl]-2-(4-ethylsulfonylphenyl)acetamide (<b>4</b>)</h3><div id="sec5_2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Step 1: <i>N</i>-(4-Bromo-2-thienyl)-2-(4-ethylsulfonylphenyl)acetamide (<b>43</b>)</h4><div class="NLM_p last">4-Bromothiophen-2-amine (<b>41</b>, 7.80 g, 43.81 mmol) was added to <b>42a</b> (10 g, 43.81 mmol), EDC (8.40 g, 43.81 mmol), and DMAP (5.35 g, 43.81 mmol) in DCM (220 mL) under nitrogen. The resulting mixture was stirred at RT for 6 h. The reaction mixture was quenched with saturated NH<sub>4</sub>Cl (500 mL) and extracted with EtOAc (3 × 500 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a dark solid, which was purified by flash silica chromatography (20–80% EtOAc in petroleum ether). Pure fractions were evaporated to dryness to afford <b>43</b> (9.0 g, 53%) as a gray solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 1.31 (t, <i>J</i> = 7.5 Hz, 3H), 3.13 (q, <i>J</i> = 7.5 Hz, 2H), 3.80 (s, 2H), 6.58 (d, <i>J</i> = 1.6 Hz, 1H), 6.77 (d, <i>J</i> = 1.6 Hz, 1H), 7.46 (d, <i>J</i> = 8.4 Hz, 2H), 7.79 (d, <i>J</i> = 8.4 Hz, 2H), 8.79 (bs, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 388, 390 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Step 2: Synthesis of (<b>4</b>)</h4><div class="NLM_p last">To a round-bottom flask containing <b>43</b> (50 mg, 0.13 mmol) and 4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (102 mg, 0.39 mmol) were added potassium carbonate (53 mg, 0.39 mmol), dioxane (4 mL), and water (1 mL) under nitrogen. Pd(dppf)Cl<sub>2</sub> (DCM adduct, 5.3 mg, 6.4 μmol) was added to the resulting suspension, and the mixture was stirred under nitrogen for 12 h at 80 °C. The reaction mixture was cooled to ambient temperature, diluted with 30 mL of water, and extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with water (30 mL) and brine (30 mL). After drying over sodium sulfate and evaporation, the residue was applied onto a silica-gel column and eluted with EtOAc/petroleum ether (1:1) affording 30 mg (52%) of <b>4</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.10 (t, <i>J</i> = 7.4 Hz, 3H), 3.28 (q, <i>J</i> = 7.4 Hz, 2H), 3.86 (s, 2H), 7.14 (s, 1H), 7.54–7.67 (m, 3H), 7.85 (d, <i>J</i> = 8.2 Hz, 2H), 7.92 (s, 1H), 8.07 (s, 1H), 8.14 (s, 1H), 11.63 (s, 1H). <sup>13</sup>C NMR (126 MHz, DMSO): δ 7.2, 41.5, 49.2, 109.2, 113.7, 115.5, 117.6, 127.9, 128.1, 129.8, 130.1, 130.3, 134.3, 134.5, 137.0, 138.2, 140.8, 141.5, 166.9. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 445 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>21</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>3</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 445.0447, found 445.0464.</div></div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-[4-(5-Cyano-3-fluoro-2-methoxy-phenyl)-2-thienyl]-2-(4-ethylsulfonylphenyl)-acetamide (<b>7</b>)</h3><div class="NLM_p last">From <b>43</b> and 3-fluoro-4-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (<b>52</b>, see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf" class="ext-link">Supporting Information</a>); 17 mg (11%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.10 (t, <i>J</i> = 7.3 Hz, 3H), 3.28 (q, <i>J</i> = 7.3 Hz, 2H), 3.86 (s, 2H), 3.89 (d, <i>J</i> = 2.4 Hz, 3H), 7.09 (d, <i>J</i> = 1.7 Hz, 1H), 7.41 (d, <i>J</i> = 1.7 Hz, 1H), 7.61 (d, <i>J</i> = 8.3 Hz, 2H), 7.83–7.91 (m, 4H), 11.61 (s, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 459 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>22</sub>H<sub>20</sub>FN<sub>2</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 459.0848, found 459.0861.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-[4-(5-Cyano-2-methoxy-3-pyridyl)-2-thienyl]-2-(4-ethylsulfonylphenyl)acetamide (<b>12</b>)</h3><div class="NLM_p last">From <b>43</b> and (5-cyano-2-methoxypyridin-3-yl)boronic acid; 13 mg (5%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.10 (t, <i>J</i> = 7.3 Hz, 3H), 3.28 (q, <i>J</i> = 7.3 Hz, 2H), 3.86 (s, 2H), 4.03 (s, 3H), 7.16 (d, <i>J</i> = 1.2 Hz, 1H), 7.50 (d, <i>J</i> = 1.2 Hz, 1H), 7.60 (d, <i>J</i> = 8.2 Hz, 2H), 7.86 (d, <i>J</i> = 8.2 Hz, 2H), 8.37 (d, <i>J</i> = 2.0 Hz, 1H), 8.62 (d, <i>J</i> = 2.0 Hz, 1H), 11.60 (s, 1H). <sup>13</sup>C NMR (126 MHz, DMSO): δ 166.72, 161.84, 149.64, 141.52, 139.45, 139.38, 136.94, 130.46, 130.24, 127.88, 119.36, 117.43, 117.35, 111.22, 102.34, 54.47, 49.19, 41.58, 7.15. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 442 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 442.0895, found 442.0887.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-[4-[2-[(<i>E</i>)-Cinnamyl]oxy-3-pyridyl]-2-thienyl]-2-(4-ethylsulfonylphenyl)acetamide (<b>22</b>)</h3><div class="NLM_p last">Following the procedure described for <b>29</b>, compound <b>44</b> (0.37 mmol) and 1.5 equiv of (<i>E</i>)-3-phenylprop-2-en-1-ol were reacted to yield a crude product, which was purified by preparative HPLC (SunFire Prep C18 OBD column, 5 μm silica, 50 mm diameter, 150 mm length), using decreasingly polar mixtures of water (containing 0.05% NH<sub>4</sub>HCO<sub>3</sub>) and MeCN as eluents to afford <b>22</b> (89 mg, 46%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.09 (t, <i>J</i> = 7.3 Hz, 3H), 3.29 (q, <i>J</i> = 7.3 Hz, 2H), 3.85 (s, 2H), 5.09 (d, <i>J</i> = 5.8 Hz, 2H), 6.59 (dt, <i>J</i> = 5.8, 16.0 Hz, 1H), 6.76 (d, <i>J</i> = 16.0 Hz, 1H), 7.08 (dd, <i>J</i> = 4.9, 7.4 Hz, 1H), 7.17 (d, <i>J</i> = 2.3 Hz, 1H), 7.24–7.29 (m, 1H), 7.31–7.37 (m, 2H), 7.42 (d, <i>J</i> = 2.3 Hz, 1H), 7.50 (d, <i>J</i> = 7.5 Hz, 2H), 7.63 (d, <i>J</i> = 8.2 Hz, 2H), 7.88 (d, <i>J</i> = 8.2 Hz, 2H), 7.95 (dd, <i>J</i> = 1.8, 8.4 Hz, 1H), 8.16 (dd, <i>J</i> = 1.8, 4.9 Hz, 1H), 11.59 (s, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 519 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>28</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 519.1412, found 519.1414.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-[4-[2-(4-Cyanophenoxy)-3-pyridyl]-2-thienyl]-2-(4-ethylsulfonylphenyl)acetamide (<b>26</b>)</h3><div id="sec5_2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Step 1: 2-(4-Ethylsulfonylphenyl)-<i>N</i>-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-thienyl]acetamide (<b>45</b>)</h4><div class="NLM_p last">PdCl<sub>2</sub>(dppf) (DCM adduct, 1.052 g, 1.29 mmol) was added to <b>43</b> (10 g, 25.75 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (8.50 g, 33.48 mmol) and potassium acetate (7.58 g, 77.26 mmol) in 1,4-dioxane (200 mL) under nitrogen. The resulting mixture was stirred at 100 °C for 3 h. The reaction mixture was quenched with water (20 mL) and extracted with EtOAc (2 × 20 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a brown oil. The crude product was purified by flash silica chromatography (0–50% EtOAc in petroleum ether) to afford <b>45</b> (6.0 g, 54%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.09 (t, <i>J</i> = 7.3 Hz, 3H), 1.26 (s, 12H); 3.27 (q, <i>J</i> = 7.3 Hz, 2H), 3.84 (s, 2H), 6.81 (d, <i>J</i> = 1 Hz, 1H), 7.40 (s, 1H), 7.59 (d, <i>J</i> = 8.3 Hz, 2H), 7.85 (d, <i>J</i> = 8.3 Hz, 2H), 11.42 (bs, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 436 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Step 2: 4-((3-Bromopyridin-2-yl)oxy)benzonitrile (<b>46b</b>)</h4><div class="NLM_p last">KO<sup>t</sup>Bu (510 mg, 4.55 mmol), 3-bromo-2-chloropyridine (875 mg, 4.55 mmol), and 4-iodophenol (500 mg, 2.27 mmol) were dissolved in THF (12 mL) and sealed in a microwave tube. The reaction was heated to 140 °C for 150 min in the microwave reactor and cooled to RT. The reaction mixture was quenched with water (20 mL) and extracted with EtOAc (2 × 75 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford an orange oil, which was purified by flash silica chromatography (0–5% EtOAc in heptane) to give <b>46a</b> (350 mg, 41%) as a white solid. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 376 [M + H]<sup>+</sup>. (<i>S</i>)-Pyrrolidine-2-carboxylic acid (367 mg, 3.19 mmol) was added to CuCN (286 mg, 3.19 mmol) and <b>46a</b> (600 mg, 1.60 mmol) in DMF (10 mL) at ambient temperature under nitrogen. The resulting solution was stirred at 100 °C for 24 h. The reaction mixture was quenched with water (100 mL) and extracted with EtOAc (2 × 150 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a yellow oil. The crude product was purified by flash silica chromatography (0–25% EtOAc in pentane) to afford <b>46b</b> (230 mg, 52%) as a solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.20 (dd, <i>J</i> = 4.8, 7.8 Hz, 1H), 7.37 (d, <i>J</i> = 8.6 Hz, 2H), 7.92 (d, <i>J</i> = 8.6 Hz, 2H), 8.18 (d, <i>J</i> = 4.7 Hz, 1H), 8.26 (dd, <i>J</i> = 1.1, 7.8 Hz, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 275, 277 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step 3: Synthesis of <b>26</b></h4><div class="NLM_p last">PdCl<sub>2</sub>(dppf) (DCM-adduct, 68.3 mg, 0.08 mmol), K<sub>2</sub>CO<sub>3</sub> (231 mg, 1.67 mmol), <b>45</b> (546 mg, 1.25 mmol), and <b>46b</b> (230 mg, 0.84 mmol) were dissolved in DME (15 mL) and H<sub>2</sub>O (3.0 mL) and sealed in a microwave tube. The reaction was heated to 130 °C for 25 min in the microwave reactor and cooled to RT. The reaction mixture was quenched with water (5 mL) and extracted with EtOAc (2 × 100 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a yellow residue. The crude product was purified by flash C18-flash chromatography (0–100% MeCN in water) to afford <b>26</b> (60 mg, 14.3%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.09 (t, <i>J</i> = 7.3 Hz, 3H), 3.27 (q, <i>J</i> = 7.3 Hz, 2H), 3.83 (s, 2H), 7.15 (d, <i>J</i> = 1.7 Hz, 1H), 7.29 (dd, <i>J</i> = 4.9, 7.5 Hz, 1H), 7.32–7.39 (m, 2H), 7.43 (d, <i>J</i> = 1.7 Hz, 1H), 7.58 (d, <i>J</i> = 8.4 Hz, 2H), 7.85 (d, <i>J</i> = 8.4 Hz, 2H), 7.87–7.94 (m, 2H), 8.08–8.16 (m, 2H), 11.57 (s, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 504 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>26</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 502.0895, found 502.0873.</div></div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-(4-Ethylsulfonylphenyl)-<i>N</i>-[4-[2-[[4-(trifluoromethoxy)phenyl]methoxy]-3-pyridyl]-2-thienyl]acetamide (<b>27</b>)</h3><div id="sec5_2_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Step 1: 3-Iodo-2-((4-(trifluoromethoxy)benzyl)oxy)pyridine (<b>46c</b>)</h4><div class="NLM_p last">2-Fluoro-3-iodopyridine (9.05 g, 40.6 mmol) was added to a suspension of (4-(trifluoromethoxy)phenyl)-methanol (6.0 g, 31.23 mmol) and NaH (1.50 g, 37.47 mmol) in DMF (200 mL) cooled to 0 °C under nitrogen. The resulting mixture was stirred at 80 °C for 4 h. The reaction mixture was quenched with water (200 mL) and extracted with EtOAc (3 × 300 mL), and the organic layer was washed with water (3 × 50 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and evaporation afforded a brown oil, which was purified by C18-flash chromatography (20 to 100% MeCN in water) to afford <b>46c</b> (6.0 g, 48.6%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 5.43 (s, 2H), 6.82 (dd, <i>J</i> = 4.9, 7.5 Hz, 1H), 7.39 (d, <i>J</i> = 8.4 Hz, 2H), 7.59 (d, <i>J</i> = 8.4 Hz, 2H), 8.16 (dd, <i>J</i> = 1.5, 4.9 Hz, 1H), 8.23 (dd, <i>J</i> = 1.6, 7.5 Hz, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 396 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Step 2: Synthesis of <b>27</b></h4><div class="NLM_p last">Following the procedure for compound <b>26</b>, <b>46c</b> (300 mg, 0.76 mmol) was reacted with <b>45</b> (364 mg, 0.84 mmol). The crude product was purified by flash silica chromatography (0 to 50% EtOAc in petroleum ether) to afford <b>27</b> (290 mg, 66%) as a colorless solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.10 (t, <i>J</i> = 7.4 Hz, 3H), 3.28 (q, <i>J</i> = 7.4 Hz, 2H) 3.85 (s, 2H), 5.53 (s, 2H), 7.09 (dd, <i>J</i> = 4.9, 7.4 Hz, 1H), 7.16 (d, <i>J</i> = 1.6 Hz, 1H), 7.35–7.40 (m, 3H), 7.59 (d, <i>J</i> = 8.3 Hz, 2H), 7.61 (d, <i>J</i> = 8.1 Hz, 2H), 7.85 (d, <i>J</i> = 8.3 Hz, 2H), 7.94 (dd, <i>J</i> = 1.8, 7.4 Hz, 1H), 8.11 (dd, <i>J</i> = 1.7, 4.5 Hz, 1H), 11.57 (s, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 577 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>27</sub>H<sub>24</sub>F<sub>3</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 577.1078, found 577.1058.</div></div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-(4-Ethylsulfonylphenyl)-<i>N</i>-[4-[2-[[4-(trifluoromethoxy)phenoxy]-3-pyridyl]-2-thienyl]acetamide (<b>28</b>)</h3><div id="sec5_2_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Step 1: 3-Iodo-2-((4-(trifluoromethoxy)phenoxy)pyridine (<b>46d</b>)</h4><div class="NLM_p last">2-Fluoro-3-iodopyridine (100 mg, 0.45 mmol) was added to a suspension of (4-(trifluoromethoxy)phenol (88 mg, 0.49 mmol) and NaH (36 mg, 0.90 mmol) in DMF (4 mL) cooled to 0 °C under nitrogen. The resulting mixture was stirred at 80 °C for 4 h and then treated as described for the synthesis of <b>46c</b>. The crude product was purified by flash chromatography on silica gel (0–10% EtOAc in petroleum ether) to afford <b>46d</b> (120 mg, 70%) as a pale yellow solid. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 382 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Step 2: Synthesis of <b>28</b></h4><div class="NLM_p last">Following the procedure for compound <b>26</b>, <b>46d</b> (67 mg, 0.18 mmol) was reacted with <b>45</b> (70 mg, 0.16 mmol) in 1,4-dioxane (4 mL) and H<sub>2</sub>O (0.5 mL) in the presence of NaHCO<sub>3</sub> (27 mg, 0.32 mmol) at 100 °C for 3 h. The crude product was purified by flash silica chromatography (0 to 50% EtOAc in petroleum ether) to afford <b>28</b> (50 mg, 55%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.09 (t, <i>J</i> = 7.4 Hz, 3H), 3.27 (q, <i>J</i> = 7.4 Hz, 2H) 3.83 (s, 2H), 7.21 (d, <i>J</i> = 1.7 Hz, 1H), 7.23 (dd, <i>J</i> = 4.8, 7.5 Hz, 1H), 7.27–7.33 (m, 2H), 7.40–7.48 (m, 3H), 7.59 (d, <i>J</i> = 8.3 Hz, 2H), 7.85 (d, <i>J</i> = 8.3 Hz, 2H), 8.06 (dd, <i>J</i> = 1.8, 4.8 Hz, 1H), 8.09 (dd, <i>J</i> = 1.8, 7.5 Hz, 1H), 11.57 (s, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 563 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>26</sub>H<sub>22</sub>F<sub>3</sub>N<sub>2</sub>O<sub>5</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 563.0922, found 563.0956.</div></div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-[4-(5-Cyano-2-methoxy-3-pyridyl)-2-thienyl]-2-(4-ethylsulfonylphenyl)acetamide (<b>29</b>)</h3><div id="sec5_2_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Step 1: 2-(4-Ethylsulfonylphenyl)-<i>N</i>-[4-(2-fluoro-3-pyridyl)-2-thienyl]acetamide (<b>44</b>)</h4><div class="NLM_p last">To a flask containing a mixture of 1,4-dioxane (100 mL) and water (25 mL) at ambient temperature were added <b>43</b> (3.0 g, 7.73 mmol), (2-fluoropyridin-3-yl)boronic acid (1.63 g, 11.59 mmol), and K<sub>2</sub>CO<sub>3</sub> (2.14 g, 15.45 mmol). After 2 min of stirring, PdCl<sub>2</sub>(dppf) (DCM adduct, 0.315 g, 0.39 mmol) was added, and the mixture heated to 100 °C for 6 h. The reaction mixture was cooled to RT, diluted with EtOAc (500 mL), and washed sequentially with water (2 × 500 mL) and saturated brine (2 × 500 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a crude product, which was purified by flash silica chromatography (25–80% EtOAc in petroleum ether) to afford compound <b>44</b> (2.0 g, 64%) as a gray solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 1.30 (t, <i>J</i> = 7.4 Hz, 3H), 3.14 (q, <i>J</i> = 7.4 Hz, 2H), 3.87 (s, 2H), 7.02 (s, 1H), 7.22 (s, 1H), 7.22–7.26 (m, 1H), 7.54 (d, <i>J</i> = 8.1 Hz, 2H), 7.86 (d, <i>J</i> = 8.1 Hz, 2H), 7.91–7.95 (m, 1H), 8.12 (d, <i>J</i> = 4.5 Hz, 1H), 8.70 (bs, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 405 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Step 2: Synthesis of <b>29</b></h4><div class="NLM_p last">2,2,2-Trifluoroethanol (45 mg, 0.45 mmol) was added to <b>44</b> (90 mg, 0.22 mmol) and KO<sup>t</sup>Bu (50 mg, 0.45 mmol) in THF (5 mL) under nitrogen. The resulting mixture was stirred at 80 °C for 2 h, when LC/MS indicated consumption of <b>44</b>. The reaction mixture was cooled to ambient temperature, quenched with water (50 mL), and extracted with EtOAc (3 × 50 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford the crude product, which was first purified by flash C18-flash chromatography on a C18 cartridge (0–100% MeCN in water) and then purified further by preparative HPLC (Waters XBridge Prep C18 OBD column, 5 μm silica, 19 mm diameter, 100 mm length), using decreasingly polar mixtures of water containing 5% NH<sub>4</sub>HCO<sub>3</sub> and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford <b>29</b> (43 mg, 40%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.10 (t, <i>J</i> = 7.3 Hz, 3H), 3.28 (q, <i>J</i> = 7.3 Hz, 2H), 3.87 (s, 2H), 5.09 (q, <i>J</i> = 9.1 Hz, 2H), 7.10 (d, <i>J</i> = 1.6 Hz, 1H), 7.19 (dd, <i>J</i> = 4.9, 7.5 Hz, 1H), 7.33 (s, 1H), 7.61 (d, <i>J</i> = 8.3 Hz, 2H), 7.86 (d, <i>J</i> = 8.3 Hz, 2H), 8.01 (dd, <i>J</i> = 1.8, 7.5 Hz, 1H), 8.14 (dd, <i>J</i> = 1.7, 4.9 Hz, 1H), 11.60 (s, 1H). <sup>13</sup>C NMR (126 MHz, DMSO): δ 166.70, 157.20, 144.77, 141.57, 139.48, 138.18, 136.92, 131.71, 130.25, 127.87, 119.11, 118.67, 115.96, 111.06, 61.46 (q), 49.20, 41.53, 7.15. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 485 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>21</sub>H<sub>20</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 485.0816, found 485.0781.</div></div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-[4-[5-Cyano-2-(2,2,2-trifluoroethoxy)-3-pyridyl]-2-thienyl]-2-(4-ethylsulfonylphenyl) acetamide (<b>30</b>)</h3><div id="sec5_2_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Step 1: 5-Bromo-6-(2,2,2-trifluoroethoxy)nicotinonitrile (<b>46e</b>)</h4><div class="NLM_p last">5-Bromo-6-chloronicotinonitrile (300 mg, 1.38 mmol) was added to 2,2,2-trifluoroethanol (166 mg, 1.66 mmol) and KO<sup>t</sup>Bu (232 mg, 2.07 mmol) in THF (3 mL) at 0 °C. The resulting solution was stirred at ambient temperature for 12 h. The reaction mixture was diluted with EtOAc (100 mL) and washed with saturated brine (3 × 100 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a crude product, which was purified by flash silica chromatography (0–10% EtOAc in petroleum ether) to yield <b>46e</b> (360 mg, 93%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.86 (q, <i>J</i> = 8.2 Hz, 2H), 8.12 (d, <i>J</i> = 2.0 Hz, 1H), 8.41 (d, <i>J</i> = 2.0 Hz, 1H).</div></div><div id="sec5_2_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Step 2: <i>tert</i>-Butyl (4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)carbamate (<b>47</b>)</h4><div class="NLM_p last">Compound <b>40</b> (2.7 g, 9.71 mmol), KOAc (3.81 g, 38.83 mmol), and 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (7.39 g, 29.12 mmol) were dissolved in dioxane (10 mL) and stirred under nitrogen for 1 h. Pd(dppf)Cl<sub>2</sub> (0.793 g, 0.97 mmol) was added, and the vial was stirred for 24 h at 70 °C. The mixture was concentrated in vacuo and partitioned between DCM (100 mL) and H<sub>2</sub>O (100 mL). The organic layer was dried in a phase separator and concentrated. The residue was purified by automated flash chromatography on a Biotage KP-SIL 100 g column (0 to 25% EtOAc in heptane over 13 column volumes) to give <b>47</b> (2.0 g, 63%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 1.27 (s, 12H), 1.31 (s, 9H), 6.75 (d, <i>J</i> = 1.0 Hz, 1H), 6.86 (bs, 1H), 7.43 (d, <i>J</i> = 1.0 Hz, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 326 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Step 3: <i>tert</i>-Butyl (4-(5-Cyano-2-(2,2,2-trifluoroethoxy)pyridin-3-yl)thiophen-2-yl)carbamate (<b>48a</b>)</h4><div class="NLM_p last">PdCl2(dppf) (DCM-adduct, 90 mg, 0.11 mmol) was added to <b>47</b> (360 mg, 1.11 mmol), sodium hydrogen carbonate (232 mg, 2.77 mmol), and <b>46f</b> (373 mg, 1.33 mmol) in 1,4-dioxane (12 mL) and water (3 mL) at ambient temperature. The resulting solution was stirred at 90 °C for 12 h. The reaction mixture was diluted with EtOAc (100 mL) and washed with saturated brine (2 × 100 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a crude product, which was purified by flash silica chromatography (0–10% EtOAc in petroleum ether) to afford <b>48a</b> (360 mg, 81%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.55 (s, 9H), 4.89 (q, <i>J</i> = 8.4 Hz, 2H), 6.86 (s, 1H), 7.03 (bs, 1H), 7.29 (s, 1H), 8.00 (d, <i>J</i> = 1.9 Hz, 1H), 8.36 (d, <i>J</i> = 1.9 Hz, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 400.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Step 4: 5-(5-Aminothiophen-3-yl)-6-(2,2,2-trifluoroethoxy)nicotinonitrile (<b>49a</b>)</h4><div class="NLM_p last">TBSOTf (331 mg, 1.25 mmol) was added to <b>48a</b> (200 mg, 0.50 mmol) in DCM (10 mL) at 0 °C over a period of 3 min under nitrogen. The resulting solution was stirred at RT for 3 h. The reaction mixture was quenched with saturated NaHCO<sub>3</sub> (10 mL) and extracted with EtOAc (3 × 20 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford <b>49a</b> (220 mg, 147%) as a brown solid, which was used without further purification. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 300 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Step 5: Synthesis of <b>30</b></h4><div class="NLM_p last">Compound <b>49a</b> (60 mg, 0.20 mmol) was added to <b>41a</b> (50.3 mg, 0.22 mmol), DMAP (73.5 mg, 0.60 mmol), and EDC (50.0 mg, 0.26 mmol) in DCM (3 mL) under nitrogen. The resulting solution was stirred at RT for 2 h. The reaction mixture was quenched with saturated NH<sub>4</sub>Cl (15 mL) and extracted with DCM (3 × 15 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a brown oil. The crude product was purified by flash silica chromatography (0–40% EtOAc in petroleum ether) to afford <b>30</b> (95 mg, 93%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.10 (t, <i>J</i> = 7.4 Hz, 3H), 3.26 (q, <i>J</i> = 7.4 Hz, 2H) 3.88 (s, 2H), 5.17 (q, <i>J</i> = 8.9 Hz, 2H), 7.14 (d, <i>J</i> = 1.6 Hz, 1H), 7.46 (d, <i>J</i> = 1.6 Hz, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 2H), 7.85 (d, <i>J</i> = 8.3 Hz, 2H), 8.50 (d, <i>J</i> = 2.1 Hz, 1H), 8.67 (d, <i>J</i> = 2.1 Hz, 1H), 11.64 (bs, 1H). <sup>13</sup>C NMR (126 MHz, DMSO): δ 169.47, 166.66, 159.27, 149.29, 143.39, 140.83, 139.26, 138.18, 130.02, 128.36, 128.17, 122.74, 119.33, 117.98, 116.86, 111.78, 104.16, 62.36 (q), 55.96, 49.10, 22.28, 7.07. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 510 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>22</sub>H<sub>19</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub> [M+NH<sub>4</sub>]<sup>+</sup> calculated 527.1035, found 527.1074.</div></div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Acetamido-<i>N</i>-[4-(5-cyano-3-fluoro-2-methoxy-phenyl)-2-thienyl]-2-(4-ethylsulfonyl-phenyl)acetamide (<b>32</b>)</h3><div id="sec5_2_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Step 1: <i>tert</i>-Butyl (4-(5-Cyano-3-fluoro-2-methoxyphenyl)thiophen-2-yl)carbamate (<b>48b</b>)</h4><div class="NLM_p last">A mixture of <b>52</b> (1.2 g, 4.33 mmol), <b>40</b> (1.6 g, 5.63 mmol), Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.5 g, 0.43 mmol), and sodium carbonate (0.9 g, 8.66 mmol) in dioxane (20 mL) and water (5 mL) was stirred at 130 °C for 30 min in the microwave under nitrogen. The reaction mixture was diluted with water (20 mL) and extracted with EtOAc (3 × 50 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a crude product, which was purified by flash silica chromatography (5–20% EtOAc in petroleum ether). Pure fractions were evaporated to dryness to afford <b>48b</b> (1.0 g, 66.3%) as a brown solid. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 349 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.49 (s, 9H), 3.88 (s, 3H), 6.91 (d, <i>J</i> = 1.8 Hz, 1H), 7.35 (d, <i>J</i> = 1.8 Hz, 1H), 7.81–7.88 (m, 2H), 10.53 s, 1H).</div></div><div id="sec5_2_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Step 2: 2-Amino-<i>N</i>-(4-(5-cyano-3-fluoro-2-methoxyphenyl)thiophen-2-yl)propanamide (<b>49b</b>)</h4><div class="NLM_p last">TBSOTf (677 mg, 2.56 mmol) was added to <b>48b</b> (430 mg, 1.23 mmol) in DCM (20 mL) at 0 °C over a period of 2 min under nitrogen. The resulting solution was stirred at RT for 2 h. The reaction mixture was quenched with saturated NaHCO<sub>3</sub> (20 mL) and extracted with DCM (3 × 20 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford <b>49b</b> (300 mg, 92%) as a brown solid. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 249 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.91 (s, 3H), 5.66 (bs, 2H), 6.34 (d, <i>J</i> = 1.6 Hz, 1H), 6.90 (d, <i>J</i> = 1.6 Hz, 1H), 7.81 (d, <i>J</i> = 1.6 Hz, 1H), 7.85 (dd, <i>J</i> = 1.6, 11.2 Hz, 1H).</div></div><div id="sec5_2_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Step 3: <i>tert</i>-Butyl (2-{[4-(5-Cyano-3-fluoro-2-methoxyphenyl)thiophen-2-yl]amino}-1-[4-(ethylsulfonyl)phenyl]-2-oxoethyl)carbamate (<b>53a</b>)</h4><div class="NLM_p last">Compound <b>49b</b> (1.2 g, 4.85 mmol) was added to <b>42b</b> (2.0 g, 5.82 mmol, see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf" class="ext-link">Supporting Information</a>), DIPEA (1.5 g, 11.65 mmol), EDC (1.1 g, 5.82 mmol), and HOBt (0.9 g, 5.82 mmol) in DCM (20 mL) at 0 °C under nitrogen. The resulting mixture was stirred at RT for 16 h. The reaction mixture was quenched with saturated NH<sub>4</sub>Cl (2 mL) and extracted with DCM (3 × 10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford yellow solid, which was purified by flash silica chromatography (0 to 50% EtOAc in petroleum ether). Pure fractions were evaporated to dryness to afford <b>53a</b> (1.8 g, 64%) as a yellow solid. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 547 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.28 (t, <i>J</i> = 7.2 Hz, 3H), 1.48 (s, 9H), 3.14 (q, <i>J</i> = 7.6 Hz, 2H), 3.95 (s, 3H), 5.59 (bs, 1H), 5.95 (bs, 1H), 6.97 (s, 1H), 7.24 (s, 1H), 7.34 (dd, <i>J</i> = 2.0, 10.8 Hz, 1H), 7.50 (s, 1H), 7.69 (d, <i>J</i> = 8.0 Hz, 2H), 7.90 (d, <i>J</i> = 8.0 Hz, 2H), 9.35 (bs, 1H).</div></div><div id="sec5_2_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Step 4: 2-Amino-<i>N</i>-[4-(5-cyano-3-fluoro-2-methoxyphenyl)thiophen-2-yl]-2-[4-(ethyl-sulfonyl)phenyl]acetamide (<b>33</b>)</h4><div class="NLM_p last">TBSOTf (1.8 g, 6.97 mmol) was added to <b>53a</b> (1.6 g, 2.79 mmol) in DCM (20 mL) at 0 °C over a period of 3 min under nitrogen. The resulting solution was stirred at RT for 2 h. The reaction mixture was quenched with saturated NaHCO<sub>3</sub> (20 mL) and extracted with DCM (3 × 20 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford yellow solid. The crude product was purified by crystallization from EtOAc/petroleum ether to afford <b>33</b> (1.3 g, 98%) as a yellow solid. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 474 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 1.28 (t, <i>J</i> = 7.2 Hz, 3H), 1.96 (bs, 2H), 3.10 (q, <i>J</i> = 7.6 Hz, 2H), 3.85 (s, 3H), 4.88 (bs, 1H), 7.07 (s, 1H), 7.22 (s, 1H), 7.32 (dd, <i>J</i> = 1.6, 10.8 Hz, 1H), 7.53 (s, 1H), 7.67 (d, <i>J</i> = 8.0 Hz, 2H), 7.91 (d, <i>J</i> = 8.0 Hz, 2H), 10.18 (bs, 1H). HRMS (ES<sup>+</sup>) for C<sub>22</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 474.0957, found 474.0925.</div></div><div id="sec5_2_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Step 5: Synthesis of <b>32</b></h4><div class="NLM_p last">Compound <b>33</b> (0.025 g, 0.05 mmol) was dissolved in DCM (1 mL) and triethylamine (0.015 mL, 0.11 mmol). Acetyl chloride (1 M in DCM, 0.063 mL, 0.06 mmol) was added, and the resulting mixture was stirred at ambient temperature for 2 h. The reaction mixture was partitioned between dichloromethane (5 mL) and saturated NaHCO<sub>3</sub> (1 mL). The layers were separated in a phase separator, and the organic layer was concentrated under reduced pressure. The residue was dissolved in DMSO (1 mL), filtered, and purified by RP-HPLC to give <b>32</b> (14 mg, 51%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.10 (t, <i>J</i> = 7.3 Hz, 3H), 1.95 (s, 3H), 3.28 (q, <i>J</i> = 7.6 Hz, 2H), 3.89 (d, <i>J</i> = 2.1 Hz, 3H), 5.76 (d, <i>J</i> = 7.6 Hz, 1H), 7.11 (d, <i>J</i> = 1.7 Hz, 1H), 7.44 (d, <i>J</i> = 1.7 Hz, 1H), 7.72 (d, <i>J</i> = 8.3 Hz, 2H), 7.84–7.89 (m, 2H), 7.92 (d, <i>J</i> = 8.3 Hz, 2H), 8.93 (d, <i>J</i> = 7.6 Hz, 1H), 11.80 (s, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 516 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>24</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>5</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 516.1063, found 516.1060.</div></div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-Acetamido-2-(4-ethylsulfonylphenyl)-<i>N</i>-[4-[2-[[4-(trifluoromethoxy)phenyl]methoxy]-3-pyridyl]-2-thienyl]acetamide (<b>35</b>)</h3><div id="sec5_2_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Step 1: <i>tert</i>-Butyl <i>N</i>-[4-[2-[[4-(Trifluoromethoxy)-phenyl]methoxy]-3-pyridyl]-2-thienyl]carbamate (<b>48c</b>)</h4><div class="NLM_p last">PdCl<sub>2</sub>(dppf) (0.41 g, 0.51 mmol) was added to a mixture of <b>46c</b> (4.0 g, 10.12 mmol), <b>47</b> (3.95 g, 12.15 mmol), and K<sub>2</sub>CO<sub>3</sub> (2.80 g, 20.25 mmol) in 1,4-dioxane (80 mL) and water (20 mL) under nitrogen. The resulting mixture was stirred at 100 °C for 4 h. The reaction mixture was diluted with EtOAc (400 mL) and washed sequentially with water (2 × 500 mL) and saturated brine (2 × 500 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to afford a crude product, which was purified by flash silica chromatography (0–10% EtOAc in petroleum ether) to give <b>48c</b> (3.80 g, 80%) as a yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.49 (s, 9H), 5.51 (s, 2H), 7.01 (d, <i>J</i> = 1.7, 1H), 7.08 (dd, <i>J</i> = 4.9, 7.4 Hz, 1H), 7.29 (d, <i>J</i> = 1.6 Hz, 1H), 7.37 (d, <i>J</i> = 7.9 Hz, 2H), 7.60 (d, <i>J</i> = 8.5 Hz, 2H), 7.87 (dd, <i>J</i> = 1.8, 7.5 Hz, 1H), 8.09 (dd, <i>J</i> = 1.8, 4.9 Hz, 1H), 10.50 (s, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 467 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Step 2: 4-[2-[[4-(Trifluoromethoxy)phenyl]methoxy]-3-pyridyl]thiophen-2-amine (<b>49c</b>)</h4><div class="NLM_p last">TBSOTf (0.985 mL, 4.29 mmol) was added dropwise to <b>48c</b> (500 mg, 1.07 mmol) in DCM (40 mL), and the mixture was stirred at RT for 20 min. The reaction mixture was washed with NaOH (1 M, 2 × 30 mL), dried in a phase separator, and concentrated to give crude <b>49c</b> (393 mg, 100%). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 368 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Step 3: <i>tert</i>-Butyl (1-[4-(Ethylsulfonyl)phenyl]-2-oxo-2-{[4-(2-{[4-(trifluoromethoxy)benzyl]-oxy}pyridin-3-yl)thiophen-2-yl]amino}ethyl)carbamate (<b>53b</b>)</h4><div class="NLM_p last">Compounds <b>49c</b> (392 mg, 1.07 mmol) and <b>42b</b> (441 mg, 1.28 mmol) were dissolved in DCM (20 mL), and Et<sub>3</sub>N (0.447 mL, 3.21 mmol) and TBTU (515 mg, 1.61 mmol) were added. The resulting mixture was stirred at RT for 2 h. The reaction mixture was washed with NaHCO<sub>3</sub> (10 mL) and concentrated. The residue was purified by preparative HPLC (XBridge C18 column (10 μm, 250 × 50 mm i.d.); gradient of 35–95% acetonitrile in H<sub>2</sub>O/ACN/NH<sub>3</sub> = 95/5/0.2 buffer) to give <b>53b</b> (440 mg, 59%). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 692.7 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (600 MHz, DMSO): δ 1.08 (t, <i>J</i> = 7.4, 3H), 1.40 (s, 9H), 3.27 (q, <i>J</i> = 7.4, 2H), 5.48–5.54 (m, 3H), 7.08 (dd, <i>J</i> = 4.9, 7.4, 1H), 7.19 (d, <i>J</i> = 1.5, 1H), 7.34–7.39 (m, 3H), 7.56–7.59 (m, 2H), 7.73 (d, <i>J</i> = 8.3, 2H), 7.87–7.93 (m, 4H), 8.10 (dd, <i>J</i> = 1.8, 4.9, 1H), 11.67 (s, 1H).</div></div><div id="sec5_2_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Step 4: 2-Amino-2-[4-(ethylsulfonyl)phenyl]-<i>N</i>-[4-(2-{[4-(trifluoromethoxy)benzyl]oxy}-pyridin-3-yl)thiophen-2-yl]acetamide (<b>54</b>)</h4><div class="NLM_p last">Compound <b>53b</b> (420 mg, 0.61 mmol) was dissolved in DCM (20 mL), and HCl in dioxane (4M, 5 mL, 20 mmol) was added. The reaction mixture was stirred for 1 h at RT and then concentrated to give the crude amine (380 mg, 100%). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 592 [M + H]<sup>+</sup>. A small sample was purified by preparative HPLC to give <b>54</b> as a solid. <sup>1</sup>H NMR (600 MHz, DMSO): δ 1.09 (t, <i>J</i> = 7.4, 3H), 3.26 (q, <i>J</i> = 7.3, 2H), 4.75 (s, 1H), 5.52 (s, 2H), 7.08 (dd, <i>J</i> = 4.9, 7.4, 1H), 7.27 (d, <i>J</i> = 1.74, 1H), 7.36 (s, 1H), 7.36–7.38 (m, 2H), 7.57–7.6 (m, 2H), 7.73–7.76 (m, 2H), 7.86–7.88 (m, 2H), 7.91 (dd, <i>J</i> = 1.8, 7.5, 1H), 8.10 (dd, <i>J</i> = 1.8, 4.9, 1H).</div></div><div id="sec5_2_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Step 5: Synthesis of <b>35</b></h4><div class="NLM_p">Amine <b>54</b> (90 mg, 0.15 mmol) was dissolved in pyridine (1 mL), Ac<sub>2</sub>O (0.014 mL, 0.15 mmol) was added, and the mixture was stirred for 5 min at RT. The mixture was concentrated, and the residue was purified by automated flash chromatography on a Biotage KP-SIL column (gradient 30–100% EtOAc). Fractions containing the product were evaporated to give <b>35</b> (65 mg, 67%) as a solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 1.22 (t, <i>J</i> = 7.4, 3H), 2.12 (s, 3H), 3.04 (q, <i>J</i> = 7.4, 2H), 5.46 (d, <i>J</i> = 12.9, 1H), 5.50 (d, <i>J</i> = 12.9, 1H), 6.14 (d, <i>J</i> = 7.6, 1H), 6.93 (dd, <i>J</i> = 7.4, 5.0, 1H), 7.03 (d, <i>J</i> = 1.7, 1H), 7.14–7.18 (m, 2H), 7.25–7.27 (m, 1H), 7.33 (d, <i>J</i> = 7.6, 1H), 7.42–7.46 (m, 2H), 7.64–7.7 (m, 3H), 7.76–7.8 (m, 2H), 8.07 (dd, <i>J</i> = 5.0, 1.8, 1H), 10.41 (s, 1H). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 635 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>29</sub>H<sub>27</sub>F<sub>3</sub>N<sub>3</sub>O<sub>6</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 634.1293, found 634.1281.</div><div class="NLM_p">The enantiomers of <b>35</b> (180 mg) were separated by preparative chromatography on a Supersep 600 SFC system from Novasep with a Chiralpak ID column (5 μm, 250 × 30 mm i.d.) and a mobile phase of 30% 2-propanol in carbon dioxide (120 bar). The temperature was 40 °C, the flow rate was 160 mL/min, and the injection volume was 2 mL of a 36 mg/mL EtOH/DCM solution (1:1).</div><div class="NLM_p">Isomer 1 (peak 1): (2<i>R</i>)-2-Acetamido-2-(4-ethylsulfonylphenyl)-<i>N</i>-[4-[2-[[4-(trifluoromethoxy)phenyl]methoxy]-3-pyridyl]-2-thienyl]acetamide (<b>38</b>), 75 mg (98.7% ee by analytical chiral SFC). [α]<sub>D</sub><sup>589</sup> +6° (<i>c</i> = 1, CH<sub>3</sub>CN). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 1.26 (t, <i>J</i> = 7.4 Hz, 3H), 2.11 (s, 3H), 3.09 (q, <i>J</i> = 7.4 Hz, 2H), 5.50 (q, <i>J</i> = 12.8 Hz, 2H), 6.17 (d, <i>J</i> = 7.6 Hz, 1H), 6.94 (dd, <i>J</i> = 5.0, 7.4 Hz, 1H), 7.13 (d, <i>J</i> = 1.5 Hz, 2H), 7.17 (d, <i>J</i> = 8.1 Hz, 2H), 7.34 (d, <i>J</i> = 7.6 Hz, 1H), 7.43–7.46 (m, 2H), 7.70 (dd, <i>J</i> = 1.7, 7.4 Hz, 1H), 7.73 (q, <i>J</i> = 8.4 Hz, 4H), 8.07 (dd, <i>J</i> = 1.7, 5.0 Hz, 1H), 10.48 (s, 1H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 171, 165.9, 159.5, 148.8, 148.8, 144.7, 143.1, 138.9, 138.1, 137.6, 136.1, 133.1, 129.2, 129.0, 128.2, 121.1, 119.4, 117.7, 117.4, 113.7, 67.4, 56.5, 50.7, 23.4, 7.5. LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 635 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>29</sub>H<sub>27</sub>F<sub>3</sub>N<sub>3</sub>O<sub>6</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 634.1293, found 634.1319.</div><div class="NLM_p last">Isomer 2 (peak 2): (2<i>S</i>)-2-Acetamido-2-(4-ethylsulfonylphenyl)-<i>N</i>-[4-[2-[[4-(trifluoromethoxy)phenyl]methoxy]-3-pyridyl]-2-thienyl]acetamide (<b>39</b>), 80 mg (99.8% ee by analytical chiral SFC). [α]<sub>D</sub><sup>589</sup> −6° (<i>c</i> = 1, CH<sub>3</sub>CN). LC/MS ES<sup>+</sup><i>m</i>/<i>z</i> = 635 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>) for C<sub>29</sub>H<sub>2/</sub>F<sub>3</sub>N<sub>3</sub>O<sub>6</sub>S<sub>2</sub> [M + H]<sup>+</sup> calculated 634.1293, found 634.1313.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> X-ray Analysis of Ligand Complexes</h3><div class="NLM_p last">Protein-production and -crystallization conditions have been previously described.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> A general description as well as a table containing the data and refinement statistics can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Assays</h3><div class="NLM_p last">The conditions for the RORγ SPA and FRET assays have been previously described and can also be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf" class="ext-link">Supporting Information</a>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The RORα and RORβ assays are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Inhibition of IL-17 Release from Human T<sub>H</sub>17 Cells</h3><div class="NLM_p">Peripheral-blood mononuclear cells (PBMC) were isolated from heparin-treated human whole blood from healthy donors by density-gradient centrifugation. T<sub>H</sub>17 cells (CD4<sup>+</sup>CXCR3<sup>–</sup>CCR6<sup>+</sup>) were enriched using a human T<sub>H</sub>17 Cell Enrichment Kit (Stemcell Technologies) according to the manufacturer’s protocol. The isolated T<sub>H</sub>17 cells were activated with aCD2aCD3aCD28 beads (MACS Miltenyi) and cultured in X-Vivo15 medium (Lonza) supplemented with <span class="smallcaps smallerCapital">l</span>-glutamine, β-mercaptoethanol, and a cytokine cocktail consisting of IL-2, IL-23, IL-1β, IL-6, and TGF-β. Cells were seeded at 8000 cells/well in a 384-plate (Corning, #3707) in the presence of compounds or DMSO and cultured for 4 days (37 °C, 5% CO<sub>2</sub>). On day 4, supernatants were collected, and IL-17A was measured using a Human IL-17 HTRF Assay kit (Cisbio Bioassays) according to the manufacturer’s protocol. The IC<sub>50</sub> values for the tested compounds was calculated using Genedata Screener software using the following calculation method:<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_m001.gif" alt="" id="_i61" /></img></span>where <i>X</i> represents the normalized value for the compound based on the min and max inhibition controls (DMSO and 10 μM 3-(benzo[<i>d</i>][1,3]dioxol-5-yl)-1-(3,5-dimethylpiperidin-1-yl)-3-(2-hydroxy-4,6-dimethoxyphenyl)propan-1-one, respectively).</div><div class="NLM_p last">In addition, the cytotoxic effects of the compounds were evaluated on cell plates (after the removal of cell media supernatants for IL-17 analysis) using the CellTiter-Glo Luminescent Cell Viability assay (Promega), which measured ATP levels, indicating the presence of metabolically active cells.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00783" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00783" class="ext-link">10.1021/acs.jmedchem.8b00783</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular-formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Synthetic routes and characterization for final compounds <b>5</b>, <b>6</b>, <b>8</b>–<b>11</b>, <b>13</b>–<b>21</b>, <b>23</b>–<b>25</b>, <b>31</b>, <b>34</b>, <b>36</b>, and <b>37</b> and their intermediates; protein-production protocols; assay procedures; and information on the X-ray crystallographic analysis (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_001.csv">jm8b00783_si_001.csv (2.69 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf">jm8b00783_si_002.pdf (0.99 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors are deposited in the Protein Data Bank and will be released upon publication. PDB IDs have been provided in figure legends (<b>1</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI5">5NI5</a>; <b>8</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI7">5NI7</a>; <b>10</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI8">5NI8</a>; <b>23</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGQ">6FGQ</a>; <b>25</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NIB">5NIB</a>; <b>32</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ESN">6ESN</a>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00783" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21232" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21232" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Narjes</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3104-7771" title="Orcid link">http://orcid.org/0000-0002-3104-7771</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f6908497989dd89897849c9385b697858284978c9398939597d895999b"><span class="__cf_email__" data-cfemail="fb9d899a9590d5959a89919e88bb9a888f899a819e959e989ad5989496">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yafeng Xue</span> - <span class="hlFld-Affiliation affiliation">Structure, Biophysics & FBLG and , Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan von Berg</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jesper Malmberg</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Llinas</span> - <span class="hlFld-Affiliation affiliation">DMPK, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4620-9363" title="Orcid link">http://orcid.org/0000-0003-4620-9363</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roine I. Olsson</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johan Jirholt</span> - <span class="hlFld-Affiliation affiliation">Bioscience, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanna Grindebacke</span> - <span class="hlFld-Affiliation affiliation">Bioscience, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agnes Leffler</span> - <span class="hlFld-Affiliation affiliation">Bioscience, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nafizal Hossain</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matti Lepistö</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linda Thunberg</span> - <span class="hlFld-Affiliation affiliation">Early
Product Development, Pharmaceutical Sciences,
IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanna Leek</span> - <span class="hlFld-Affiliation affiliation">Early
Product Development, Pharmaceutical Sciences,
IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Aagaard</span> - <span class="hlFld-Affiliation affiliation">Structure, Biophysics & FBLG and , Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane McPheat</span> - <span class="hlFld-Affiliation affiliation">Mechanistic Biology and Profiling and , Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva L. Hansson</span> - <span class="hlFld-Affiliation affiliation">Mechanistic Biology and Profiling and , Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabeth Bäck</span> - <span class="hlFld-Affiliation affiliation">Mechanistic Biology and Profiling and , Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Tångefjord</span> - <span class="hlFld-Affiliation affiliation">Structure, Biophysics & FBLG and , Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rongfeng Chen</span> - <span class="hlFld-Affiliation affiliation">Pharmaron
Beijing Company, Ltd., Taihe Road, BDA, Beijing 100176, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yao Xiong</span> - <span class="hlFld-Affiliation affiliation">Pharmaron
Beijing Company, Ltd., Taihe Road, BDA, Beijing 100176, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ge Hongbin</span> - <span class="hlFld-Affiliation affiliation">Pharmaron
Beijing Company, Ltd., Taihe Road, BDA, Beijing 100176, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas G. Hansson</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , and , Respiratory,
Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, SE-43183 Mölndal, Sweden</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">All authors except R.P.L. were AstraZeneca full-time employees when this study was performed. All rat experiments were approved by the Pharmaron’s Institutional Animal Care and Use Committee (IACUC) and by the Gothenburg Ethics Committee for Experimental Animals, Sweden; both conform to Directive 2010/63/EU. Animal handling conformed to standards established by the Council of Europe ETS123 AppA, NIH guidelines on animal welfare, Chinese legislation, Pharmaron’s IACUC policies and procedures, the Helsinki Convention for the Use and Care of Animals, Swedish legislation, and AstraZeneca Global Internal Standards.<br /></br>The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6231-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06820" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06820" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank the analytical- and separation-science teams at Gothenburg for the purification of the final compounds and analytical support. We are also grateful to David Keeling and Emma Winship for proof-reading the manuscript and stimulating discussions.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence-resonance-energy transfer</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand-binding domain</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">PgP</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">ROR</td><td class="NLM_def"><p class="first last">retinoic acid receptor related orphan receptor</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SPA</td><td class="NLM_def"><p class="first last">scintillation proximity assay</p></td></tr><tr><td class="NLM_term">SRC</td><td class="NLM_def"><p class="first last">steroid-receptor coactivator</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 60 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism</span>. <i>Nucl. Recept. Signal.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1621%2Fnrs.07003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=19381306" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&author=A.+M.+Jetten&title=Retinoid-related+orphan+receptors+%28RORs%29%3A+critical+roles+in+development%2C+immunity%2C+circadian+rhythm%2C+and+cellular+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1621%2Fnrs.07003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1621%252Fnrs.07003%26sid%3Dliteratum%253Aachs%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DRetinoid-related%2520orphan%2520receptors%2520%2528RORs%2529%253A%2520critical%2520roles%2520in%2520development%252C%2520immunity%252C%2520circadian%2520rhythm%252C%2520and%2520cellular%2520metabolism%26jtitle%3DNucl.%2520Recept.%2520Signal.%26date%3D2009%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tato, C. M.</span></span> <span> </span><span class="NLM_article-title">Innate IL-17-producing cells: the sentinels of the immune system</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1038/nri2800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnri2800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=20559326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=479-489&author=D.+J.+Cuaauthor=C.+M.+Tato&title=Innate+IL-17-producing+cells%3A+the+sentinels+of+the+immune+system&doi=10.1038%2Fnri2800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Innate IL-17-producing cells: the sentinels of the immune system</span></div><div class="casAuthors">Cua, Daniel J.; Tato, Cristina M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">479-489</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The cytokine interleukin-17 (IL-17) has received considerable attention since the discovery of a distinct CD4+ T helper (TH) cell subset that produces it, known as the TH17 cell subset.  Despite the fact that most of the recent literature describes IL-17 as a T cell-secreted cytokine, much of the IL-17 released during an inflammatory response is produced by innate immune cells.  In this Review, we explore the many innate immune cell populations that are an early source of IL-17 in response to stress, injury or pathogens.  These early sources have been shown to have a central role in the initiation of IL-17-dependent immune responses, even before the first CD4+T cell sees its cognate antigen and initiates the TH17 cell developmental program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8LPNpjMbg57Vg90H21EOLACvtfcHk0ljuZQguFTu_3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKjtr0%253D&md5=f51e10df5c5d510d599e2bf88f349d55</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnri2800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2800%26sid%3Dliteratum%253Aachs%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DTato%26aufirst%3DC.%2BM.%26atitle%3DInnate%2520IL-17-producing%2520cells%253A%2520the%2520sentinels%2520of%2520the%2520immune%2520system%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D479%26epage%3D489%26doi%3D10.1038%2Fnri2800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">RORγ: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>205</i></span>,  <span class="NLM_fpage">1976</span>– <span class="NLM_lpage">1983</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1994.2902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1006%2Fbbrc.1994.2902" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1994&pages=1976-1983&author=T.+Hiroseauthor=R.+J.+Smithauthor=A.+M.+Jetten&title=ROR%CE%B3%3A+the+third+member+of+ROR%2FRZR+orphan+receptor+subfamily+that+is+highly+expressed+in+skeletal+muscle&doi=10.1006%2Fbbrc.1994.2902"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1994.2902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1994.2902%26sid%3Dliteratum%253Aachs%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DR.%2BJ.%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DROR%25CE%25B3%253A%2520the%2520third%2520member%2520of%2520ROR%252FRZR%2520orphan%2520receptor%2520subfamily%2520that%2520is%2520highly%2520expressed%2520in%2520skeletal%2520muscle%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1994%26volume%3D205%26spage%3D1976%26epage%3D1983%26doi%3D10.1006%2Fbbrc.1994.2902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepelley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.cell.2006.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=16990136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=1121-1133&author=I.+I.+Ivanovauthor=B.+S.+McKenzieauthor=L.+Zhouauthor=C.+E.+Tadokoroauthor=A.+Lepelleyauthor=J.+J.+Lafailleauthor=D.+J.+Cuaauthor=D.+R.+Littman&title=The+orphan+nuclear+receptor+ROR%CE%B3t+directs+the+differentiation+program+of+proinflammatory+IL-17%2B+T+helper+cells&doi=10.1016%2Fj.cell.2006.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells</span></div><div class="casAuthors">Ivanov, Ivaylo I.; McKenzie, Brent S.; Zhou, Liang; Tadokoro, Carlos E.; Lepelley, Alice; Lafaille, Juan J.; Cua, Daniel J.; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1133</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease.  The authors show here that the orphan nuclear receptor RORγt is the key transcription factor that orchestrates the differentiation of this effector cell lineage.  RORγt induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naive CD4+ T helper cells and is required for their expression in response to IL-6 and TGF-β, the cytokines known to induce IL-17.  Th17 cells are constitutively present throughout the intestinal lamina propria, express RORγt, and are absent in mice deficient for RORγt or IL-6.  Mice with RORγt-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells.  Together, these studies suggest that RORγt is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYsJd6RyFqWrVg90H21EOLACvtfcHk0ljdkZyt_3wO3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE&md5=4f5693603c30dca4f6a2d0994aeaf9b0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aufirst%3DI.%2BI.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTadokoro%26aufirst%3DC.%2BE.%26aulast%3DLepelley%26aufirst%3DA.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520orphan%2520nuclear%2520receptor%2520ROR%25CE%25B3t%2520directs%2520the%2520differentiation%2520program%2520of%2520proinflammatory%2520IL-17%252B%2520T%2520helper%2520cells%26jtitle%3DCell%26date%3D2006%26volume%3D126%26spage%3D1121%26epage%3D1133%26doi%3D10.1016%2Fj.cell.2006.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">Retinoic Acid-Related Orphan Receptors (RORs): Regulatory Functions in Immunity, Development, Circadian Rhythm, and Metabolism</span>. <i>Nucl. Receptor Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">101185</span> <span class="refDoi"> DOI: 10.11131/2015/101185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.11131%2F2015%2F101185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=26878025" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&author=D.+N.+Cookauthor=H.+S.+Kangauthor=A.+M.+Jetten&title=Retinoic+Acid-Related+Orphan+Receptors+%28RORs%29%3A+Regulatory+Functions+in+Immunity%2C+Development%2C+Circadian+Rhythm%2C+and+Metabolism&doi=10.11131%2F2015%2F101185"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.11131%2F2015%2F101185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.11131%252F2015%252F101185%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DD.%2BN.%26aulast%3DKang%26aufirst%3DH.%2BS.%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DRetinoic%2520Acid-Related%2520Orphan%2520Receptors%2520%2528RORs%2529%253A%2520Regulatory%2520Functions%2520in%2520Immunity%252C%2520Development%252C%2520Circadian%2520Rhythm%252C%2520and%2520Metabolism%26jtitle%3DNucl.%2520Receptor%2520Res.%26date%3D2015%26volume%3D2%26doi%3D10.11131%2F2015%2F101185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oukka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">IL-17 and Th17 Cells</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.021908.132710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1146%2Fannurev.immunol.021908.132710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=19132915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=485-517&author=T.+Kornauthor=E.+Bettelliauthor=M.+Oukkaauthor=V.+K.+Kuchroo&title=IL-17+and+Th17+Cells&doi=10.1146%2Fannurev.immunol.021908.132710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">IL-17 and Th17 cells</span></div><div class="casAuthors">Korn, Thomas; Bettelli, Estelle; Oukka, Mohamed; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">485-517</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  CD4+ T cells, upon activation and expansion, develop into different T helper cell subsets with different cytokine profiles and distinct effector functions.  Until recently, T cells were divided into Th1 or Th2 cells, depending on the cytokines they produce.  A third subset of IL-17-producing effector T helper cells, called Th17 cells, has now been discovered and characterized.  Here, the authors summarize the current information on the differentiation and effector functions of the Th17 lineage.  Th17 cells produce IL-17, IL-17F, and IL-22, thereby inducing a massive tissue reaction owing to the broad distribution of the IL-17 and IL-22 receptors.  Th17 cells also secrete IL-21 to communicate with the cells of the immune system.  The differentiation factors (TGF-β plus IL-6 or IL-21), the growth and stabilization factor (IL-23), and the transcription factors (STAT3, RORγt, and RORα) involved in the development of Th17 cells have just been identified.  The participation of TGF-β in the differentiation of Th17 cells places the Th17 lineage in close relation with CD4+CD25+Foxp3+ regulatory T cells (Tregs), as TGF-β also induces differentiation of native T cells into Foxp3+ Tregs in the peripheral immune compartment.  The investigation of the differentiation, effector function, and regulation of Th17 cells has opened up a new framework for understanding T cell differentiation.  Furthermore, the importance of Th17 cells is now appreciated in clearing pathogens during host defense reactions and in inducing tissue inflammation in autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAJvCEP9y1fLVg90H21EOLACvtfcHk0ljdkZyt_3wO3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrY%253D&md5=fffce537e2b70751fd9113e25962419e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.021908.132710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.021908.132710%26sid%3Dliteratum%253Aachs%26aulast%3DKorn%26aufirst%3DT.%26aulast%3DBettelli%26aufirst%3DE.%26aulast%3DOukka%26aufirst%3DM.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DIL-17%2520and%2520Th17%2520Cells%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D27%26spage%3D485%26epage%3D517%26doi%3D10.1146%2Fannurev.immunol.021908.132710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejiri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyasu, S.</span></span> <span> </span><span class="NLM_article-title">Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1111/gtc.12039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1111%2Fgtc.12039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=23383714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFWgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=247-265&author=Y.+Kurebayashiauthor=S.+Nagaiauthor=A.+Ikejiriauthor=S.+Koyasu&title=Recent+advances+in+understanding+the+molecular+mechanisms+of+the+development+and+function+of+Th17+cells&doi=10.1111%2Fgtc.12039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells</span></div><div class="casAuthors">Kurebayashi, Yutaka; Nagai, Shigenori; Ikejiri, Ai; Koyasu, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">247-265</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  IL-17-producing T helper (Th17) cells comprise a distinct Th subset involved in epithelial cell- and neutrophil-mediated immune responses against extracellular microbes.  At the same time, Th17 cells play significant roles in the development of autoimmune diseases including rheumatoid arthritis and multiple sclerosis.  Since the identification of Th17 cells approx. a decade ago, the mol. mechanisms of their differentiation have been intensively studied and a no. of signaling cascades and transcription factors have been shown to be involved.  Here, we review the current knowledge regarding the function of Th17 cells in vivo as well as several key concepts for the mol. mechanisms of Th17 differentiation.  We also discuss the emerging roles of phosphoinositide 3-kinase (PI3K), mammalian target of rapamycin complex 1 (mTORC1) and hypoxia-inducible factor 1 (HIF-1) in the differentiation of Th17 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7J4hr3fa_4bVg90H21EOLACvtfcHk0ljdkZyt_3wO3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFWgtb0%253D&md5=f2788bcef6e6e21ad07ecca22ab6bc2a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fgtc.12039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgtc.12039%26sid%3Dliteratum%253Aachs%26aulast%3DKurebayashi%26aufirst%3DY.%26aulast%3DNagai%26aufirst%3DS.%26aulast%3DIkejiri%26aufirst%3DA.%26aulast%3DKoyasu%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520understanding%2520the%2520molecular%2520mechanisms%2520of%2520the%2520development%2520and%2520function%2520of%2520Th17%2520cells%26jtitle%3DGenes%2520Cells%26date%3D2013%26volume%3D18%26spage%3D247%26epage%3D265%26doi%3D10.1111%2Fgtc.12039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1040</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2015.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.immuni.2015.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=26682981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVajtb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=1040-1051&author=D.+D.+Patelauthor=V.+K.+Kuchroo&title=Th17+Cell+Pathway+in+Human+Immunity%3A+Lessons+from+Genetics+and+Therapeutic+Interventions&doi=10.1016%2Fj.immuni.2015.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions</span></div><div class="casAuthors">Patel, Dhavalkumar D.; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1040-1051</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The T helper 17 (Th17) cell pathway has been linked by genome-wide assocn. studies to multiple autoimmune diseases.  Identification of the genetic causes of primary immunodeficiency diseases revealed that Th17 cells are also crit. in host immunity to mucocutaneous candida infections and Staphylococcus aureus.  Therapeutic interventions with inhibitors of the different components of the pathway such as interleukin-12 (IL-12), IL-23, IL-17A, and IL-17RA have variably beneficial effects in psoriasis, Crohn's disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-infectious uveitis, and multiple sclerosis.  Thus, whereas Th17 cells are protective against Candida albicans and to a lesser degree Staphylococcus aureus, they are pathogenic in many autoimmune diseases.  Here, we compare and contrast the effects of human genetic mutations of and therapeutic interventions targeted at Th17 cell mols.  We discuss that although there are similarities when Th17 cell pathway mols. are modulated, each mol. has unique non-Th17 cell features that lead to different functional outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb--L2SA4SpLVg90H21EOLACvtfcHk0ljUbARG1vSENA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVajtb7I&md5=5af767afe2a213dafa7c07f2b4271242</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2015.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2015.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DTh17%2520Cell%2520Pathway%2520in%2520Human%2520Immunity%253A%2520Lessons%2520from%2520Genetics%2520and%2520Therapeutic%2520Interventions%26jtitle%3DImmunity%26date%3D2015%26volume%3D43%26spage%3D1040%26epage%3D1051%26doi%3D10.1016%2Fj.immuni.2015.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaffen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span> <span> </span><span class="NLM_article-title">The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">600</span>, <span class="refDoi"> DOI: 10.1038/nri3707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnri3707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=25145755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSit7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=585-600&author=S.+L.+Gaffenauthor=R.+Jainauthor=A.+V.+Gargauthor=D.+J.+Cua&title=The+IL-23-IL-17+immune+axis%3A+from+mechanisms+to+therapeutic+testing&doi=10.1038%2Fnri3707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing</span></div><div class="casAuthors">Gaffen, Sarah L.; Jain, Renu; Garg, Abhishek V.; Cua, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">585-600</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the mol. mechanisms of T cell lineage commitment and function.  In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues.  We also discuss the emerging clin. data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsrf-chGl_n7Vg90H21EOLACvtfcHk0ljUbARG1vSENA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSit7%252FL&md5=3b78e054323aae062527ce32ec8e05e2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnri3707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3707%26sid%3Dliteratum%253Aachs%26aulast%3DGaffen%26aufirst%3DS.%2BL.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DGarg%26aufirst%3DA.%2BV.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520IL-23-IL-17%2520immune%2520axis%253A%2520from%2520mechanisms%2520to%2520therapeutic%2520testing%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D14%26spage%3D585%26epage%3D600%26doi%3D10.1038%2Fnri3707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isono, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita-Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span> <span> </span><span class="NLM_article-title">Inhibiting RORγt/Th17 axis for autoimmune disorders</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1205</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.drudis.2014.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=24792721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1205-1211&author=F.+Isonoauthor=S.+Fujita-Satoauthor=S.+Ito&title=Inhibiting+ROR%CE%B3t%2FTh17+axis+for+autoimmune+disorders&doi=10.1016%2Fj.drudis.2014.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting RORγt/Th17 axis for autoimmune disorders</span></div><div class="casAuthors">Isono, Fujio; Fujita-Sato, Saori; Ito, Shuichiro</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1205-1211</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent success reported in late-stage clin. trials for the treatment of psoriasis by antibodies directed against interleukin (IL)-17 or its receptor has validated and strongly supports the development of inhibitors of the IL-17 pathway as a new therapeutic modality in chronic inflammation and autoimmunity.  These results also encourage the drug discovery of orally available small mols. that can modulate down the prodn. of IL-17 by Th17 cells (the major IL-17 producers) or the downstream signaling of the IL-17 receptor.  Here, we review these strategies with an emphasis on inhibiting the retinoic-acid-related orphan nuclear receptor RORγt, which is the master regulator of Th17 cells and a promising therapeutic target for the treatment of multiple autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQi4K-X9vSobVg90H21EOLACvtfcHk0ljUbARG1vSENA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D&md5=aaa82e8d21bcd0c879b0219a7b84e126</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DIsono%26aufirst%3DF.%26aulast%3DFujita-Sato%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DS.%26atitle%3DInhibiting%2520ROR%25CE%25B3t%252FTh17%2520axis%2520for%2520autoimmune%2520disorders%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1205%26epage%3D1211%26doi%3D10.1016%2Fj.drudis.2014.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miossec, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolls, J. K.</span></span> <span> </span><span class="NLM_article-title">Targeting IL-17 and TH17 cells in chronic inflammation</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1038/nrd3794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnrd3794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=23023676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqsb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=763-776&author=P.+Miossecauthor=J.+K.+Kolls&title=Targeting+IL-17+and+TH17+cells+in+chronic+inflammation&doi=10.1038%2Fnrd3794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IL-17 and TH17 cells in chronic inflammation</span></div><div class="casAuthors">Miossec, Pierre; Kolls, Jay K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">763-776</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The key role of interleukin-17 (IL-17) and T helper 17 (TH17) cells in tissue inflammation, autoimmunity and host defense led to the exptl. targeting of these mols. in mouse models of diseases as well as in clin. settings.  Moreover, the demonstration that IL-17 and TH17 cells contribute to local and systemic aspects of disease pathogenesis, as well as the finding that the IL-17-TH17 cell pathway is regulated by IL-23, prompted the identification of inhibitors.  These inhibitors include biotechnol. products that target IL-23 as well as the leading member of the IL-17 family, IL-17A, and one of its receptors, IL-17 receptor A.  Several clin. trials of these inhibitors are underway, and pos. results have been obtained in psoriasis, rheumatoid arthritis and ankylosing spondylitis.  This Review focuses on the current knowledge of the IL-17-TH17 cell pathway to better understand the pos. as well as potential neg. consequences of targeting them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLAiqCF66JHrVg90H21EOLACvtfcHk0ljh6HD12jgGvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqsb7L&md5=0627e4086ae6e50881cc3de52f1a2752</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd3794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3794%26sid%3Dliteratum%253Aachs%26aulast%3DMiossec%26aufirst%3DP.%26aulast%3DKolls%26aufirst%3DJ.%2BK.%26atitle%3DTargeting%2520IL-17%2520and%2520TH17%2520cells%2520in%2520chronic%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D763%26epage%3D776%26doi%3D10.1038%2Fnrd3794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suematsu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwakura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takayanagi, H.</span></span> <span> </span><span class="NLM_article-title">Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">2673</span>– <span class="NLM_lpage">2682</span>, <span class="refDoi"> DOI: 10.1084/jem.20061775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1084%2Fjem.20061775" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=2673-2682&author=K.+Satoauthor=A.+Suematsuauthor=K.+Okamotoauthor=A.+Yamaguchiauthor=Y.+Morishitaauthor=Y.+Kadonoauthor=S.+Tanakaauthor=T.+Kodamaauthor=S.+Akiraauthor=Y.+Iwakuraauthor=D.+J.+Cuaauthor=H.+Takayanagi&title=Th17+functions+as+an+osteoclastogenic+helper+T+cell+subset+that+links+T+cell+activation+and+bone+destruction&doi=10.1084%2Fjem.20061775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1084%2Fjem.20061775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20061775%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DK.%26aulast%3DSuematsu%26aufirst%3DA.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DA.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DKadono%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DIwakura%26aufirst%3DY.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DTh17%2520functions%2520as%2520an%2520osteoclastogenic%2520helper%2520T%2520cell%2520subset%2520that%2520links%2520T%2520cell%2520activation%2520and%2520bone%2520destruction%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D2673%26epage%3D2682%26doi%3D10.1084%2Fjem.20061775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beringer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miossec, P.</span></span> <span> </span><span class="NLM_article-title">IL-17 in Chronic Inflammation: From Discovery to Targeting</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2016.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.molmed.2016.01.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=230-241&author=A.+Beringerauthor=M.+Noackauthor=P.+Miossec&title=IL-17+in+Chronic+Inflammation%3A+From+Discovery+to+Targeting&doi=10.1016%2Fj.molmed.2016.01.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DBeringer%26aufirst%3DA.%26aulast%3DNoack%26aufirst%3DM.%26aulast%3DMiossec%26aufirst%3DP.%26atitle%3DIL-17%2520in%2520Chronic%2520Inflammation%253A%2520From%2520Discovery%2520to%2520Targeting%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D230%26epage%3D241%26doi%3D10.1016%2Fj.molmed.2016.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korman, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fretzin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyirady, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyring, S.</span></span> <span> </span><span class="NLM_article-title">Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis</span>. <i>J. Dermatol. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">384</span>, <span class="refDoi"> DOI: 10.1080/09546634.2016.1255306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1080%2F09546634.2016.1255306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27832717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvF2ms7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=384&author=N.+J.+Kormanauthor=H.+Sofenauthor=S.+Fretzinauthor=P.+Richauthor=Y.+Zhaoauthor=V.+Herreraauthor=J.+Nyiradyauthor=N.+Williamsauthor=M.+Mordinauthor=S.+Tyring&title=Secukinumab+provides+better+relief+from+the+impact+of+psoriasis+on+daily+activities+and+personal+relationships+than+etanercept%3A+results+of+two+phase+3+placebo-controlled+randomized+clinical+trials+in+moderate-to-severe+psoriasis&doi=10.1080%2F09546634.2016.1255306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis</span></div><div class="casAuthors">Korman, Neil J.; Sofen, Howard; Fretzin, Scott; Rich, Phoebe; Zhao, Yang; Herrera, Vivian; Nyirady, Judit; Williams, Nicole; Mordin, Margaret; Tyring, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Treatment</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">384-389</span>CODEN:
                <span class="NLM_cas:coden">JDTREY</span>;
        ISSN:<span class="NLM_cas:issn">0954-6634</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Psoriasis can greatly impact patients' lives, influencing what clothing they wear and impairing their sexual functioning.  To provide a detailed comparison of the impact of secukinumab vs. etanercept on enabling patients with psoriasis to have more normal lives with respect to daily activities (DA) (e.g. choosing clothing) and personal relationships (PR) (e.g. sexual functioning).  Baseline to Week 52 ERASURE and FIXTURE data for secukinumab 300 mg and etanercept were analyzed.  Treatment differences in mean scores on the DA and PR subscales and items from the Dermatol. Life Quality Index were compared.  The proportions of subscale and item responders (score = 0) were compared.  Subjects receiving secukinumab (n = 572) achieved greater mean improvement in DA and items (q3 and q4) than subjects receiving etanercept (n = 326; all p < .01 through Week 52).  Subjects receiving secukinumab achieved greater mean improvement in PR and items (q8 and q9) than subjects receiving etanercept (subscale: p < .05 at Weeks 8 and 12).  Response rates were significantly higher for secukinumab than for etanercept for DA (all p < .0001) and PR (all p < .05 except Weeks 4 and 36).  Secukinumab 300 mg provides greater improvements and more effective relief from psoriasis impact on DA and PR than etanercept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuYoD9EUwlWbVg90H21EOLACvtfcHk0ljh6HD12jgGvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvF2ms7jP&md5=f0ed8803c651f11e165c01a39eff9640</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1080%2F09546634.2016.1255306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09546634.2016.1255306%26sid%3Dliteratum%253Aachs%26aulast%3DKorman%26aufirst%3DN.%2BJ.%26aulast%3DSofen%26aufirst%3DH.%26aulast%3DFretzin%26aufirst%3DS.%26aulast%3DRich%26aufirst%3DP.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DHerrera%26aufirst%3DV.%26aulast%3DNyirady%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DN.%26aulast%3DMordin%26aufirst%3DM.%26aulast%3DTyring%26aufirst%3DS.%26atitle%3DSecukinumab%2520provides%2520better%2520relief%2520from%2520the%2520impact%2520of%2520psoriasis%2520on%2520daily%2520activities%2520and%2520personal%2520relationships%2520than%2520etanercept%253A%2520results%2520of%2520two%2520phase%25203%2520placebo-controlled%2520randomized%2520clinical%2520trials%2520in%2520moderate-to-severe%2520psoriasis%26jtitle%3DJ.%2520Dermatol.%2520Treat.%26date%3D2017%26volume%3D28%26spage%3D384%26doi%3D10.1080%2F09546634.2016.1255306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greisenegger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenschein, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClanahan, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marbury, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachariae, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zandvliet, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Aarle, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalilieh, S.</span></span> <span> </span><span class="NLM_article-title">Clinical improvement in psoriasis with specific targeting of interleukin-23</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>521</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1038/nature14175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnature14175" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=521&publication_year=2015&pages=222-226&author=T.+Koppauthor=E.+Riedlauthor=C.+Bangertauthor=E.+P.+Bowmanauthor=E.+Greiseneggerauthor=A.+Horowitzauthor=H.+Kittlerauthor=W.+M.+Blumenscheinauthor=T.+K.+McClanahanauthor=T.+Marburyauthor=C.+Zachariaeauthor=D.+Xuauthor=X.+S.+Houauthor=A.+Mehtaauthor=A.+S.+Zandvlietauthor=D.+Montgomeryauthor=F.+van+Aarleauthor=S.+Khalilieh&title=Clinical+improvement+in+psoriasis+with+specific+targeting+of+interleukin-23&doi=10.1038%2Fnature14175"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature14175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14175%26sid%3Dliteratum%253Aachs%26aulast%3DKopp%26aufirst%3DT.%26aulast%3DRiedl%26aufirst%3DE.%26aulast%3DBangert%26aufirst%3DC.%26aulast%3DBowman%26aufirst%3DE.%2BP.%26aulast%3DGreisenegger%26aufirst%3DE.%26aulast%3DHorowitz%26aufirst%3DA.%26aulast%3DKittler%26aufirst%3DH.%26aulast%3DBlumenschein%26aufirst%3DW.%2BM.%26aulast%3DMcClanahan%26aufirst%3DT.%2BK.%26aulast%3DMarbury%26aufirst%3DT.%26aulast%3DZachariae%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DHou%26aufirst%3DX.%2BS.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DZandvliet%26aufirst%3DA.%2BS.%26aulast%3DMontgomery%26aufirst%3DD.%26aulast%3Dvan%2BAarle%26aufirst%3DF.%26aulast%3DKhalilieh%26aufirst%3DS.%26atitle%3DClinical%2520improvement%2520in%2520psoriasis%2520with%2520specific%2520targeting%2520of%2520interleukin-23%26jtitle%3DNature%26date%3D2015%26volume%3D521%26spage%3D222%26epage%3D226%26doi%3D10.1038%2Fnature14175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mease, P. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis</span>. <i>Curr. Opin. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1097/BOR.0000000000000147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1097%2FBOR.0000000000000147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=25599143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFCis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=127-133&author=P.+J.+Mease&title=Inhibition+of+interleukin-17%2C+interleukin-23+and+the+TH17+cell+pathway+in+the+treatment+of+psoriatic+arthritis+and+psoriasis&doi=10.1097%2FBOR.0000000000000147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis</span></div><div class="casAuthors">Mease, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Rheumatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-133</span>CODEN:
                <span class="NLM_cas:coden">CORHES</span>;
        ISSN:<span class="NLM_cas:issn">1040-8711</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: In recent years, there has been an increasing understanding of the importance of the TH17 lineage of T cells and related cytokines, including interleukin (IL)17 and IL23, not only in the biol. of innate host defense but also in the pathogenesis of inflammatory/autoimmune diseases.  These diseases include psoriasis, psoriatic arthritis, the broader category of spondyloarthritides including ankylosing spondylitis and rheumatoid arthritis.  It is postulated that in genetically predisposed individuals, external or internal stimuli such as microbial antigens, alterations in the intestinal microbiome, biomech. stress and/or immunol. dysregulation may lead to an increased expression of cytokines such as IL23, which in turn stimulate the differentiation and activation of TH17 and other immune cells, which are a part of the innate immune system that trigger adaptive immune processes and chronic inflammatory diseases.  Herein, we explore the effect of targeting this pathway therapeutically.  Recent findings: New drugs that are designed to inhibit steps in this pathway, the IL12/IL23 inhibitor, ustekinumab, the IL17A inhibitors secukinumab and ixekizumab, the IL17A receptor inhibitor, brodalumab, and the IL23 inhibitors guselkumab and tildrakizumab, have demonstrated significant effectiveness in treating these diseases, particularly psoriasis, psoriatic arthritis and ankylosing spondylitis.  Summary: This article reviews the relevant biol., efficacy and safety of new medications targeting the TH17 pathway, including inhibition of IL17 and IL23, particularly in psoriasis and psoriatic arthritis.  Esp. for patients who have not gained benefit from, lost effectiveness to or could not use antitumor necrosis factor (TNF) medications for safety or tolerability reasons, having effective medicines with an alternative mechanism of action will improve our ability to diminish disease activity impact on patient lives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryNc3Fy2wnNrVg90H21EOLACvtfcHk0lg1LC3P0kD6-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFCis7g%253D&md5=452435fc597207937abb44f188614662</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1097%2FBOR.0000000000000147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FBOR.0000000000000147%26sid%3Dliteratum%253Aachs%26aulast%3DMease%26aufirst%3DP.%2BJ.%26atitle%3DInhibition%2520of%2520interleukin-17%252C%2520interleukin-23%2520and%2520the%2520TH17%2520cell%2520pathway%2520in%2520the%2520treatment%2520of%2520psoriatic%2520arthritis%2520and%2520psoriasis%26jtitle%3DCurr.%2520Opin.%2520Rheumatol.%26date%3D2015%26volume%3D27%26spage%3D127%26epage%3D133%26doi%3D10.1097%2FBOR.0000000000000147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumbley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundasen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojetin, D. J.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptors and their selective pharmacologic modulators</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">778</span>, <span class="refDoi"> DOI: 10.1124/pr.112.006833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1124%2Fpr.112.006833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=23457206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslCisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=710-778&author=T.+P.+Burrisauthor=L.+A.+Soltauthor=Y.+Wangauthor=C.+Crumbleyauthor=S.+Banerjeeauthor=K.+Griffettauthor=T.+Lundasenauthor=T.+Hughesauthor=D.+J.+Kojetin&title=Nuclear+receptors+and+their+selective+pharmacologic+modulators&doi=10.1124%2Fpr.112.006833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptors and their selective pharmacologic modulators</span></div><div class="casAuthors">Burris, Thomas P.; Solt, Laura A.; Wang, Yongjun; Crumbley, Christine; Banerjee, Subhashis; Griffett, Kristine; Lundasen, Thomas; Hughes, Travis; Kojetin, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">710-778, 69 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors are ligand-activated transcription factors and include the receptors for steroid hormones, lipophilic vitamins, sterols, and bile acids.  These receptors serve as targets for development of myriad drugs that target a range of disorders.  Classically defined ligands that bind to the ligand-binding domain of nuclear receptors, whether they are endogenous or synthetic, either activate receptor activity (agonists) or block activation (antagonists) and due to the ability to alter activity of the receptors are often termed receptor "modulators".  The complex pharmacol. of nuclear receptors has provided a class of ligands distinct from these simple modulators where ligands display agonist/partial agonist/antagonist function in a tissue or gene selective manner.  This class of ligands is defined as selective modulators.  Here, we review the development and pharmacol. of a range of selective nuclear receptor modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodFD-Tf1vBUrVg90H21EOLACvtfcHk0lg1LC3P0kD6-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslCisrY%253D&md5=33c34757a837d2a80674fbe5c1660fe2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fpr.112.006833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.112.006833%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCrumbley%26aufirst%3DC.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DGriffett%26aufirst%3DK.%26aulast%3DLundasen%26aufirst%3DT.%26aulast%3DHughes%26aufirst%3DT.%26aulast%3DKojetin%26aufirst%3DD.%2BJ.%26atitle%3DNuclear%2520receptors%2520and%2520their%2520selective%2520pharmacologic%2520modulators%26jtitle%3DPharmacol.%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D710%26epage%3D778%26doi%3D10.1124%2Fpr.112.006833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savkur, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">The coactivator LXXLL nuclear receptor recognition motif</span>. <i>J. Pept. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1111/j.1399-3011.2004.00126.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1111%2Fj.1399-3011.2004.00126.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=15049832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtlKlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2004&pages=207-212&author=R.+S.+Savkurauthor=T.+P.+Burris&title=The+coactivator+LXXLL+nuclear+receptor+recognition+motif&doi=10.1111%2Fj.1399-3011.2004.00126.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The coactivator LXXLL nuclear receptor recognition motif</span></div><div class="casAuthors">Savkur, R. S.; Burris, T. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-212</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors require coactivator binding in order to activate transcription of their cognate target genes.  Ligands regulate nuclear receptor (NR)-mediated recruitment of coactivators by binding to the ligand-binding domain of the receptor and inducing a conformational change allowing for recognition of a specific motif contained within the coactivator protein.  This motif is known as the NR box or LXXLL (where L is leucine and X is any amino acid) domain.  Here, we review the discovery of the domain as well as its characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-3lqTiOQ-E7Vg90H21EOLACvtfcHk0lg1LC3P0kD6-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtlKlsrk%253D&md5=31d0ef26857300ea80b32378bb2b2771</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.2004.00126.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.2004.00126.x%26sid%3Dliteratum%253Aachs%26aulast%3DSavkur%26aufirst%3DR.%2BS.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DThe%2520coactivator%2520LXXLL%2520nuclear%2520receptor%2520recognition%2520motif%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D2004%26volume%3D63%26spage%3D207%26epage%3D212%26doi%3D10.1111%2Fj.1399-3011.2004.00126.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gronemeyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, V.</span></span> <span> </span><span class="NLM_article-title">Principles for modulation of the nuclear receptor superfamily</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">950</span>– <span class="NLM_lpage">964</span>, <span class="refDoi"> DOI: 10.1038/nrd1551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnrd1551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=15520817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=950-964&author=H.+Gronemeyerauthor=J.+A.+Gustafssonauthor=V.+Laudet&title=Principles+for+modulation+of+the+nuclear+receptor+superfamily&doi=10.1038%2Fnrd1551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Principles for modulation of the nuclear receptor superfamily</span></div><div class="casAuthors">Gronemeyer, Hinrich; Gustafsson, Jan-A.; Laudet, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">950-964</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors are major targets for drug discovery and have key roles in development and homeostasis, as well as in many diseases such as obesity, diabetes and cancer.  This review provides a general overview of the mechanism of action of nuclear receptors and explores the various factors that are instrumental in modulating their pharmacol.  In most cases, the response of a given receptor to a particular ligand in a specific tissue will be dictated by the set of proteins with which the receptor is able to interact.  One of the most promising aspects of nuclear receptor pharmacol. is that it is now possible to develop ligands with a large spectrum of full, partial or inverse agonist or antagonist activities, but also compds., called selective nuclear receptor modulators, that activate only a subset of the functions induced by the cognate ligand or that act in a cell-type-selective manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSWL9yf1CceLVg90H21EOLACvtfcHk0li81kzq0k49UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFemtrY%253D&md5=aedb60785c235bf44cb5f0ea34236090</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd1551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1551%26sid%3Dliteratum%253Aachs%26aulast%3DGronemeyer%26aufirst%3DH.%26aulast%3DGustafsson%26aufirst%3DJ.%2BA.%26aulast%3DLaudet%26aufirst%3DV.%26atitle%3DPrinciples%2520for%2520modulation%2520of%2520the%2520nuclear%2520receptor%2520superfamily%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D950%26epage%3D964%26doi%3D10.1038%2Fnrd1551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helvering, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumbley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stayrook, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">Modulation of Retinoic Acid Receptor-related Orphan Receptor α and γ Activity by 7-Oxygenated Sterol Ligands</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">5013</span>– <span class="NLM_lpage">5025</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.080614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1074%2Fjbc.M109.080614" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=5013-5025&author=Y.+Wangauthor=N.+Kumarauthor=L.+A.+Soltauthor=T.+I.+Richardsonauthor=L.+M.+Helveringauthor=C.+Crumbleyauthor=R.+D.+Garcia-Ordonezauthor=K.+R.+Stayrookauthor=X.+Zhangauthor=S.+Novickauthor=M.+J.+Chalmersauthor=P.+R.+Griffinauthor=T.+P.+Burris&title=Modulation+of+Retinoic+Acid+Receptor-related+Orphan+Receptor+%CE%B1+and+%CE%B3+Activity+by+7-Oxygenated+Sterol+Ligands&doi=10.1074%2Fjbc.M109.080614"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.080614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.080614%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DRichardson%26aufirst%3DT.%2BI.%26aulast%3DHelvering%26aufirst%3DL.%2BM.%26aulast%3DCrumbley%26aufirst%3DC.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%2BD.%26aulast%3DStayrook%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DNovick%26aufirst%3DS.%26aulast%3DChalmers%26aufirst%3DM.%2BJ.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DModulation%2520of%2520Retinoic%2520Acid%2520Receptor-related%2520Orphan%2520Receptor%2520%25CE%25B1%2520and%2520%25CE%25B3%2520Activity%2520by%25207-Oxygenated%2520Sterol%2520Ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D5013%26epage%3D5025%26doi%3D10.1074%2Fjbc.M109.080614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soroosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandridge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tootoonchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenkrants, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milla, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span> <span> </span><span class="NLM_article-title">Oxysterols are agonist ligands of RORgt and drive Th17 cell differentiation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12163</span>– <span class="NLM_lpage">12168</span>, <span class="refDoi"> DOI: 10.1073/pnas.1322807111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1073%2Fpnas.1322807111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12163-12168&author=P.+Sorooshauthor=J.+Wuauthor=X.+Xueauthor=J.+Songauthor=S.+W.+Suttonauthor=M.+Sabladauthor=J.+Yuauthor=M.+I.+Nelenauthor=X.+Liuauthor=G.+Castroauthor=R.+Lunaauthor=S.+Crawfordauthor=H.+Banieauthor=R.+A.+Dandridgeauthor=X.+Dengauthor=A.+Bittnerauthor=C.+Kueiauthor=M.+Tootoonchiauthor=N.+Rozenkrantsauthor=K.+Hermanauthor=J.+Gaoauthor=X.+V.+Yangauthor=K.+Sachenauthor=K.+Ngoauthor=W.+P.+Fung-Leungauthor=S.+Nguyenauthor=A.+de+Leon-Tabaldoauthor=J.+Blevittauthor=Y.+Zhangauthor=M.+D.+Cummingsauthor=T.+Raoauthor=N.+S.+Maniauthor=C.+Liuauthor=M.+McKinnonauthor=M.+E.+Millaauthor=A.+M.+Fourieauthor=S.+Sun&title=Oxysterols+are+agonist+ligands+of+RORgt+and+drive+Th17+cell+differentiation&doi=10.1073%2Fpnas.1322807111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1322807111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1322807111%26sid%3Dliteratum%253Aachs%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DLuna%26aufirst%3DR.%26aulast%3DCrawford%26aufirst%3DS.%26aulast%3DBanie%26aufirst%3DH.%26aulast%3DDandridge%26aufirst%3DR.%2BA.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DBittner%26aufirst%3DA.%26aulast%3DKuei%26aufirst%3DC.%26aulast%3DTootoonchi%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DHerman%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%2BV.%26aulast%3DSachen%26aufirst%3DK.%26aulast%3DNgo%26aufirst%3DK.%26aulast%3DFung-Leung%26aufirst%3DW.%2BP.%26aulast%3DNguyen%26aufirst%3DS.%26aulast%3Dde%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DBlevitt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DRao%26aufirst%3DT.%26aulast%3DMani%26aufirst%3DN.%2BS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DMilla%26aufirst%3DM.%2BE.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DSun%26aufirst%3DS.%26atitle%3DOxysterols%2520are%2520agonist%2520ligands%2520of%2520RORgt%2520and%2520drive%2520Th17%2520cell%2520differentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D12163%26epage%3D12168%26doi%3D10.1073%2Fpnas.1322807111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huh, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, M. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krout, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malapaka, R. R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciofani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuesta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santori, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gin, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>472</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1038/nature09978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnature09978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=21441909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2011&pages=486-490&author=J.+R.+Huhauthor=M.+W.+L.+Leungauthor=P.+Huangauthor=D.+A.+Ryanauthor=M.+R.+Kroutauthor=R.+R.+V.+Malapakaauthor=J.+Chowauthor=N.+Manelauthor=M.+Ciofaniauthor=S.+V.+Kimauthor=A.+Cuestaauthor=F.+R.+Santoriauthor=J.+J.+Lafailleauthor=H.+E.+Xuauthor=D.+Y.+Ginauthor=F.+Rastinejadauthor=D.+R.+Littman&title=Digoxin+and+its+derivatives+suppress+TH17+cell+differentiation+by+antagonizing+ROR%CE%B3t+activity&doi=10.1038%2Fnature09978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity</span></div><div class="casAuthors">Huh, Jun R.; Leung, Monica W. L.; Huang, Pengxiang; Ryan, Daniel A.; Krout, Michael R.; Malapaka, Raghu R. V.; Chow, Jonathan; Manel, Nicolas; Ciofani, Maria; Kim, Sangwon V.; Cuesta, Adolfo; Santori, Fabio R.; Lafaille, Juan J.; Xu, H. Eric; Gin, David Y.; Rastinejad, Fraydoon; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">472</span>
        (<span class="NLM_cas:issue">7344</span>),
    <span class="NLM_cas:pages">486-490</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CD4+ T helper lymphocytes that express interleukin-17 (TH17 cells) have crit. roles in mouse models of autoimmunity, and there is mounting evidence that they also influence inflammatory processes in humans.  Genome-wide assocn. studies in humans have linked genes involved in TH17 cell differentiation and function with susceptibility to Crohn's disease, rheumatoid arthritis and psoriasis.  Thus, the pathway towards differentiation of TH17 cells and, perhaps, of related innate lymphoid cells with similar effector functions, is an attractive target for therapeutic applications.  Mouse and human TH17 cells are distinguished by expression of the retinoic acid receptor-related orphan nuclear receptor RORγt, which is required for induction of IL-17 transcription and for the manifestation of TH17-dependent autoimmune disease in mice.  By performing a chem. screen with an insect cell-based reporter system, we identified the cardiac glycoside digoxin as a specific inhibitor of RORγt transcriptional activity.  Digoxin inhibited murine TH17 cell differentiation without affecting differentiation of other T cell lineages and was effective in delaying the onset and reducing the severity of autoimmune disease in mice.  At high concns., digoxin is toxic for human cells, but non-toxic synthetic derivs. 20,22-dihydrodigoxin-21,23-diol and digoxin-21-salicylidene specifically inhibited induction of IL-17 in human CD4+ T cells.  Using these small-mol. compds., we demonstrate that RORγt is important for the maintenance of IL-17 expression in mouse and human effector T cells.  These data indicate that derivs. of digoxin can be used as chem. templates for the development of RORγt-targeted therapeutic agents that attenuate inflammatory lymphocyte function and autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZeBtm9HrHi7Vg90H21EOLACvtfcHk0lhAcKWAEBC4lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOisr8%253D&md5=d25efc57bc2849ed23456c95c59cc006</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnature09978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09978%26sid%3Dliteratum%253Aachs%26aulast%3DHuh%26aufirst%3DJ.%2BR.%26aulast%3DLeung%26aufirst%3DM.%2BW.%2BL.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DRyan%26aufirst%3DD.%2BA.%26aulast%3DKrout%26aufirst%3DM.%2BR.%26aulast%3DMalapaka%26aufirst%3DR.%2BR.%2BV.%26aulast%3DChow%26aufirst%3DJ.%26aulast%3DManel%26aufirst%3DN.%26aulast%3DCiofani%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%2BV.%26aulast%3DCuesta%26aufirst%3DA.%26aulast%3DSantori%26aufirst%3DF.%2BR.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DGin%26aufirst%3DD.%2BY.%26aulast%3DRastinejad%26aufirst%3DF.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DDigoxin%2520and%2520its%2520derivatives%2520suppress%2520TH17%2520cell%2520differentiation%2520by%2520antagonizing%2520ROR%25CE%25B3t%2520activity%26jtitle%3DNature%26date%3D2011%26volume%3D472%26spage%3D486%26epage%3D490%26doi%3D10.1038%2Fnature09978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendling, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toogood, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G. D.</span></span> <span> </span><span class="NLM_article-title">Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnchembio.1714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=25558972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=141-147&author=X.+Huauthor=Y.+Wangauthor=L.-Y.+Haoauthor=X.+Liuauthor=C.+A.+Leschauthor=B.+M.+Sanchezauthor=J.+M.+Wendlingauthor=R.+W.+Morganauthor=T.+D.+Aicherauthor=L.+L.+Carterauthor=P.+L.+Toogoodauthor=G.+D.+Glick&title=Sterol+metabolism+controls+TH17+differentiation+by+generating+endogenous+ROR%CE%B3+agonists&doi=10.1038%2Fnchembio.1714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists</span></div><div class="casAuthors">Hu, Xiao; Wang, Yahong; Hao, Ling-Yang; Liu, Xikui; Lesch, Chuck A.; Sanchez, Brian M.; Wendling, Jay M.; Morgan, Rodney W.; Aicher, Tom D.; Carter, Laura L.; Toogood, Peter L.; Glick, Gary D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-147</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptor γ (RORγt) controls the differentiation of naive CD4+ T cells into the TH17 lineage, which are crit. cells in the pathogenesis of autoimmune diseases.  Here the authors report that during TH17 differentiation, cholesterol biosynthesis and uptake programs are induced, whereas their metab. and efflux programs are suppressed.  These changes result in the accumulation of the cholesterol precursor, desmosterol, which functions as a potent endogenous RORγ agonist.  Generation of cholesterol precursors is essential for TH17 differentiation as blocking cholesterol synthesis with chem. inhibitors at steps before the formation of active precursors reduces differentiation.  Upon activation, metabolic changes also lead to prodn. of specific sterol-sulfate conjugates that favor activation of RORγ over the TH17-inhibiting sterol receptor LXR.  Thus, TH17 differentiation is orchestrated by coordinated sterol synthesis, mobilization and metab. to selectively activate RORγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKonRBn05nmbVg90H21EOLACvtfcHk0liQaXYozYYRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislOltQ%253D%253D&md5=e82af9d561a1e4683a86b815cb734971</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1714%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DL.-Y.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLesch%26aufirst%3DC.%2BA.%26aulast%3DSanchez%26aufirst%3DB.%2BM.%26aulast%3DWendling%26aufirst%3DJ.%2BM.%26aulast%3DMorgan%26aufirst%3DR.%2BW.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DGlick%26aufirst%3DG.%2BD.%26atitle%3DSterol%2520metabolism%2520controls%2520TH17%2520differentiation%2520by%2520generating%2520endogenous%2520ROR%25CE%25B3%2520agonists%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D141%26epage%3D147%26doi%3D10.1038%2Fnchembio.1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martynowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORγ</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1210/me.2009-0507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1210%2Fme.2009-0507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=20203100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=923-929&author=L.+Jinauthor=D.+Martynowskiauthor=S.+Zhengauthor=T.+Wadaauthor=W.+Xieauthor=Y.+Li&title=Structural+basis+for+hydroxycholesterols+as+natural+ligands+of+orphan+nuclear+receptor+ROR%CE%B3&doi=10.1210%2Fme.2009-0507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORγ</span></div><div class="casAuthors">Jin, Lihua; Martynowski, Dariusz; Zheng, Songyang; Wada, Taira; Xie, Wen; Li, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">923-929</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The retinoic acid-related orphan receptor γ (RORγ) has important roles in development and metabolic homeostasis.  Although the biol. functions of RORγ have been studied extensively, no ligands for RORγ have been identified, and no structure of RORγ has been reported.  In this study, we showed that hydroxycholesterols promote the recruitment of coactivators by RORγ using biochem. assays.  We also report the crystal structures of the RORγ ligand-binding domain bound with hydroxycholesterols.  The structures reveal the binding modes of various hydroxycholesterols in the RORγ pocket, with the receptors all adopting the canonical active conformation.  Mutations that disrupt the binding of hydroxycholesterols abolish the constitutive activity of RORγ.  Our observations suggest an important role for the endogenous hydroxycholesterols in modulating RORγ-dependent biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-ndP3ZSYebVg90H21EOLACvtfcHk0liQaXYozYYRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D&md5=1651fa21702f2a06451377fa11aa80bc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0507%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMartynowski%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520for%2520hydroxycholesterols%2520as%2520natural%2520ligands%2520of%2520orphan%2520nuclear%2520receptor%2520ROR%25CE%25B3%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D923%26epage%3D929%26doi%3D10.1210%2Fme.2009-0507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita-Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isono, F.</span></span> <span> </span><span class="NLM_article-title">Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 production</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">31409</span>– <span class="NLM_lpage">31417</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.254003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1074%2Fjbc.M111.254003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=31409-31417&author=S.+Fujita-Satoauthor=S.+Itoauthor=T.+Isobeauthor=T.+Ohyamaauthor=K.+Wakabayashiauthor=K.+Morishitaauthor=O.+Andoauthor=F.+Isono&title=Structural+basis+of+digoxin+that+antagonizes+RORgamma+t+receptor+activity+and+suppresses+Th17+cell+differentiation+and+interleukin+%28IL%29-17+production&doi=10.1074%2Fjbc.M111.254003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.254003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.254003%26sid%3Dliteratum%253Aachs%26aulast%3DFujita-Sato%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DOhyama%26aufirst%3DT.%26aulast%3DWakabayashi%26aufirst%3DK.%26aulast%3DMorishita%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DO.%26aulast%3DIsono%26aufirst%3DF.%26atitle%3DStructural%2520basis%2520of%2520digoxin%2520that%2520antagonizes%2520RORgamma%2520t%2520receptor%2520activity%2520and%2520suppresses%2520Th17%2520cell%2520differentiation%2520and%2520interleukin%2520%2528IL%2529-17%2520production%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D31409%26epage%3D31417%26doi%3D10.1074%2Fjbc.M111.254003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5871</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1021/jm401901d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401901d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5871-5892&author=B.+P.+Fauberauthor=S.+Magnuson&title=Modulators+of+the+Nuclear+Receptor+Retinoic+Acid+Receptor-Related+Orphan+Receptor-%CE%B3+%28ROR%CE%B3+or+RORc%29&doi=10.1021%2Fjm401901d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)</span></div><div class="casAuthors">Fauber, Benjamin P.; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5871-5892</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the biol. surrounding the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORγ or RORc) continues to evolve, significant effort has been invested in discovering modulators of this potentially important target for the treatment of metabolic and immunol. diseases.  Several major pharmaceutical and biotechnol. companies have disclosed RORc inhibitors or partnered with other players in the field.  In this perspective, we discuss both the biol. and the underlying structural biol. of RORc, and summarize the RORc modulators disclosed in the scientific and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhzxefrY4hLVg90H21EOLACvtfcHk0lhcYqztiNRgug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D&md5=42b350bff7776d4b5689275eab214d86</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm401901d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401901d%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DModulators%2520of%2520the%2520Nuclear%2520Receptor%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor-%25CE%25B3%2520%2528ROR%25CE%25B3%2520or%2520RORc%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5871%26epage%3D5892%26doi%3D10.1021%2Fjm401901d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyda, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Synthetic modulators of the retinoic acid receptor-related orphan receptors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">764</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1039/c3md00005b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1039%2Fc3md00005b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVygsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=764-776&author=T.+M.+Kameneckaauthor=B.+Lydaauthor=M.+R.+Changauthor=P.+R.+Griffin&title=Synthetic+modulators+of+the+retinoic+acid+receptor-related+orphan+receptors&doi=10.1039%2Fc3md00005b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic modulators of the retinoic acid receptor-related orphan receptors</span></div><div class="casAuthors">Kamenecka, Theodore M.; Lyda, Brent; Chang, Mi Ra; Griffin, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">764-776</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NR) are ligand-regulated transcription factors that control the expression of target genes involved in a range of physiol. processes such as development, metab., and immunity.  The retinoic acid receptor-related orphan receptors alpha, beta, and gamma (RORA, RORB, and RORC) comprise a distinct subfamily of nuclear receptors and are considered orphan' receptors, as they have no known generally agreed upon endogenous ligands, although these receptors do bind to and are modulated by oxysterols.  Several recent reports have highlighted the potential role for RORs in human disease, and more importantly, studies have demonstrated that these receptors can be modulated by exogenous synthetic ligands.  The identification of potent and selective ROR ligands will allow for a better understanding of the roles of the ROR receptors in human disease, and potentially pave the way for development of novel therapeutics.  Here we review the current status of synthetic ligand development from both the primary and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOh7XjR1TYObVg90H21EOLACvtfcHk0lhcYqztiNRgug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVygsL0%253D&md5=1985ee3df0c0476b65bcd68f7e9bc126</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fc3md00005b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00005b%26sid%3Dliteratum%253Aachs%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DLyda%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DSynthetic%2520modulators%2520of%2520the%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptors%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D764%26epage%3D776%26doi%3D10.1039%2Fc3md00005b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cyr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">Recent progress on nuclear receptor RORγ modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4387</span>– <span class="NLM_lpage">4393</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2016.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27542308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4387-4393&author=P.+Cyrauthor=S.+M.+Bronnerauthor=J.+J.+Crawford&title=Recent+progress+on+nuclear+receptor+ROR%CE%B3+modulators&doi=10.1016%2Fj.bmcl.2016.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress on nuclear receptor RORγ modulators</span></div><div class="casAuthors">Cyr, Patrick; Bronner, Sarah M.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4387-4393</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The retinoic acid receptor-related orphan receptor RORγ plays key roles in the development and differentiation of TH17 cells, and thus in IL-17 expression, thymocyte development and regulation of metab.  With the recent progression into phase 2 clin. trials of both oral and topically administered inverse agonists, and with others close behind, there is significant interest in the discovery of RORγ modulators.  This digest covers key developments around RORγ agonists, antagonists and inverse agonists; orthosteric and allosteric binders; and aims to summarize the available information concerning the potential utility of RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD6nrse0GiBLVg90H21EOLACvtfcHk0ljx36DTHZE4IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL&md5=688885fc5c71ce01b86df6c9703b51ec</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DCyr%26aufirst%3DP.%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DRecent%2520progress%2520on%2520nuclear%2520receptor%2520ROR%25CE%25B3%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4387%26epage%3D4393%26doi%3D10.1016%2Fj.bmcl.2016.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">ROR nuclear receptors: structures, related diseases, and drug discovery</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1038/aps.2014.120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Faps.2014.120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=25500868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=71-87&author=Y.+Zhangauthor=X.-y.+Luoauthor=D.-h.+Wuauthor=Y.+Xu&title=ROR+nuclear+receptors%3A+structures%2C+related+diseases%2C+and+drug+discovery&doi=10.1038%2Faps.2014.120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">ROR nuclear receptors: structures, related diseases, and drug discovery</span></div><div class="casAuthors">Zhang, Yan; Luo, Xiao-yu; Wu, Dong-hai; Xu, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-87</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NRs) are ligand-regulated transcription factors that regulate metab., development and immunity.  The NR superfamily is one of the major classes of drug targets for human diseases.  Retinoic acid receptor-related orphan receptor (ROR) α, β and γ belong to the NR superfamily, and these receptors are still considered as 'orphan' receptors because the identification of their endogenous ligands has been controversial.  Recent studies have demonstrated that these receptors are regulated by synthetic ligands, thus emerge as important drug targets for the treatment of multiple sclerosis, rheumatoid arthritis, psoriasis, etc.  Studying the structural basis and ligand development of RORs will pave the way for a better understanding of the roles of these receptors in human diseases.  Here, we review the structural basis, disease relevance, strategies for ligand identification, and current status of development of therapeutic ligands for RORs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoupXZKlp8kzbVg90H21EOLACvtfcHk0ljx36DTHZE4IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGgtw%253D%253D&md5=5f5c6e553f7860890bb9f3d9d42be14b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Faps.2014.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2014.120%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DX.-y.%26aulast%3DWu%26aufirst%3DD.-h.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DROR%2520nuclear%2520receptors%253A%2520structures%252C%2520related%2520diseases%252C%2520and%2520drug%2520discovery%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2015%26volume%3D36%26spage%3D71%26epage%3D87%26doi%3D10.1038%2Faps.2014.120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zbieg, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">RORγ antagonists and inverse agonists: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1236918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1080%2F13543776.2017.1236918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27629281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=101-112&author=S.+M.+Bronnerauthor=J.+R.+Zbiegauthor=J.+J.+Crawford&title=ROR%CE%B3+antagonists+and+inverse+agonists%3A+a+patent+review&doi=10.1080%2F13543776.2017.1236918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">RORγ antagonists and inverse agonists: a patent review</span></div><div class="casAuthors">Bronner, Sarah M.; Zbieg, Jason R.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The transcription factor RORγ plays a crit. role in the expression of pro-inflammatory cytokine interleukin IL-17 and is therefore an attractive target for the treatment of inflammatory diseases.  Interest in this mol. target has been heightened by the advancement of orally and topically administered RORγ modulators into clin. trials.  The present review seeks to summarize published patent applications from assignee companies that have disclosed Investigational New Drug (IND) filings for small mol. RORγ/RORγt antagonists and inverse agonists.  The field of RORγ research is extremely competitive, with the majority of companies targeting psoriasis as the primary disease indication.  Vitae Pharmaceuticals is currently the most advanced, with a potential first-in-class oral RORγ-modulator for the treatment of psoriasis.  Future efforts will likely expand into potential applications of RORγ-modulators in the lesser explored immune-related areas of rheumatoid arthritis, type 1 diabetes, lupus, and irritable bowel disorder, as well as cancer immunotherapy and castration-resistant prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj8lMzWsYVA7Vg90H21EOLACvtfcHk0lhrrpXPBARrOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP&md5=d80db6c4c948bc12c5d0ce4b41edd2fb</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1236918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1236918%26sid%3Dliteratum%253Aachs%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DZbieg%26aufirst%3DJ.%2BR.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DROR%25CE%25B3%2520antagonists%2520and%2520inverse%2520agonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D101%26epage%3D112%26doi%3D10.1080%2F13543776.2017.1236918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonemori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujitani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmc.2017.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=29262987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=483-500&author=J.+Shiraiauthor=Y.+Tomataauthor=M.+Konoauthor=A.+Ochidaauthor=Y.+Fukaseauthor=A.+Satoauthor=S.+Masadaauthor=T.+Kawamotoauthor=K.+Yonemoriauthor=R.+Koyamaauthor=H.+Nakagawaauthor=M.+Nakayamaauthor=K.+Ugaauthor=A.+Shibataauthor=K.+Kogaauthor=T.+Okuiauthor=M.+Shirasakiauthor=R.+Skeneauthor=B.+Sangauthor=I.+Hoffmanauthor=W.+Laneauthor=Y.+Fujitaniauthor=M.+Yamasakiauthor=S.+Yamamoto&title=Discovery+of+orally+efficacious+ROR%CE%B3t+inverse+agonists%2C+part+1%3A+Identification+of+novel+phenylglycinamides+as+lead+scaffolds&doi=10.1016%2Fj.bmc.2017.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds</span></div><div class="casAuthors">Shirai, Junya; Tomata, Yoshihide; Kono, Mitsunori; Ochida, Atsuko; Fukase, Yoshiyuki; Sato, Ayumu; Masada, Shinichi; Kawamoto, Tetsuji; Yonemori, Kazuko; Koyama, Ryoukichi; Nakagawa, Hideyuki; Nakayama, Masaharu; Uga, Keiko; Shibata, Akira; Koga, Keiko; Okui, Toshitake; Shirasaki, Mikio; Skene, Robert; Sang, Bi Ching; Hoffman, Isaac; Lane, Wes; Fujitani, Yasushi; Yamasaki, Masashi; Yamamoto, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">483-500</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel phenylglycinamides as retinoic acid receptor-related orphan receptor-gamma t (RORγt) inverse agonists were discovered through optimization of a high-throughput screen hit 1.  (R)-N-(2-((3,5-Difluoro-4-(trimethylsilyl)phenyl) amino)-1-(4-methoxyphenyl)-2-oxoethyl)-3-hydroxy-N-methylisoxazole-5-carboxamide (22) was identified as one of the best of these compds.  It displayed higher subtype selectivity and specificity over other nuclear receptors and demonstrated in vivo potency to suppress the transcriptional activity of RORγt in a mouse PD (pharmacodynamic) model upon oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIW-zVUDTjKLVg90H21EOLACvtfcHk0lhrrpXPBARrOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLbJ&md5=649c3527a6f7e383456dd59551e35628</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DTomata%26aufirst%3DY.%26aulast%3DKono%26aufirst%3DM.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DMasada%26aufirst%3DS.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DYonemori%26aufirst%3DK.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DKoga%26aufirst%3DK.%26aulast%3DOkui%26aufirst%3DT.%26aulast%3DShirasaki%26aufirst%3DM.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DSang%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DI.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DFujitani%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520orally%2520efficacious%2520ROR%25CE%25B3t%2520inverse%2520agonists%252C%2520part%25201%253A%2520Identification%2520of%2520novel%2520phenylglycinamides%2520as%2520lead%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D483%26epage%3D500%26doi%3D10.1016%2Fj.bmc.2017.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yukawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujitani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmc.2017.12.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=470-482&author=M.+Konoauthor=T.+Odaauthor=M.+Tawadaauthor=T.+Imadaauthor=Y.+Bannoauthor=N.+Tayaauthor=T.+Kawamotoauthor=H.+Tokuharaauthor=Y.+Tomataauthor=N.+Ishiiauthor=A.+Ochidaauthor=Y.+Fukaseauthor=T.+Yukawaauthor=S.+Fukumotoauthor=H.+Watanabeauthor=K.+Ugaauthor=A.+Shibataauthor=H.+Nakagawaauthor=M.+Shirasakiauthor=Y.+Fujitaniauthor=M.+Yamasakiauthor=J.+Shiraiauthor=S.+Yamamoto&title=Discovery+of+orally+efficacious+ROR%CE%B3t+inverse+agonists.+Part+2%3A+Design%2C+synthesis%2C+and+biological+evaluation+of+novel+tetrahydroisoquinoline+derivatives&doi=10.1016%2Fj.bmc.2017.12.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DOda%26aufirst%3DT.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DImada%26aufirst%3DT.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DTaya%26aufirst%3DN.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DTokuhara%26aufirst%3DH.%26aulast%3DTomata%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DYukawa%26aufirst%3DT.%26aulast%3DFukumoto%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DShirasaki%26aufirst%3DM.%26aulast%3DFujitani%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520orally%2520efficacious%2520ROR%25CE%25B3t%2520inverse%2520agonists.%2520Part%25202%253A%2520Design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520tetrahydroisoquinoline%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D470%26epage%3D482%26doi%3D10.1016%2Fj.bmc.2017.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karmakar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemagiri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raut, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pudzianowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borowski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arienzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galella, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somerville, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, T. G. M.</span></span> <span> </span><span class="NLM_article-title">Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2017.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=29233651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCqtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=85-93&author=H.+Gongauthor=D.+S.+Weinsteinauthor=Z.+Luauthor=J.+J.+W.+Duanauthor=S.+Stachuraauthor=L.+Haqueauthor=A.+Karmakarauthor=H.+Hemagiriauthor=D.+K.+Rautauthor=A.+K.+Guptaauthor=J.+Khanauthor=D.+Camacauthor=J.+S.+Sackauthor=A.+Pudzianowskiauthor=D.-R.+Wuauthor=M.+Yardeauthor=D.-R.+Shenauthor=V.+Borowskiauthor=J.+H.+Xieauthor=H.+Sunauthor=C.+D%E2%80%99Arienzoauthor=M.+Dabrosauthor=M.+A.+Galellaauthor=F.+Wangauthor=C.+A.+Weigeltauthor=Q.+Zhaoauthor=W.+Fosterauthor=J.+E.+Somervilleauthor=L.+M.+Salter-Cidauthor=J.+C.+Barrishauthor=P.+H.+Carterauthor=T.+G.+M.+Dhar&title=Identification+of+bicyclic+hexafluoroisopropyl+alcohol+sulfonamides+as+retinoic+acid+receptor-related+orphan+receptor+gamma+%28ROR%CE%B3%2FRORc%29+inverse+agonists.+Employing+structure-based+drug+design+to+improve+pregnane+X+receptor+%28PXR%29+selectivity&doi=10.1016%2Fj.bmcl.2017.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity</span></div><div class="casAuthors">Gong, Hua; Weinstein, David S.; Lu, Zhonghui; Duan, James J.-W.; Stachura, Sylwia; Haque, Lauren; Karmakar, Ananta; Hemagiri, Hemalatha; Raut, Dhanya Kumar; Gupta, Arun Kumar; Khan, Javed; Camac, Dan; Sack, John S.; Pudzianowski, Andrew; Wu, Dauh-Rurng; Yarde, Melissa; Shen, Ding-Ren; Borowski, Virna; Xie, Jenny H.; Sun, Huadong; D'Arienzo, Celia; Dabros, Marta; Galella, Michael A.; Wang, Faye; Weigelt, Carolyn A.; Zhao, Qihong; Foster, William; Somerville, John E.; Salter-Cid, Luisa M.; Barrish, Joel C.; Carter, Percy H.; Dhar, T. G. Murali</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-93</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We disclose the optimization of a high throughput screening hit to yield benzothiazine and tetrahydroquinoline sulfonamides as potent RORγt inverse agonists.  However, a majority of these compds. showed potent activity against pregnane X receptor (PXR) and modest activity against liver X receptor α (LXRα).  Structure-based drug design (SBDD) led to the identification of benzothiazine and tetrahydroquinoline sulfonamide analogs which completely dialed out LXRα activity and were less potent at PXR.  Pharmacodynamic (PD) data for compd. 35 in an IL-23 induced IL-17 mouse model is discussed along with the implications of a high Ymax in the PXR assay for long term preclin. pharmacokinetic (PK) studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosFyMm8wpiSbVg90H21EOLACvtfcHk0lh2jg2G9jJBjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCqtr%252FJ&md5=be0dfef2d7494dca1979711a03ac7878</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DH.%26aulast%3DWeinstein%26aufirst%3DD.%2BS.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DDuan%26aufirst%3DJ.%2BJ.%2BW.%26aulast%3DStachura%26aufirst%3DS.%26aulast%3DHaque%26aufirst%3DL.%26aulast%3DKarmakar%26aufirst%3DA.%26aulast%3DHemagiri%26aufirst%3DH.%26aulast%3DRaut%26aufirst%3DD.%2BK.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DPudzianowski%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DD.-R.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DD.-R.%26aulast%3DBorowski%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%26aulast%3DDabros%26aufirst%3DM.%26aulast%3DGalella%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DFoster%26aufirst%3DW.%26aulast%3DSomerville%26aufirst%3DJ.%2BE.%26aulast%3DSalter-Cid%26aufirst%3DL.%2BM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DIdentification%2520of%2520bicyclic%2520hexafluoroisopropyl%2520alcohol%2520sulfonamides%2520as%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520gamma%2520%2528ROR%25CE%25B3%252FRORc%2529%2520inverse%2520agonists.%2520Employing%2520structure-based%2520drug%2520design%2520to%2520improve%2520pregnane%2520X%2520receptor%2520%2528PXR%2529%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D85%26epage%3D93%26doi%3D10.1016%2Fj.bmcl.2017.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kummer, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutter, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharoof, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalk-Hihi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span> <span> </span><span class="NLM_article-title">Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2047</span>– <span class="NLM_lpage">2057</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2017.02.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=28318945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2047-2057&author=D.+A.+Kummerauthor=M.+D.+Cummingsauthor=M.+Abadauthor=J.+Barbayauthor=G.+Castroauthor=R.+Wolinauthor=K.+D.+Kreutterauthor=U.+Maharoofauthor=C.+Milliganauthor=R.+Nishimuraauthor=J.+Pierceauthor=C.+Schalk-Hihiauthor=J.+Spurlinoauthor=M.+Urbanskiauthor=H.+Venkatesanauthor=A.+Wangauthor=C.+Woodsauthor=X.+Xueauthor=J.+P.+Edwardsauthor=A.+M.+Fourieauthor=K.+Leonard&title=Identification+and+structure+activity+relationships+of+quinoline+tertiary+alcohol+modulators+of+ROR%CE%B3t&doi=10.1016%2Fj.bmcl.2017.02.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt</span></div><div class="casAuthors">Kummer, David A.; Cummings, Maxwell D.; Abad, Marta; Barbay, Joseph; Castro, Glenda; Wolin, Ronald; Kreutter, Kevin D.; Maharoof, Umar; Milligan, Cynthia; Nishimura, Rachel; Pierce, Joan; Schalk-Hihi, Celine; Spurlino, John; Urbanski, Maud; Venkatesan, Hariharan; Wang, Aihua; Woods, Craig; Xue, Xiaohua; Edwards, James P.; Fourie, Anne M.; Leonard, Kristi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2047-2057</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A high-throughput screen of the ligand binding domain of the nuclear receptor retinoic acid-related orphan receptor gamma t (RORγt) employing a thermal shift assay yielded a quinoline tertiary alc. hit.  Optimization of the 2-, 3- and 4-positions of the quinoline core using structure-activity relationships and structure-based drug design methods led to the discovery of a series of modulators with improved RORγt inhibitory potency and inverse agonism properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpK1Jvozgl87Vg90H21EOLACvtfcHk0lh2jg2G9jJBjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKrt7Y%253D&md5=29a4b89fa5d539dbac771a720feeb6ee</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.044%26sid%3Dliteratum%253Aachs%26aulast%3DKummer%26aufirst%3DD.%2BA.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DAbad%26aufirst%3DM.%26aulast%3DBarbay%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DWolin%26aufirst%3DR.%26aulast%3DKreutter%26aufirst%3DK.%2BD.%26aulast%3DMaharoof%26aufirst%3DU.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DNishimura%26aufirst%3DR.%26aulast%3DPierce%26aufirst%3DJ.%26aulast%3DSchalk-Hihi%26aufirst%3DC.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DUrbanski%26aufirst%3DM.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DWoods%26aufirst%3DC.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DEdwards%26aufirst%3DJ.%2BP.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DLeonard%26aufirst%3DK.%26atitle%3DIdentification%2520and%2520structure%2520activity%2520relationships%2520of%2520quinoline%2520tertiary%2520alcohol%2520modulators%2520of%2520ROR%25CE%25B3t%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2047%26epage%3D2057%26doi%3D10.1016%2Fj.bmcl.2017.02.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutter, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummer, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharoof, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalk-Hihi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanis, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span> <span> </span><span class="NLM_article-title">6-Substituted quinolines as RORγt inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5277</span>– <span class="NLM_lpage">5283</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2017.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=29079472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslejsbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5277-5283&author=J.+K.+Barbayauthor=M.+D.+Cummingsauthor=M.+Abadauthor=G.+Castroauthor=K.+D.+Kreutterauthor=D.+A.+Kummerauthor=U.+Maharoofauthor=C.+Milliganauthor=R.+Nishimuraauthor=J.+Pierceauthor=C.+Schalk-Hihiauthor=J.+Spurlinoauthor=V.+M.+Tanisauthor=M.+Urbanskiauthor=H.+Venkatesanauthor=A.+Wangauthor=C.+Woodsauthor=R.+Wolinauthor=X.+Xueauthor=J.+P.+Edwardsauthor=A.+M.+Fourieauthor=K.+Leonard&title=6-Substituted+quinolines+as+ROR%CE%B3t+inverse+agonists&doi=10.1016%2Fj.bmcl.2017.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">6-Substituted quinolines as RORγt inverse agonists</span></div><div class="casAuthors">Barbay, J. Kent; Cummings, Maxwell D.; Abad, Marta; Castro, Glenda; Kreutter, Kevin D.; Kummer, David A.; Maharoof, Umar; Milligan, Cynthia; Nishimura, Rachel; Pierce, Joan; Schalk-Hihi, Celine; Spurlino, John; Tanis, Virginia M.; Urbanski, Maud; Venkatesan, Hariharan; Wang, Aihua; Woods, Craig; Wolin, Ronald; Xue, Xiaohua; Edwards, James P.; Fourie, Anne M.; Leonard, Kristi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5277-5283</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We identified 6-substituted quinolines as modulators of the retinoic acid receptor-related orphan receptor gamma t (RORγt).  The synthesis of this class of RORγt modulators is reported, and optimization of the substituents at the quinoline 6-position that produced compds. with high affinity for the receptor is detailed.  This effort identified mols. that act as potent, full inverse agonists in a RORγt-driven cell-based reporter assay.  The X-ray crystal structures of two full inverse agonists, I and II, from this chem. series bound to the RORγt ligand binding domain are disclosed, and we highlight the interaction of a hydrogen-bond acceptor on the 6-position substituent of the inverse agonist with Glu379:NH as a conserved binding contact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmNK7flW-DSbVg90H21EOLACvtfcHk0ljfGDdbu8FtLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslejsbrO&md5=7df780bf52c1750414412d1c0067e280</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DAbad%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DKreutter%26aufirst%3DK.%2BD.%26aulast%3DKummer%26aufirst%3DD.%2BA.%26aulast%3DMaharoof%26aufirst%3DU.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DNishimura%26aufirst%3DR.%26aulast%3DPierce%26aufirst%3DJ.%26aulast%3DSchalk-Hihi%26aufirst%3DC.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DTanis%26aufirst%3DV.%2BM.%26aulast%3DUrbanski%26aufirst%3DM.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DWoods%26aufirst%3DC.%26aulast%3DWolin%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DEdwards%26aufirst%3DJ.%2BP.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DLeonard%26aufirst%3DK.%26atitle%3D6-Substituted%2520quinolines%2520as%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5277%26epage%3D5283%26doi%3D10.1016%2Fj.bmcl.2017.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soroosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna-Roman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenkrants, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria-Babi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlueter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budelsky, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic modulation of RORgt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">37977</span>, <span class="refDoi"> DOI: 10.1038/srep37977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fsrep37977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27905482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWnsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=37977&author=X.+Xueauthor=P.+Sorooshauthor=A.+De+Leon-Tabaldoauthor=R.+Luna-Romanauthor=M.+Sabladauthor=N.+Rozenkrantsauthor=J.+Yuauthor=G.+Castroauthor=H.+Banieauthor=W.+P.+Fung-Leungauthor=L.+Santamaria-Babiauthor=T.+Schlueterauthor=M.+Albersauthor=K.+Leonardauthor=A.+L.+Budelskyauthor=A.+M.+Fourie&title=Pharmacologic+modulation+of+RORgt+translates+to+efficacy+in+preclinical+and+translational+models+of+psoriasis+and+inflammatory+arthritis&doi=10.1038%2Fsrep37977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis</span></div><div class="casAuthors">Xue, Xiaohua; Soroosh, Pejman; De Leon-Tabaldo, Aimee; Luna-Roman, Rosa; Sablad, Marciano; Rozenkrants, Natasha; Yu, Jingxue; Castro, Glenda; Banie, Homayon; Fung-Leung, Wai-Ping; Santamaria-Babi, Luis; Schlueter, Thomas; Albers, Michael; Leonard, Kristi; Budelsky, Alison L.; Fourie, Anne M.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37977</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The IL-23/IL-17 pathway is implicated in autoimmune diseases, particularly psoriasis, where biologics targeting IL-23 and IL-17 have shown significant clin. efficacy.  Retinoid-related orphan nuclear receptor gamma t (RORγt) is required for Th17 differentiation and IL-17 prodn. in adaptive and innate immune cells.  We identified JNJ-54271074, a potent and highly-selective RORγt inverse agonist, which dose-dependently inhibited RORγt-driven transcription, decreased co-activator binding and promoted interaction with co-repressor protein.  This compd. selectively blocked Th17 differentiation, significantly reduced IL-17A prodn. from memory T cells, and decreased IL-17A- and IL-22-producing human and murine γδ and NKT cells.  In a murine collagen-induced arthritis model, JNJ-54271074 dose-dependently suppressed joint inflammation.  Furthermore, JNJ-54271074 suppressed IL-17A prodn. in human PBMC from rheumatoid arthritis patients.  RORγt-deficient mice showed decreased IL-23-induced psoriasis-like skin inflammation and cytokine gene expression, consistent with dose-dependent inhibition in wild-type mice through oral dosing of JNJ-54271074.  In a translational model of human psoriatic epidermal cells and skin-homing T cells, JNJ-54271074 selectively inhibited streptococcus ext.-induced IL-17A and IL-17F.  JNJ-54271074 is thus a potent, selective RORγt modulator with therapeutic potential in IL-23/IL-17 mediated autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6V70xff8x77Vg90H21EOLACvtfcHk0ljfGDdbu8FtLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWnsr3F&md5=2dea294b5db93b110af4818dbfcb589b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsrep37977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep37977%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DDe%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DLuna-Roman%26aufirst%3DR.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DBanie%26aufirst%3DH.%26aulast%3DFung-Leung%26aufirst%3DW.%2BP.%26aulast%3DSantamaria-Babi%26aufirst%3DL.%26aulast%3DSchlueter%26aufirst%3DT.%26aulast%3DAlbers%26aufirst%3DM.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DBudelsky%26aufirst%3DA.%2BL.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26atitle%3DPharmacologic%2520modulation%2520of%2520RORgt%2520translates%2520to%2520efficacy%2520in%2520preclinical%2520and%2520translational%2520models%2520of%2520psoriasis%2520and%2520inflammatory%2520arthritis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D37977%26doi%3D10.1038%2Fsrep37977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.-l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1516</span>– <span class="NLM_lpage">1524</span>, <span class="refDoi"> DOI: 10.1038/aps.2016.32</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Faps.2016.32" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=1516-1524&author=X.-S.+Wuauthor=R.+Wangauthor=Y.-l.+Xingauthor=X.-q.+Xueauthor=Y.+Zhangauthor=Y.-z.+Luauthor=Y.+Songauthor=X.-Y.+Luoauthor=C.+Wuauthor=Y.-l.+Zhouauthor=J.-q.+Jiangauthor=Y.+Xu&title=Discovery+and+structural+optimization+of+4-%284-%28benzyloxy%29phenyl%29-3%2C4-dihydropyrimidin-2%281H%29-ones+as+RORc+inverse+agonists&doi=10.1038%2Faps.2016.32"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Faps.2016.32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2016.32%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.-S.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DXing%26aufirst%3DY.-l.%26aulast%3DXue%26aufirst%3DX.-q.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.-z.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DX.-Y.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DY.-l.%26aulast%3DJiang%26aufirst%3DJ.-q.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520structural%2520optimization%2520of%25204-%25284-%2528benzyloxy%2529phenyl%2529-3%252C4-dihydropyrimidin-2%25281H%2529-ones%2520as%2520RORc%2520inverse%2520agonists%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2016%26volume%3D37%26spage%3D1516%26epage%3D1524%26doi%3D10.1038%2Faps.2016.32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rene, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4455</span>– <span class="NLM_lpage">4461</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.07.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2016.07.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27524313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCit7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4455-4461&author=O.+Reneauthor=B.+P.+Fauberauthor=A.+Barnardauthor=K.+Chapmanauthor=Y.+Dengauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=A.+R.+Johnsonauthor=H.+Laauthor=M.+Normanauthor=G.+Salmonauthor=S.+Summerhillauthor=H.+Wong&title=Discovery+of+oxa-sultams+as+RORc+inverse+agonists+showing+reduced+lipophilicity%2C+improved+selectivity+and+favorable+ADME+properties&doi=10.1016%2Fj.bmcl.2016.07.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME properties</span></div><div class="casAuthors">Rene, Olivier; Fauber, Benjamin P.; Barnard, Adrian; Chapman, Kerry; Deng, Yuzhong; Eidenschenk, Celine; Everett, Christine; Gobbi, Alberto; Johnson, Adam R.; La, Hank; Norman, Maxine; Salmon, Gary; Summerhill, Susan; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4455-4461</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Modification of the δ-sultam ring of RORc inverse agonist 2 led to the discovery of more polar oxa-sultam 65.  The less lipophilic inverse agonist (65) displayed high potency in a biochem. assay, which translated into inhibition of IL-17 prodn. in human peripheral blood mononuclear cells.  The successful redn. of lipophilicity of this new analog gave rise to addnl. improvements in ROR selectivity and aq. kinetic soly., as well as redn. in plasma protein binding, while maintaining high cellular permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptgLNGbT0tzrVg90H21EOLACvtfcHk0lg9pvlUw9xe7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCit7nO&md5=59c6fb759488c507052efaffafc9a17b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.07.081%26sid%3Dliteratum%253Aachs%26aulast%3DRene%26aufirst%3DO.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DBarnard%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DSalmon%26aufirst%3DG.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520oxa-sultams%2520as%2520RORc%2520inverse%2520agonists%2520showing%2520reduced%2520lipophilicity%252C%2520improved%2520selectivity%2520and%2520favorable%2520ADME%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4455%26epage%3D4461%26doi%3D10.1016%2Fj.bmcl.2016.07.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aagaard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPheat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirholt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grindebacke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span> <span> </span><span class="NLM_article-title">Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1002%2Fcmdc.201500432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=26553345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=207-216&author=R.+I.+Olssonauthor=Y.+Xueauthor=S.+von+Bergauthor=A.+Aagaardauthor=J.+McPheatauthor=E.+L.+Hanssonauthor=J.+Bernstroemauthor=P.+Hanssonauthor=J.+Jirholtauthor=H.+Grindebackeauthor=A.+Lefflerauthor=R.+Chenauthor=Y.+Xiongauthor=H.+Geauthor=T.+G.+Hanssonauthor=F.+Narjes&title=Benzoxazepines+Achieve+Potent+Suppression+of+IL-17+Release+in+Human+T-Helper+17+%28TH17%29+Cells+through+an+Induced-Fit+Binding+Mode+to+the+Nuclear+Receptor+ROR%CE%B3&doi=10.1002%2Fcmdc.201500432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ</span></div><div class="casAuthors">Olsson, Roine I.; Xue, Yafeng; von Berg, Stefan; Aagaard, Anna; McPheat, Jane; Hansson, Eva L.; Bernstroem, Jenny; Hansson, Pia; Jirholt, Johan; Grindebacke, Hanna; Leffler, Agnes; Chen, Rongfeng; Xiong, Yao; Ge, Hongbin; Hansson, Thomas G.; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">RORγt, an isoform of the retinoic acid-related orphan receptor gamma (RORc, RORγ), has been identified as the master regulator of T-helper 17 (TH17) cell function and development, making it an attractive target for the treatment of autoimmune diseases.  Validation for this target comes from antibodies targeting interleukin-17 (IL-17), the signature cytokine produced by TH17 cells, which have shown impressive results in clin. trials.  Through focused screening of our compd. collection, we identified a series of N-sulfonylated benzoxazepines, which displayed micromolar affinity for the RORγ ligand-binding domain (LBD) in a radioligand binding assay.  Optimization of these initial hits resulted in potent binders, which dose-dependently decreased the ability of the RORγ-LBD to interact with a peptide derived from steroid receptor coactivator 1, and inhibited the release of IL-17 secretion from isolated and cultured human TH17 cells with nanomolar potency.  A cocrystal structure of inverse agonist 15 (2-chloro-6-fluoro-N-(4-{[3-(trifluoromethyl)phenyl]sulfonyl}-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)benzamide) bound to the RORγ-LBD illustrated that both hydrophobic interactions, leading to an induced fit around the substituted benzamide moiety of 15, as well as a hydrogen bond from the amide NH to His479 seemed to be important for the mechanism of action.  This structure is compared with the structure of agonist 25 (N-(2-fluorophenyl)-4-[(4-fluorophenyl)sulfonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-6-amine ) and structures of other known RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorSpjXrs3zSrVg90H21EOLACvtfcHk0lg9pvlUw9xe7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N&md5=ed6fa69d887818da7acd4f9abbd2ff93</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500432%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DR.%2BI.%26aulast%3DXue%26aufirst%3DY.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DAagaard%26aufirst%3DA.%26aulast%3DMcPheat%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DE.%2BL.%26aulast%3DBernstroem%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJirholt%26aufirst%3DJ.%26aulast%3DGrindebacke%26aufirst%3DH.%26aulast%3DLeffler%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DH.%26aulast%3DHansson%26aufirst%3DT.%2BG.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DBenzoxazepines%2520Achieve%2520Potent%2520Suppression%2520of%2520IL-17%2520Release%2520in%2520Human%2520T-Helper%252017%2520%2528TH17%2529%2520Cells%2520through%2520an%2520Induced-Fit%2520Binding%2520Mode%2520to%2520the%2520Nuclear%2520Receptor%2520ROR%25CE%25B3%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D207%26epage%3D216%26doi%3D10.1002%2Fcmdc.201500432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obika, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asahina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aratsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steensma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiozaki, M.</span></span> <span> </span><span class="NLM_article-title">SAR Exploration Guided by LE and Fsp3: Discovery of a Selective and Orally Efficacious RORγ Inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00253</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00253" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKlt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=23-27&author=K.+Hirataauthor=M.+Kotokuauthor=N.+Sekiauthor=T.+Maebaauthor=K.+Maedaauthor=S.+Hirashimaauthor=T.+Sakaiauthor=S.+Obikaauthor=A.+Horiauthor=Y.+Haseauthor=T.+Yamaguchiauthor=Y.+Katsudaauthor=T.+Hataauthor=N.+Miyagawaauthor=K.+Aritaauthor=Y.+Nomuraauthor=K.+Asahinaauthor=Y.+Aratsuauthor=M.+Kamadaauthor=T.+Adachiauthor=M.+Noguchiauthor=S.+Doiauthor=P.+Croweauthor=E.+Bradleyauthor=R.+Steensmaauthor=H.+Taoauthor=M.+Fennauthor=R.+Babineauthor=X.+Liauthor=S.+Thacherauthor=H.+Hashimotoauthor=M.+Shiozaki&title=SAR+Exploration+Guided+by+LE+and+Fsp3%3A+Discovery+of+a+Selective+and+Orally+Efficacious+ROR%CE%B3+Inhibitor&doi=10.1021%2Facsmedchemlett.5b00253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">SAR Exploration Guided by LE and Fsp3: Discovery of a Selective and Orally Efficacious RORγ Inhibitor</span></div><div class="casAuthors">Hirata, Kazuyuki; Kotoku, Masayuki; Seki, Noriyoshi; Maeba, Takaki; Maeda, Katsuya; Hirashima, Shintaro; Sakai, Takayuki; Obika, Shingo; Hori, Akimi; Hase, Yasunori; Yamaguchi, Takayuki; Katsuda, Yoshiaki; Hata, Takahiro; Miyagawa, Naoki; Arita, Kojo; Nomura, Yukihiro; Asahina, Kota; Aratsu, Yusuke; Kamada, Masafumi; Adachi, Tsuyoshi; Noguchi, Masato; Doi, Satoki; Crowe, Paul; Bradley, Erin; Steensma, Ruo; Tao, Haiyan; Fenn, Morgan; Babine, Robert; Li, Xiaolin; Thacher, Scott; Hashimoto, Hiromasa; Shiozaki, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of RORγ inhibitors was identified starting with the HTS hit compd. 2-(5-(2,3-dihydro-1H-inden-2-yl)-4-ethyl-4-H-1,2,4-triazol-3-ylthio)-N-(naphthalen-1-yl)acetamide.  After SAR investigation based on a prospective consideration of two drug-likeness metrics, ligand efficiency (LE) and fraction of Sp3 carbon atoms (Fsp3), significant improvement of metabolic stability as well as redn. of CYP inhibition was obsd., which finally led to discovery of a selective and orally efficacious RORγ inhibitor (3R,4R)-1-acetyl-4-(4-cyclopropyl-5-(cis-3-isobutylcyclobutyl)-4H-1,2,4-triazol-3-yl)-M-(2,4-dimethylphenyl) pyrrolidine-3-carboxamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojA7KFHVtsOrVg90H21EOLACvtfcHk0lg9pvlUw9xe7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKlt77P&md5=fc2736f8baafee2084bb3adce7bb1a2e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00253%26sid%3Dliteratum%253Aachs%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DKotoku%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DMaeba%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DObika%26aufirst%3DS.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DKatsuda%26aufirst%3DY.%26aulast%3DHata%26aufirst%3DT.%26aulast%3DMiyagawa%26aufirst%3DN.%26aulast%3DArita%26aufirst%3DK.%26aulast%3DNomura%26aufirst%3DY.%26aulast%3DAsahina%26aufirst%3DK.%26aulast%3DAratsu%26aufirst%3DY.%26aulast%3DKamada%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DCrowe%26aufirst%3DP.%26aulast%3DBradley%26aufirst%3DE.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DFenn%26aufirst%3DM.%26aulast%3DBabine%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DThacher%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DShiozaki%26aufirst%3DM.%26atitle%3DSAR%2520Exploration%2520Guided%2520by%2520LE%2520and%2520Fsp3%253A%2520Discovery%2520of%2520a%2520Selective%2520and%2520Orally%2520Efficacious%2520ROR%25CE%25B3%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D23%26epage%3D27%26doi%3D10.1021%2Facsmedchemlett.5b00253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rene, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-{4-[3-Fluoro-4-((3S,6R)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5308</span>– <span class="NLM_lpage">5322</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVansL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5308-5322&author=B.+P.+Fauberauthor=O.+Reneauthor=Y.+Dengauthor=J.+DeVossauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Ganguliauthor=A.+Gobbiauthor=J.+Hawkinsauthor=A.+R.+Johnsonauthor=H.+Laauthor=J.+Leschauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=S.+Summerhillauthor=H.+Wong&title=Discovery+of+1-%7B4-%5B3-Fluoro-4-%28%283S%2C6R%29-3-methyl-1%2C1-dioxo-6-phenyl-%5B1%2C2%5Dthiazinan-2-ylmethyl%29-phenyl%5D-piperazin-1-yl%7D-ethanone+%28GNE-3500%29%3A+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+Retinoic+Acid+Receptor-Related+Orphan+Receptor+C+%28RORc+or+ROR%CE%B3%29+Inverse+Agonist&doi=10.1021%2Facs.jmedchem.5b00597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1-{4-[3-Fluoro-4-((3S,6R)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist</span></div><div class="casAuthors">Fauber, Benjamin P.; Rene, Olivier; Deng, Yuzhong; DeVoss, Jason; Eidenschenk, Celine; Everett, Christine; Ganguli, Arunima; Gobbi, Alberto; Hawkins, Julie; Johnson, Adam R.; La, Hank; Lesch, Justin; Lockey, Peter; Norman, Maxine; Ouyang, Wenjun; Summerhill, Susan; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5308-5322</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptor C (RORc, RORγ, or NR1F3) is a nuclear receptor that plays a major role in the prodn. of interleukin (IL)-17.  Considerable efforts have been directed toward the discovery of selective RORc inverse agonists as potential treatments of inflammatory diseases such as psoriasis and rheumatoid arthritis.  Using the previously reported tertiary sulfonamide as a starting point, the authors engineered structural modifications that significantly improved human and rat metabolic stabilities while maintaining a potent and highly selective RORc inverse agonist profile.  The most advanced δ-sultam compd. I possessed favorable RORc cellular potency with 75-fold selectivity for RORc over other ROR family members and >200-fold selectivity over 25 addnl. nuclear receptors in a cell assay panel.  The favorable potency, selectivity, in vitro ADME properties, in vivo PK, and dose-dependent inhibition of IL-17 in a PK/PD model support the evaluation of I in preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgSG0WeUAvc7Vg90H21EOLACvtfcHk0li59J3cNZYQbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVansL3M&md5=86f291aa61281c4ec98a34cdd31963e0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00597%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DRene%26aufirst%3DO.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGanguli%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLesch%26aufirst%3DJ.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%25201-%257B4-%255B3-Fluoro-4-%2528%25283S%252C6R%2529-3-methyl-1%252C1-dioxo-6-phenyl-%255B1%252C2%255Dthiazinan-2-ylmethyl%2529-phenyl%255D-piperazin-1-yl%257D-ethanone%2520%2528GNE-3500%2529%253A%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520C%2520%2528RORc%2520or%2520ROR%25CE%25B3%2529%2520Inverse%2520Agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5308%26epage%3D5322%26doi%3D10.1021%2Facs.jmedchem.5b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00122</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00122" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=787-792&author=Y.+Wangauthor=W.+Caiauthor=Y.+Chengauthor=T.+Yangauthor=Q.+Liuauthor=G.+Zhangauthor=Q.+Mengauthor=F.+Hanauthor=Y.+Huangauthor=L.+Zhouauthor=Z.+Xiangauthor=Y.-G.+Zhaoauthor=Y.+Xuauthor=Z.+Chengauthor=S.+Luauthor=Q.+Wuauthor=J.-N.+Xiangauthor=J.+D.+Elliottauthor=S.+Leungauthor=F.+Renauthor=X.+Lin&title=Discovery+of+Biaryl+Amides+as+Potent%2C+Orally+Bioavailable%2C+and+CNS+Penetrant+ROR%CE%B3t+Inhibitors&doi=10.1021%2Facsmedchemlett.5b00122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors</span></div><div class="casAuthors">Wang, Yonghui; Cai, Wei; Cheng, Yaobang; Yang, Ting; Liu, Qian; Zhang, Guifeng; Meng, Qinghua; Han, Fangbin; Huang, Yafei; Zhou, Ling; Xiang, Zhijun; Zhao, Yong-Gang; Xu, Yan; Cheng, Ziqiang; Lu, Sijie; Wu, Qianqian; Xiang, Jia-Ning; Elliott, John D.; Leung, Stewart; Ren, Feng; Lin, Xichen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">787-792</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of biaryl amides was identified as RORγt inhibitors through core replacement of a starting hit 1.  Structure-activity relation exploration on the biaryl moiety led to discovery of potent RORγt inhibitors with good oral bioavailability and CNS penetration.  Compds. 9a and 9g demonstrated excellent in vivo efficacy in EAE mice dose dependently with once daily oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRg-_IJY0l47Vg90H21EOLACvtfcHk0li59J3cNZYQbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGmtb8%253D&md5=0011aa5b6e6952ef2f7cfced6ee1b7fc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00122%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DY.-G.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520Biaryl%2520Amides%2520as%2520Potent%252C%2520Orally%2520Bioavailable%252C%2520and%2520CNS%2520Penetrant%2520ROR%25CE%25B3t%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D787%26epage%3D792%26doi%3D10.1021%2Facsmedchemlett.5b00122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yosef, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundrud, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretschmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahl, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2014.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.immuni.2014.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=24745332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVKltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=477-489&author=S.+Xiaoauthor=N.+Yosefauthor=J.+Yangauthor=Y.+Wangauthor=L.+Zhouauthor=C.+Zhuauthor=C.+Wuauthor=E.+Balogluauthor=D.+Schmidtauthor=R.+Rameshauthor=M.+Loberaauthor=M.+S.+Sundrudauthor=P.-Y.+Tsaiauthor=Z.+Xiangauthor=J.+Wangauthor=Y.+Xuauthor=X.+Linauthor=K.+Kretschmerauthor=P.+B.+Rahlauthor=R.+A.+Youngauthor=Z.+Zhongauthor=D.+A.+Haflerauthor=A.+Regevauthor=S.+Ghoshauthor=A.+Marsonauthor=V.+K.+Kuchroo&title=Small-Molecule+ROR%CE%B3t+Antagonists+Inhibit+T+Helper+17+Cell+Transcriptional+Network+by+Divergent+Mechanisms&doi=10.1016%2Fj.immuni.2014.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms</span></div><div class="casAuthors">Xiao, Sheng; Yosef, Nir; Yang, Jianfei; Wang, Yonghui; Zhou, Ling; Zhu, Chen; Wu, Chuan; Baloglu, Erkan; Schmidt, Darby; Ramesh, Radha; Lobera, Mercedes; Sundrud, Mark S.; Tsai, Pei-Yun; Xiang, Zhijun; Wang, Jinsong; Xu, Yan; Lin, Xichen; Kretschmer, Karsten; Rahl, Peter B.; Young, Richard A.; Zhong, Zhong; Hafler, David A.; Regev, Aviv; Ghosh, Shomir; Marson, Alexander; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-489</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We identified three retinoid-related orphan receptor gamma t (RORγt)-specific inhibitors that suppress T helper 17 (Th17) cell responses, including Th17-cell-mediated autoimmune disease.  We systemically characterized RORγt binding in the presence and absence of drugs with corresponding whole-genome transcriptome sequencing.  RORγt acts as a direct activator of Th17 cell signature genes and a direct repressor of signature genes from other T cell lineages; its strongest transcriptional effects are on cis-regulatory sites contg. the RORα binding motif.  RORγt is central in a densely interconnected regulatory network that shapes the balance of T cell differentiation.  Here, the three inhibitors modulated the RORγt-dependent transcriptional network to varying extents and through distinct mechanisms.  Whereas one inhibitor displaced RORγt from its target loci, the other two inhibitors affected transcription predominantly without removing DNA binding.  Our work illustrates the power of a system-scale anal. of transcriptional regulation to characterize potential therapeutic compds. that inhibit pathogenic Th17 cells and suppress autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo23p8R83CDDbVg90H21EOLACvtfcHk0lhCrh-YpmkYcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVKltr0%253D&md5=940074c565211bc00832179574e5231a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2014.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DYosef%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBaloglu%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DSundrud%26aufirst%3DM.%2BS.%26aulast%3DTsai%26aufirst%3DP.-Y.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKretschmer%26aufirst%3DK.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DHafler%26aufirst%3DD.%2BA.%26aulast%3DRegev%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DMarson%26aufirst%3DA.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DSmall-Molecule%2520ROR%25CE%25B3t%2520Antagonists%2520Inhibit%2520T%2520Helper%252017%2520Cell%2520Transcriptional%2520Network%2520by%2520Divergent%2520Mechanisms%26jtitle%3DImmunity%26date%3D2014%26volume%3D40%26spage%3D477%26epage%3D489%26doi%3D10.1016%2Fj.immuni.2014.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gege, C.</span></span> <span> </span><span class="NLM_article-title">Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">744</span>, <span class="refDoi"> DOI: 10.1517/13543776.2016.1153066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1517%2F13543776.2016.1153066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=26895086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslKht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=737-744&author=C.+Gege&title=Retinoid-related+orphan+receptor+gamma+t+%28ROR%CE%B3t%29+inhibitors+from+Vitae+Pharmaceuticals+%28WO2015116904%29+and+structure+proposal+for+their+Phase+I+candidate+VTP-43742&doi=10.1517%2F13543776.2016.1153066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742</span></div><div class="casAuthors">Gege, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-744</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan nuclear receptor gamma t (RORγt or RORC2) is a key transcription factor for the differentiation of naive proinflammatory CD4+ T cells and the prodn. of T helper-17 (TH17) cells.  Inhibiting RORγt activity is thought to be beneficial in targeting a variety of inflammatory and autoimmune disorders, however current candidates remain to be validated in the clinic.  Recently Vitae Pharmaceuticals successfully finished its Phase 1 single ascending dose clin. study with their proprietary RORγt inverse agonist.  On the basis of the reported promising results, Vitae Pharmaceuticals could currently be considered as having the leading clin. candidate in the RORγt inverse agonist category.  This prompts the interest on the exact chem. structure of their clin. candidate.  The first relevant patent application (WO2014179564) from Vitae Pharmaceuticals describes RORγt inverse agonists with a 5,6-dihydro-4H-pyrrolo[3,4-d]thiazole core, while in the second and latest patent application (WO2015116904) this element has changed towards a 6,7-dihydro-5H-pyrrolo[3,4-b]pyridine core.  By combining information from Vitae's patent applications and trustworthy online information, the potential elucidation of the chem. structure of clin. candidate is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGookgjg34nmU7Vg90H21EOLACvtfcHk0lhCrh-YpmkYcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslKht74%253D&md5=f0a556f34d0cd87ee97e630bac6a16cf</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1153066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1153066%26sid%3Dliteratum%253Aachs%26aulast%3DGege%26aufirst%3DC.%26atitle%3DRetinoid-related%2520orphan%2520receptor%2520gamma%2520t%2520%2528ROR%25CE%25B3t%2529%2520inhibitors%2520from%2520Vitae%2520Pharmaceuticals%2520%2528WO2015116904%2529%2520and%2520structure%2520proposal%2520for%2520their%2520Phase%2520I%2520candidate%2520VTP-43742%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D737%26epage%3D744%26doi%3D10.1517%2F13543776.2016.1153066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Mackensen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemetzki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freudenberg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigger-Alberti, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span> <span> </span><span class="NLM_article-title">A Phase I Randomised Controlled Trial to Evaluate Safety and Clinical Effect of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test</span>. <i>Br. J. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">1427</span>, <span class="refDoi"> DOI: 10.1111/bjd.16131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1111%2Fbjd.16131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=29150844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A280%3ADC%252BC1M3isFWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2018&pages=1427&author=E.+G.+Kangauthor=S.+Wuauthor=A.+Guptaauthor=Y.+L.+von+Mackensenauthor=H.+Siemetzkiauthor=J.+M.+Freudenbergauthor=W.+Wigger-Albertiauthor=Y.+Yamaguchi&title=A+Phase+I+Randomised+Controlled+Trial+to+Evaluate+Safety+and+Clinical+Effect+of+Topically+Applied+GSK2981278+Ointment+in+a+Psoriasis+Plaque+Test&doi=10.1111%2Fbjd.16131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test</span></div><div class="casAuthors">Kang E G; Wu S; Gupta A; Freudenberg J M; Yamaguchi Y; von Mackensen Y-L; Siemetzki H; Wigger-Alberti W</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1427-1429</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2LnZBzvo4YtFxYDaSSP8XfW6udTcc2eYca_gt4_wg97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3isFWltg%253D%253D&md5=c480c28f5973de8ccba8f8e290d8e8ab</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fbjd.16131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbjd.16131%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DE.%2BG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3Dvon%2BMackensen%26aufirst%3DY.%2BL.%26aulast%3DSiemetzki%26aufirst%3DH.%26aulast%3DFreudenberg%26aufirst%3DJ.%2BM.%26aulast%3DWigger-Alberti%26aufirst%3DW.%26aulast%3DYamaguchi%26aufirst%3DY.%26atitle%3DA%2520Phase%2520I%2520Randomised%2520Controlled%2520Trial%2520to%2520Evaluate%2520Safety%2520and%2520Clinical%2520Effect%2520of%2520Topically%2520Applied%2520GSK2981278%2520Ointment%2520in%2520a%2520Psoriasis%2520Plaque%2520Test%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2018%26volume%3D178%26spage%3D1427%26doi%3D10.1111%2Fbjd.16131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span> <i>VTP-43742 demonstrated statistically
significant efficacy and was
well tolerated. Company plans to move VTP-43742 forward into 16-week
study. Conference call to discuss results at 5:00 p.m. ET, March 16,
2016. James Krueger, M.D., Ph.D., Head of the Laboratory for Investigative
Dermatology at Rockefeller University, to join call</i>; Press
Release for <span class="NLM_publisher-name">Vitae Pharmaceuticals</span>, March 16, <span class="NLM_year">2016</span>. Available at <a href="http://ir.vitaepharma.com/phoenix.zhtml?c=219654&amp;p=irol-newsArticle&amp;ID=2149044" class="extLink">http://ir.vitaepharma.com/phoenix.zhtml?c=219654&p=irol-newsArticle&ID=2149044</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+VTP-43742+demonstrated+statistically%0Asignificant+efficacy+and+was%0Awell+tolerated.+Company+plans+to+move+VTP-43742+forward+into+16-week%0Astudy.+Conference+call+to+discuss+results+at+5%3A00+p.m.+ET%2C+March+16%2C%0A2016.+James+Krueger%2C+M.D.%2C+Ph.D.%2C+Head+of+the+Laboratory+for+Investigative%0ADermatology+at+Rockefeller+University%2C+to+join+call%3B+Press%0ARelease+for+Vitae+Pharmaceuticals%2C+March+16%2C+2016.+Available+at+http%3A%2F%2Fir.vitaepharma.com%2Fphoenix.zhtml%3Fc%3D219654%26p%3Dirol-newsArticle%26ID%3D2149044."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DVTP-43742%2520demonstrated%2520statistically%250Asignificant%2520efficacy%2520and%2520was%250Awell%2520tolerated.%2520Company%2520plans%2520to%2520move%2520VTP-43742%2520forward%2520into%252016-week%250Astudy.%2520Conference%2520call%2520to%2520discuss%2520results%2520at%25205%253A00%2520p.m.%2520ET%252C%2520March%252016%252C%250A2016.%2520James%2520Krueger%252C%2520M.D.%252C%2520Ph.D.%252C%2520Head%2520of%2520the%2520Laboratory%2520for%2520Investigative%250ADermatology%2520at%2520Rockefeller%2520University%252C%2520to%2520join%2520call%26pub%3DVitae%2520Pharmaceuticals%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillertz, P.</span></span> <span> </span><span class="NLM_article-title">Fragment Screening of RORγt Using Cocktail Crystallography: Identification of Simultaneous Binding of Multiple Fragments</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1881</span>– <span class="NLM_lpage">1885</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1002%2Fcmdc.201600242" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1881-1885&author=Y.+Xueauthor=H.+Guoauthor=P.+Hillertz&title=Fragment+Screening+of+ROR%CE%B3t+Using+Cocktail+Crystallography%3A+Identification+of+Simultaneous+Binding+of+Multiple+Fragments&doi=10.1002%2Fcmdc.201600242"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600242%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DHillertz%26aufirst%3DP.%26atitle%3DFragment%2520Screening%2520of%2520ROR%25CE%25B3t%2520Using%2520Cocktail%2520Crystallography%253A%2520Identification%2520of%2520Simultaneous%2520Binding%2520of%2520Multiple%2520Fragments%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1881%26epage%3D1885%26doi%3D10.1002%2Fcmdc.201600242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Cai, W.</span>; <span class="NLM_string-name">Liu, Q.</span>; <span class="NLM_string-name">Xiang, J.-N.</span></span> <span> </span><span class="NLM_article-title">Preparation of thiazole derivatives as modulators of retinoid-related orphan receptor gamma</span>. <span class="NLM_patent">WO 2012027965</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=Y.+Wang&author=W.+Cai&author=Q.+Liu&author=J.-N.+Xiang&title=Preparation+of+thiazole+derivatives+as+modulators+of+retinoid-related+orphan+receptor+gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520thiazole%2520derivatives%2520as%2520modulators%2520of%2520retinoid-related%2520orphan%2520receptor%2520gamma%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huxdorf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">702</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmc.2013.12.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=692-702&author=Y.+Wangauthor=W.+Caiauthor=G.+Zhangauthor=T.+Yangauthor=Q.+Liuauthor=Y.+Chengauthor=L.+Zhouauthor=Y.+Maauthor=Z.+Chengauthor=S.+Luauthor=Y.-G.+Zhaoauthor=W.+Zhangauthor=Z.+Xiangauthor=S.+Wangauthor=L.+Yangauthor=Q.+Wuauthor=L.+A.+Orband-Millerauthor=Y.+Xuauthor=J.+Zhangauthor=R.+Gaoauthor=M.+Huxdorfauthor=J.-N.+Xiangauthor=Z.+Zhongauthor=J.+D.+Elliottauthor=S.+Leungauthor=X.+Lin&title=Discovery+of+novel+N-%285-%28arylcarbonyl%29thiazol-2-yl%29amides+and+N-%285-%28arylcarbonyl%29thiophen-2-yl%29amides+as+potent+ROR%CE%B3t+inhibitors&doi=10.1016%2Fj.bmc.2013.12.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.-G.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DR.%26aulast%3DHuxdorf%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%2520N-%25285-%2528arylcarbonyl%2529thiazol-2-yl%2529amides%2520and%2520N-%25285-%2528arylcarbonyl%2529thiophen-2-yl%2529amides%2520as%2520potent%2520ROR%25CE%25B3t%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D692%26epage%3D702%26doi%3D10.1016%2Fj.bmc.2013.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5293</span>– <span class="NLM_lpage">5302</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmc.2015.07.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5293-5302&author=Y.+Wangauthor=T.+Yangauthor=Q.+Liuauthor=Y.+Maauthor=L.+Yangauthor=L.+Zhouauthor=Z.+Xiangauthor=Z.+Chengauthor=S.+Luauthor=L.+A.+Orband-Millerauthor=W.+Zhangauthor=Q.+Wuauthor=K.+Zhangauthor=Y.+Liauthor=J.-N.+Xiangauthor=J.+D.+Elliottauthor=S.+Leungauthor=F.+Renauthor=X.+Lin&title=Discovery+of+N-%284-aryl-5-aryloxy-thiazol-2-yl%29-amides+as+potent+ROR%CE%B3t+inverse+agonists&doi=10.1016%2Fj.bmc.2015.07.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.068%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520N-%25284-aryl-5-aryloxy-thiazol-2-yl%2529-amides%2520as%2520potent%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5293%26epage%3D5302%26doi%3D10.1016%2Fj.bmc.2015.07.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izaac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Be, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arista, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span> <span> </span><span class="NLM_article-title">Structural States of RORγt: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1014</span>– <span class="NLM_lpage">1021</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1002%2Fcmdc.201700278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=28590087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFamsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1014-1021&author=J.+Kallenauthor=A.+Izaacauthor=C.+Beauthor=L.+Aristaauthor=D.+Orainauthor=K.+Kaupmannauthor=C.+Guntermannauthor=K.+Hoegenauerauthor=S.+Hintermann&title=Structural+States+of+ROR%CE%B3t%3A+X-ray+Elucidation+of+Molecular+Mechanisms+and+Binding+Interactions+for+Natural+and+Synthetic+Compounds&doi=10.1002%2Fcmdc.201700278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structural States of RORγt: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds</span></div><div class="casAuthors">Kallen, Joerg; Izaac, Aude; Be, Celine; Arista, Luca; Orain, David; Kaupmann, Klemens; Guntermann, Christine; Hoegenauer, Klemens; Hintermann, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1014-1021</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The T-cell-specific retinoic acid receptor (RAR)-related orphan receptor-γ (RORγt) is a key transcription factor for the prodn. of pro-inflammatory Th17 cytokines, which are implicated in the pathogenesis of autoimmune diseases.  Over the years, several structurally diverse RORγt inverse agonists have been reported, but combining high potency and good physicochem. properties has remained a challenging task.  We recently reported a new series of inverse agonists based on an imidazopyridine core with good physicochem. properties and excellent selectivity.  Herein we report eight new X-ray crystal structures for different classes of natural and synthetic compds., including examples selected from the patent literature.  Anal. of their resp. binding modes revealed insight into the mol. mechanisms that lead to agonism, antagonism, or inverse agonism.  We report new mol. mechanisms for RORγt agonism and propose a sepn. of the inverse agonists into two classes: those that act via steric clash and those that act via other mechanisms (for the latter, co-crystn. with a co-activator peptide and helix 12 in the agonist position is still possible).  For the non-steric clash inverse agonists, we propose a new mechanism ("water trapping") which can be combined with other mechanisms (e.g., close contacts with H479).  In addn., we compare the interactions made for selected compds. in the "back pocket" near S404 and in the "sulfate pocket" near R364 and R367.  Taken together, these new mechanistic insights should prove useful for the design and optimization of further RORγt modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2bJdGLB1okrVg90H21EOLACvtfcHk0lgeIC1tqr_obg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFamsrvK&md5=c49d7d9710f6c4f7baed7e7b207a0bf7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700278%26sid%3Dliteratum%253Aachs%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DIzaac%26aufirst%3DA.%26aulast%3DBe%26aufirst%3DC.%26aulast%3DArista%26aufirst%3DL.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DHintermann%26aufirst%3DS.%26atitle%3DStructural%2520States%2520of%2520ROR%25CE%25B3t%253A%2520X-ray%2520Elucidation%2520of%2520Molecular%2520Mechanisms%2520and%2520Binding%2520Interactions%2520for%2520Natural%2520and%2520Synthetic%2520Compounds%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D1014%26epage%3D1021%26doi%3D10.1002%2Fcmdc.201700278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span> <span> </span><span class="NLM_article-title">From RORγt agonists to two types of RORgt inverse agonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00476</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00476" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=120-124&author=Y.+Wangauthor=W.+Caiauthor=T.+Tangauthor=Q.+Liuauthor=T.+Yangauthor=L.+Yangauthor=Y.+Maauthor=G.+Zhangauthor=Y.+Huangauthor=S.+Songauthor=L.+A.+Orband-Millerauthor=Q.+Wuauthor=L.+Zhouauthor=Z.+Xiangauthor=J.-N.+Xiangauthor=S.+Leungauthor=L.+Shaoauthor=X.+Linauthor=M.+Loberaauthor=F.+Ren&title=From+ROR%CE%B3t+agonists+to+two+types+of+RORgt+inverse+agonists&doi=10.1021%2Facsmedchemlett.7b00476"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00476%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DF.%26atitle%3DFrom%2520ROR%25CE%25B3t%2520agonists%2520to%2520two%2520types%2520of%2520RORgt%2520inverse%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D120%26epage%3D124%26doi%3D10.1021%2Facsmedchemlett.7b00476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beno, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4383</span>– <span class="NLM_lpage">4438</span>, <span class="refDoi"> DOI: 10.1021/jm501853m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501853m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4383-4438&author=B.+R.+Benoauthor=K.+S.+Yeungauthor=M.+D.+Bartbergerauthor=L.+D.+Penningtonauthor=N.+A.+Meanwell&title=A+Survey+of+the+Role+of+Noncovalent+Sulfur+Interactions+in+Drug+Design&doi=10.1021%2Fjm501853m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design</span></div><div class="casAuthors">Beno, Brett R.; Yeung, Kap-Sun; Bartberger, Michael D.; Pennington, Lewis D.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4383-4438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Electron deficient, bivalent sulfur atoms have two areas of pos. electrostatic potential, a consequence of the low-lying σ* orbitals of the C-S bond that are available for interaction with electron donors including oxygen and nitrogen atoms and, possibly, π-systems.  Intramol. interactions are by far the most common manifestation of this effect, which offers a means of modulating the conformational preferences of a mol.  Although a well-documented phenomenon, a priori applications in drug design are relatively sparse and this interaction, which is often isosteric with an intramol. hydrogen-bonding interaction, appears to be underappreciated by the medicinal chem. community.  In this Perspective, we discuss the theor. basis for sulfur σ* orbital interactions and illustrate their importance in the context of drug design and org. synthesis.  The role of sulfur interactions in protein structure and function is discussed and although relatively rare, intermol. interactions between ligand C-S σ* orbitals and proteins are illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYKXRsl4BQYrVg90H21EOLACvtfcHk0lgeIC1tqr_obg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D&md5=d12f53eb3271c161cfc833fb9f7c02b3</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm501853m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501853m%26sid%3Dliteratum%253Aachs%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DYeung%26aufirst%3DK.%2BS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DA%2520Survey%2520of%2520the%2520Role%2520of%2520Noncovalent%2520Sulfur%2520Interactions%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4383%26epage%3D4438%26doi%3D10.1021%2Fjm501853m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sirvent, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lücking, U.</span></span> <span> </span><span class="NLM_article-title">Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1002%2Fcmdc.201700044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=28221724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXks1Sltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=487-501&author=J.+A.+Sirventauthor=U.+L%C3%BCcking&title=Novel+Pieces+for+the+Emerging+Picture+of+Sulfoximines+in+Drug+Discovery%3A+Synthesis+and+Evaluation+of+Sulfoximine+Analogues+of+Marketed+Drugs+and+Advanced+Clinical+Candidates&doi=10.1002%2Fcmdc.201700044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates</span></div><div class="casAuthors">Sirvent, Juan Alberto; Luecking, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">487-501</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sulfoximines have gained considerable recognition as an important structural motif in drug discovery of late.  In particular, the clin. kinase inhibitors for the treatment of cancer, roniciclib (pan-CDK inhibitor), BAY 1143572 (P-TEFb inhibitor), and AZD 6738 (ATR inhibitor), have recently drawn considerable attention.  While the interest in this underrepresented functional group in drug discovery is clearly on the rise, there remains an incomplete understanding of the medicinal-chem.-relevant properties of sulfoximines.  Herein we report the synthesis and in vitro characterization of a variety of sulfoximine analogs of marketed drugs and advanced clin. candidates to gain a better understanding of this neglected functional group and its potential in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-5kfVM3I45LVg90H21EOLACvtfcHk0lgeIC1tqr_obg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXks1Sltbo%253D&md5=5b4589d7af32c8984d4fd3027c31c168</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700044%26sid%3Dliteratum%253Aachs%26aulast%3DSirvent%26aufirst%3DJ.%2BA.%26aulast%3DL%25C3%25BCcking%26aufirst%3DU.%26atitle%3DNovel%2520Pieces%2520for%2520the%2520Emerging%2520Picture%2520of%2520Sulfoximines%2520in%2520Drug%2520Discovery%253A%2520Synthesis%2520and%2520Evaluation%2520of%2520Sulfoximine%2520Analogues%2520of%2520Marketed%2520Drugs%2520and%2520Advanced%2520Clinical%2520Candidates%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D487%26epage%3D501%26doi%3D10.1002%2Fcmdc.201700044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Truchon, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettitt, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labute, P.</span></span> <span> </span><span class="NLM_article-title">A Cavity Corrected 3D-RISM Functional for Accurate Solvation Free Energies</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">934</span>– <span class="NLM_lpage">941</span>, <span class="refDoi"> DOI: 10.1021/ct4009359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct4009359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=934-941&author=J.-F.+Truchonauthor=B.+M.+Pettittauthor=P.+Labute&title=A+Cavity+Corrected+3D-RISM+Functional+for+Accurate+Solvation+Free+Energies&doi=10.1021%2Fct4009359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A Cavity Corrected 3D-RISM Functional for Accurate Solvation Free Energies</span></div><div class="casAuthors">Truchon, Jean-Francois; Pettitt, B. Montgomery; Labute, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">934-941</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We show that an Ng bridge function modified version of the three-dimensional ref. interaction site model (3D-RISM-NgB) solvation free energy method can accurately predict the hydration free energy (HFE) of a set of 504 org. mols.  To achieve this, a single unique const. parameter was adjusted to the computed HFE of single atom Lennard-Jones solutes.  It is shown that 3D-RISM is relatively accurate at predicting the electrostatic component of the HFE without correction but requires a modification of the nonpolar contribution that originates in the formation of the cavity created by the solute in water.  We use a free energy functional with the Ng scaling of the direct correlation function.  This produces a rapid, reliable small mol. HFE calcn. for applications in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolHuFo-mVCArVg90H21EOLACvtfcHk0li0lc9h3qZ5Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFSgtQ%253D%253D&md5=85963a9a895e6f79ab54692b95eaa0cc</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fct4009359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct4009359%26sid%3Dliteratum%253Aachs%26aulast%3DTruchon%26aufirst%3DJ.-F.%26aulast%3DPettitt%26aufirst%3DB.%2BM.%26aulast%3DLabute%26aufirst%3DP.%26atitle%3DA%2520Cavity%2520Corrected%25203D-RISM%2520Functional%2520for%2520Accurate%2520Solvation%2520Free%2520Energies%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2014%26volume%3D10%26spage%3D934%26epage%3D941%26doi%3D10.1021%2Fct4009359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredlund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winiwarter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgendorf, C.</span></span> <span> </span><span class="NLM_article-title">In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.6b01059</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.6b01059" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXks1GgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=1601-1609&author=L.+Fredlundauthor=S.+Winiwarterauthor=C.+Hilgendorf&title=In+Vitro+Intrinsic+Permeability%3A+A+Transporter-Independent+Measure+of+Caco-2+Cell+Permeability+in+Drug+Design+and+Development&doi=10.1021%2Facs.molpharmaceut.6b01059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development</span></div><div class="casAuthors">Fredlund, Linda; Winiwarter, Susanne; Hilgendorf, Constanze</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1601-1609</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vitro permeability data have a central place in absorption risk assessments in drug discovery and development.  For compds. where active efflux impacts permeability in vitro, the inherent passive membrane permeability ("intrinsic permeability") gives a concn.-independent measure of the compd.'s permeability.  This work describes the validation of an in vitro intrinsic permeability assay and application of the data in a predictive in silico model.  Apparent intrinsic permeability (Papp) across Caco-2 cell monolayers is detd. in the presence of an optimized cocktail of chem. inhibitors toward the three major efflux transporters ABCB1, ABCC2, and ABCG2.  The intrinsic Papp value gives an est. of passive permeability, which is independent of transporter expression levels and not limited by soly. or cell toxicity.  An in silico model has been established to predict the Caco-2 intrinsic permeability and shown to consistently identify highly permeable compds.  The new intrinsic permeability assay is useful for early absorption ests. and suitable for absorption risk assessment in DMPK and pharmaceutical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzz4IoZ6pXJbVg90H21EOLACvtfcHk0li0lc9h3qZ5Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXks1GgsLw%253D&md5=2e3af857e97f2ce5ce9743294c50d3b9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.6b01059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.6b01059%26sid%3Dliteratum%253Aachs%26aulast%3DFredlund%26aufirst%3DL.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DHilgendorf%26aufirst%3DC.%26atitle%3DIn%2520Vitro%2520Intrinsic%2520Permeability%253A%2520A%2520Transporter-Independent%2520Measure%2520of%2520Caco-2%2520Cell%2520Permeability%2520in%2520Drug%2520Design%2520and%2520Development%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2017%26volume%3D14%26spage%3D1601%26epage%3D1609%26doi%3D10.1021%2Facs.molpharmaceut.6b01059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doebelin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patouret, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmarajan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuruvilla, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span> <span> </span><span class="NLM_article-title">N-Arylsulfonyl Indolines as Retinoic Acid Receptor-Related Orphan Receptor γ (RORγ) Agonists</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2607</span>– <span class="NLM_lpage">2620</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1002%2Fcmdc.201600491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27879053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFSlsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2607-2620&author=C.+Doebelinauthor=R.+Patouretauthor=R.+D.+Garcia-Ordonezauthor=M.+R.+Changauthor=V.+Dharmarajanauthor=D.+S.+Kuruvillaauthor=S.+J.+Novickauthor=L.+Linauthor=M.+D.+Cameronauthor=P.+R.+Griffinauthor=T.+M.+Kamenecka&title=N-Arylsulfonyl+Indolines+as+Retinoic+Acid+Receptor-Related+Orphan+Receptor+%CE%B3+%28ROR%CE%B3%29+Agonists&doi=10.1002%2Fcmdc.201600491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">N-Arylsulfonyl Indolines as Retinoic Acid Receptor-Related Orphan Receptor γ (RORγ) Agonists</span></div><div class="casAuthors">Doebelin, Christelle; Patouret, Remi; Garcia-Ordonez, Ruben D.; Chang, Mi Ra; Dharmarajan, Venkatasubramanian; Kuruvilla, Dana S.; Novick, Scott J.; Lin, Li; Cameron, Michael D.; Griffin, Patrick R.; Kamenecka, Theodore M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2607-2620</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The nuclear retinoic acid receptor-related orphan receptor γ (RORγ; NR1F3) is a key regulator of inflammatory gene programs involved in T helper 17 (TH17) cell proliferation.  As such, synthetic small-mol. repressors (inverse agonists) targeting RORγ have been extensively studied for their potential as therapeutic agents for various autoimmune diseases.  Alternatively, enhancing TH17 cell proliferation through activation (agonism) of RORγ may boost an immune response, thereby offering a potentially new approach in cancer immunotherapy.  Herein the authors describe the development of N-arylsulfonyl indolines as RORγ agonists.  Structure-activity studies reveal a crit. linker region in these mols. as the major determinant for agonism.  Hydrogen/deuterium exchange coupled to mass spectrometry (HDX-MS) anal. of RORγ-ligand complexes help rationalize the obsd. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFUjlrkpRAz7Vg90H21EOLACvtfcHk0li0lc9h3qZ5Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFSlsbzP&md5=1dfb3c08077c18e8cda3e6a287bb8194</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600491%26sid%3Dliteratum%253Aachs%26aulast%3DDoebelin%26aufirst%3DC.%26aulast%3DPatouret%26aufirst%3DR.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%2BD.%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DDharmarajan%26aufirst%3DV.%26aulast%3DKuruvilla%26aufirst%3DD.%2BS.%26aulast%3DNovick%26aufirst%3DS.%2BJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26atitle%3DN-Arylsulfonyl%2520Indolines%2520as%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520%25CE%25B3%2520%2528ROR%25CE%25B3%2529%2520Agonists%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2607%26epage%3D2620%26doi%3D10.1002%2Fcmdc.201600491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rene, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boenig, G. d. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1021/ml500420y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500420y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=276-281&author=O.+Reneauthor=B.+P.+Fauberauthor=G.+d.+L.+Boenigauthor=B.+Burtonauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=S.+G.+Hymowitzauthor=A.+R.+Johnsonauthor=J.+R.+Kieferauthor=M.+Liimattaauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=H.+A.+Wallweberauthor=H.+Wong&title=Minor+Structural+Change+to+Tertiary+Sulfonamide+RORc+Ligands+Led+to+Opposite+Mechanisms+of+Action&doi=10.1021%2Fml500420y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fml500420y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500420y%26sid%3Dliteratum%253Aachs%26aulast%3DRene%26aufirst%3DO.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DBoenig%26aufirst%3DG.%2Bd.%2BL.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DWallweber%26aufirst%3DH.%2BA.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DMinor%2520Structural%2520Change%2520to%2520Tertiary%2520Sulfonamide%2520RORc%2520Ligands%2520Led%2520to%2520Opposite%2520Mechanisms%2520of%2520Action%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D276%26epage%3D281%26doi%3D10.1021%2Fml500420y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huxdorf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1021/ml4003875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=65-68&author=T.+Yangauthor=Q.+Liuauthor=Y.+Chengauthor=W.+Caiauthor=Y.+Maauthor=L.+Yangauthor=Q.+Wuauthor=L.+A.+Orband-Millerauthor=L.+Zhouauthor=Z.+Xiangauthor=M.+Huxdorfauthor=W.+Zhangauthor=J.+Zhangauthor=J.-N.+Xiangauthor=S.+Leungauthor=Y.+Qiuauthor=Z.+Zhongauthor=J.+D.+Elliottauthor=X.+Linauthor=Y.+Wang&title=Discovery+of+Tertiary+Amine+and+Indole+Derivatives+as+Potent+ROR%CE%B3t+Inverse+Agonists&doi=10.1021%2Fml4003875"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fml4003875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003875%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DHuxdorf%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520Tertiary%2520Amine%2520and%2520Indole%2520Derivatives%2520as%2520Potent%2520ROR%25CE%25B3t%2520Inverse%2520Agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D65%26epage%3D68%26doi%3D10.1021%2Fml4003875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Vloten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontenot, J. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of biaryls as RORγ inverse agonists by using structure-based design</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2459</span>– <span class="NLM_lpage">2463</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2016.03.109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2459-2463&author=I.+J.+Enyedyauthor=N.+A.+Powellauthor=J.+Caravellaauthor=K.+van+Vlotenauthor=J.+Chaoauthor=D.+Banerjeeauthor=D.+Marcotteauthor=L.+Silvianauthor=A.+McKenzieauthor=V.+S.+Hongauthor=J.+D.+Fontenot&title=Discovery+of+biaryls+as+ROR%CE%B3+inverse+agonists+by+using+structure-based+design&doi=10.1016%2Fj.bmcl.2016.03.109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.109%26sid%3Dliteratum%253Aachs%26aulast%3DEnyedy%26aufirst%3DI.%2BJ.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DCaravella%26aufirst%3DJ.%26aulast%3Dvan%2BVloten%26aufirst%3DK.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DBanerjee%26aufirst%3DD.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DSilvian%26aufirst%3DL.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DV.%2BS.%26aulast%3DFontenot%26aufirst%3DJ.%2BD.%26atitle%3DDiscovery%2520of%2520biaryls%2520as%2520ROR%25CE%25B3%2520inverse%2520agonists%2520by%2520using%2520structure-based%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2459%26epage%3D2463%26doi%3D10.1016%2Fj.bmcl.2016.03.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Nannan Sun, Qiong Xie, Yongjun Dang, <span class="NLM_string-name hlFld-ContribAuthor">Yonghui Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Agonist Lock Touched and Untouched Retinoic Acid Receptor-Related Orphan Receptor-γt (RORγt) Inverse Agonists: Classification Based on the Molecular Mechanisms of Action. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02178%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAgonist%252BLock%252BTouched%252Band%252BUntouched%252BRetinoic%252BAcid%252BReceptor-Related%252BOrphan%252BReceptor-%2525CE%2525B3t%252B%252528ROR%2525CE%2525B3t%252529%252BInverse%252BAgonists%25253A%252BClassification%252BBased%252Bon%252Bthe%252BMolecular%252BMechanisms%252Bof%252BAction%26aulast%3DSun%26aufirst%3DNannan%26date%3D2021%26date%3D2020%26date%3D16122020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xishan Wu, Hui Shen, Yan Zhang, Chao Wang, Qiu Li, Cheng Zhang, Xiaoxi Zhuang, Chenchang Li, Yudan Shi, Yanli Xing, Qiuping Xiang, Jinxin Xu, Donghai Wu, Jinsong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Yong Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of Benzimidazole Derivative XY123 as a Potent, Selective, and Orally Available RORγ Inverse Agonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8775-8797. <a href="https://doi.org/10.1021/acs.jmedchem.1c00763" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00763%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BBenzimidazole%252BDerivative%252BXY123%252Bas%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BAvailable%252BROR%2525CE%2525B3%252BInverse%252BAgonist%26aulast%3DWu%26aufirst%3DXishan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D27042021%26date%3D14062021%26volume%3D64%26issue%3D12%26spage%3D8775%26epage%3D8797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David Marcoux, James J.-W. Duan, Qing Shi, Robert J. Cherney, Anurag S. Srivastava, Lyndon Cornelius, Douglas G. Batt, Qingjie Liu, Myra Beaudoin-Bertrand, Carolyn A. Weigelt, Purnima Khandelwal, Sureshbabu Vishwakrishnan, Kumaravel Selvakumar, Ananta Karmakar, Arun Kumar Gupta, Mushkin Basha, Sridharan Ramlingam, Naveen Manjunath, Sridhar Vanteru, Sukhen Karmakar, Nageswara Maddala, Muthalagu Vetrichelvan, Anuradha Gupta, Richard A. Rampulla, Arvind Mathur, Shiuhang Yip, Peng Li, Dauh-Rurng Wu, Javed Khan, Max Ruzanov, John S. Sack, Jinhong Wang, Melissa Yarde, Mary Ellen Cvijic, Sha Li, David J. Shuster, Virna Borowski, Jenny H. Xie, Kim W. McIntyre, Mary T. Obermeier, Aberra Fura, Kevin Stefanski, Georgia Cornelius, John Hynes, Jr., Joseph A. Tino, John E. Macor, Luisa Salter-Cid, Rex Denton, Qihong Zhao, Percy H. Carter, <span class="NLM_string-name hlFld-ContribAuthor">T. G. Murali Dhar</span>. </span><span class="cited-content_cbyCitation_article-title">Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt—Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9931-9946. <a href="https://doi.org/10.1021/acs.jmedchem.9b01369" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01369%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRationally%252BDesigned%25252C%252BConformationally%252BConstrained%252BInverse%252BAgonists%252Bof%252BROR%2525CE%2525B3t%2525E2%252580%252594Identification%252Bof%252Ba%252BPotent%25252C%252BSelective%252BSeries%252Bwith%252BBiologic-Like%252Bin%252BVivo%252BEfficacy%26aulast%3DMarcoux%26aufirst%3DDavid%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19082019%26date%3D31102019%26date%3D22102019%26volume%3D62%26issue%3D21%26spage%3D9931%26epage%3D9946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stefan von Berg, Yafeng Xue, Mia Collins, Antonio Llinas, Roine I. Olsson, Torbjörn Halvarsson, Maria Lindskog, Jesper Malmberg, Johan Jirholt, Nina Krutrök, Marie Ramnegård, Marie Brännström, Anders Lundqvist, Matti Lepistö, Anna Aagaard, Jane McPheat, Eva L. Hansson, Rongfeng Chen, Yao Xiong, Thomas G. Hansson, <span class="NLM_string-name hlFld-ContribAuthor">Frank Narjes</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (6)
                                     , 972-977. <a href="https://doi.org/10.1021/acsmedchemlett.9b00158" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00158%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BOrally%252BBioavailable%252BInverse%252BAgonists%252Bof%252Bthe%252BRetinoic%252BAcid%252BReceptor-Related%252BOrphan%252BReceptor%252BC2%26aulast%3Dvon%2BBerg%26aufirst%3DStefan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05042019%26date%3D29052019%26date%3D05062019%26date%3D29052019%26volume%3D10%26issue%3D6%26spage%3D972%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yan Zhang, Xishan Wu, Xiaoqian Xue, Chenchang Li, Junjian Wang, Rui Wang, Cheng Zhang, Chao Wang, Yudan Shi, Lingjiao Zou, Qiu Li, Zenghong Huang, Xiaojuan Hao, Kerry Loomes, Donghai Wu, Hong-Wu Chen, Jinxin Xu, <span class="NLM_string-name hlFld-ContribAuthor">Yong Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4716-4730. <a href="https://doi.org/10.1021/acs.jmedchem.9b00327" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00327%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BXY101%25252C%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BROR%2525CE%2525B3%252BInverse%252BAgonist%252Bfor%252BTreatment%252Bof%252BCastration-Resistant%252BProstate%252BCancer%26aulast%3DZhang%26aufirst%3DYan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20022019%26date%3D22042019%26date%3D09042019%26volume%3D62%26issue%3D9%26spage%3D4716%26epage%3D4730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Masayuki Kotoku, Takaki Maeba, Shingo Fujioka, Masahiro Yokota, Noriyoshi Seki, Keisuke Ito, Yoshihiro Suwa, Taku Ikenogami, Kazuyuki Hirata, Yasunori Hase, Yoshiaki Katsuda, Naoki Miyagawa, Kojo Arita, Kota Asahina, Masato Noguchi, Akihiro Nomura, Satoki Doi, Tsuyoshi Adachi, Paul Crowe, Haiyan Tao, Scott Thacher, Hiromasa Hashimoto, Takayoshi Suzuki, <span class="NLM_string-name hlFld-ContribAuthor">Makoto Shiozaki</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (5)
                                     , 2837-2842. <a href="https://doi.org/10.1021/acs.jmedchem.8b01567" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01567</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01567%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSecond%252BGeneration%252BROR%2525CE%2525B3%252BInhibitors%252BComposed%252Bof%252Ban%252BAzole%252BScaffold%26aulast%3DKotoku%26aufirst%3DMasayuki%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D09102018%26date%3D01032019%26date%3D18022019%26volume%3D62%26issue%3D5%26spage%3D2837%26epage%3D2842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Gege</span>. </span><span class="cited-content_cbyCitation_article-title">Retinoic acid-related orphan receptor gamma (RORγ) inverse agonists/antagonists for the treatment of inflammatory diseases – where are we presently?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1080/17460441.2021.1948833" title="DOI URL">https://doi.org/10.1080/17460441.2021.1948833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1948833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1948833%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRetinoic%252Bacid-related%252Borphan%252Breceptor%252Bgamma%252B%252528ROR%2525CE%2525B3%252529%252Binverse%252Bagonists%25252Fantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdiseases%252B%2525E2%252580%252593%252Bwhere%252Bare%252Bwe%252Bpresently%25253F%26aulast%3DGege%26aufirst%3DChristian%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Yafei  Huang</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Yu</span>, <span class="hlFld-ContribAuthor ">Yunpeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Ji-An  Chen</span>, <span class="hlFld-ContribAuthor ">Chenyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Meiqi  Song</span>, <span class="hlFld-ContribAuthor ">Huimin  Guo</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112536. <a href="https://doi.org/10.1016/j.ejmech.2020.112536" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112536%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bcarboxyl-containing%252Bbiaryl%252Bureas%252Bas%252Bpotent%252BROR%2525CE%2525B3t%252Binverse%252Bagonists%26aulast%3DSun%26aufirst%3DNannan%26date%3D2020%26volume%3D202%26spage%3D112536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mian  Huang</span>, <span class="hlFld-ContribAuthor ">Shelby  Bolin</span>, <span class="hlFld-ContribAuthor ">Hannah  Miller</span>, <span class="hlFld-ContribAuthor ">Ho Leung  Ng</span>. </span><span class="cited-content_cbyCitation_article-title">RORγ Structural Plasticity and Druggability. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (15)
                                     , 5329. <a href="https://doi.org/10.3390/ijms21155329" title="DOI URL">https://doi.org/10.3390/ijms21155329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21155329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21155329%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DROR%2525CE%2525B3%252BStructural%252BPlasticity%252Band%252BDruggability%26aulast%3DHuang%26aufirst%3DMian%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D15%26spage%3D5329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Asimus</span>, <span class="hlFld-ContribAuthor ">Robert  Palmér</span>, <span class="hlFld-ContribAuthor ">Muna  Albayaty</span>, <span class="hlFld-ContribAuthor ">Henrik  Forsman</span>, <span class="hlFld-ContribAuthor ">Christina  Lundin</span>, <span class="hlFld-ContribAuthor ">Marita  Olsson</span>, <span class="hlFld-ContribAuthor ">Rikard  Pehrson</span>, <span class="hlFld-ContribAuthor ">John  Mo</span>, <span class="hlFld-ContribAuthor ">Muir  Russell</span>, <span class="hlFld-ContribAuthor ">Sara  Carlert</span>, <span class="hlFld-ContribAuthor ">David  Close</span>, <span class="hlFld-ContribAuthor ">David  Keeling</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid‐related orphan receptor γ agonist AZD0284. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Clinical Pharmacology</span><span> <strong>2020,</strong> <em>86 </em>
                                    (7)
                                     , 1398-1405. <a href="https://doi.org/10.1111/bcp.14253" title="DOI URL">https://doi.org/10.1111/bcp.14253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bcp.14253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbcp.14253%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DPharmacokinetics%25252C%252Bpharmacodynamics%252Band%252Bsafety%252Bof%252Bthe%252Binverse%252Bretinoic%252Bacid%2525E2%252580%252590related%252Borphan%252Breceptor%252B%2525CE%2525B3%252Bagonist%252BAZD0284%26aulast%3DAsimus%26aufirst%3DSara%26date%3D2020%26date%3D2020%26volume%3D86%26issue%3D7%26spage%3D1398%26epage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Gege</span>, <span class="hlFld-ContribAuthor ">Michael  Albers</span>, <span class="hlFld-ContribAuthor ">Olaf  Kinzel</span>, <span class="hlFld-ContribAuthor ">Gerald  Kleymann</span>, <span class="hlFld-ContribAuthor ">Thomas  Schlüter</span>, <span class="hlFld-ContribAuthor ">Christoph  Steeneck</span>, <span class="hlFld-ContribAuthor ">Thomas  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Xue</span>, <span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>, <span class="hlFld-ContribAuthor ">John  Spurlino</span>, <span class="hlFld-ContribAuthor ">Cynthia  Milligan</span>, <span class="hlFld-ContribAuthor ">Anne M.  Fourie</span>, <span class="hlFld-ContribAuthor ">James P.  Edwards</span>, <span class="hlFld-ContribAuthor ">Kristi  Leonard</span>, <span class="hlFld-ContribAuthor ">Kevin  Coe</span>, <span class="hlFld-ContribAuthor ">Brian  Scott</span>, <span class="hlFld-ContribAuthor ">Dan  Pippel</span>, <span class="hlFld-ContribAuthor ">Steven D.  Goldberg</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (12)
                                     , 127205. <a href="https://doi.org/10.1016/j.bmcl.2020.127205" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127205%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Band%252Bbiological%252Bevaluation%252Bof%252Bthiazole-bis-amide%252Binverse%252Bagonists%252Bof%252BROR%2525CE%2525B3t%26aulast%3DGege%26aufirst%3DChristian%26date%3D2020%26volume%3D30%26issue%3D12%26spage%3D127205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Ma</span>, <span class="hlFld-ContribAuthor ">Kaifeng  Zhou</span>, <span class="hlFld-ContribAuthor ">Chen  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhonglian  Cao</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111984. <a href="https://doi.org/10.1016/j.ejmech.2019.111984" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111984</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111984%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BN-sulfonamide-tetrahydroquinolines%252Bas%252Bpotent%252Bretinoic%252Bacid%252Breceptor-related%252Borphan%252Breceptor%252B%2525CE%2525B3t%252Binverse%252Bagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bautoimmune%252Bdiseases%26aulast%3DSun%26aufirst%3DNannan%26date%3D2020%26volume%3D187%26spage%3D111984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton M.  Jetten</span>, <span class="hlFld-ContribAuthor ">Donald N.  Cook</span>. </span><span class="cited-content_cbyCitation_article-title">(Inverse) Agonists of Retinoic Acid–Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2020,</strong> <em>60 </em>
                                    (1)
                                     , 371-390. <a href="https://doi.org/10.1146/annurev-pharmtox-010919-023711" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-010919-023711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-010919-023711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-010919-023711%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3D%252528Inverse%252529%252BAgonists%252Bof%252BRetinoic%252BAcid%2525E2%252580%252593Related%252BOrphan%252BReceptor%252B%2525CE%2525B3%25253A%252BRegulation%252Bof%252BImmune%252BResponses%25252C%252BInflammation%25252C%252Band%252BAutoimmune%252BDisease%26aulast%3DJetten%26aufirst%3DAnton%2BM.%26date%3D2020%26volume%3D60%26issue%3D1%26spage%3D371%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suwipa  Saen-Oon</span>, <span class="hlFld-ContribAuthor ">Estrella  Lozoya</span>, <span class="hlFld-ContribAuthor ">Victor  Segarra</span>, <span class="hlFld-ContribAuthor ">Victor  Guallar</span>, <span class="hlFld-ContribAuthor ">Robert  Soliva</span>. </span><span class="cited-content_cbyCitation_article-title">Atomistic simulations shed new light on the activation mechanisms of RORγ and classify it as Type III nuclear hormone receptor regarding ligand-binding paths. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-52319-x" title="DOI URL">https://doi.org/10.1038/s41598-019-52319-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-52319-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-52319-x%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAtomistic%252Bsimulations%252Bshed%252Bnew%252Blight%252Bon%252Bthe%252Bactivation%252Bmechanisms%252Bof%252BROR%2525CE%2525B3%252Band%252Bclassify%252Bit%252Bas%252BType%252BIII%252Bnuclear%252Bhormone%252Breceptor%252Bregarding%252Bligand-binding%252Bpaths%26aulast%3DSaen-Oon%26aufirst%3DSuwipa%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Yu</span>, <span class="hlFld-ContribAuthor ">Huimin  Guo</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl-substituted indole and indoline derivatives as RORγt agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111589. <a href="https://doi.org/10.1016/j.ejmech.2019.111589" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111589%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Baryl-substituted%252Bindole%252Band%252Bindoline%252Bderivatives%252Bas%252BROR%2525CE%2525B3t%252Bagonists%26aulast%3DZhu%26aufirst%3DYan%26date%3D2019%26volume%3D182%26spage%3D111589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cong-min  Yuan</span>, <span class="hlFld-ContribAuthor ">Hai-hong  Chen</span>, <span class="hlFld-ContribAuthor ">Nan-nan  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-jun  Ma</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics simulations on RORγt: insights into its functional agonism and inverse agonism. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2019,</strong> <em>40 </em>
                                    (11)
                                     , 1480-1489. <a href="https://doi.org/10.1038/s41401-019-0259-z" title="DOI URL">https://doi.org/10.1038/s41401-019-0259-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-019-0259-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-019-0259-z%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DMolecular%252Bdynamics%252Bsimulations%252Bon%252BROR%2525CE%2525B3t%25253A%252Binsights%252Binto%252Bits%252Bfunctional%252Bagonism%252Band%252Binverse%252Bagonism%26aulast%3DYuan%26aufirst%3DCong-min%26date%3D2019%26date%3D2019%26volume%3D40%26issue%3D11%26spage%3D1480%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuyu  Lao</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Huanpeng  Chen</span>, <span class="hlFld-ContribAuthor ">Fengjiao  Wei</span>, <span class="hlFld-ContribAuthor ">Zhaofeng  Huang</span>, <span class="hlFld-ContribAuthor ">Chuan  Bai</span>. </span><span class="cited-content_cbyCitation_article-title">5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>90 </em>, 103077. <a href="https://doi.org/10.1016/j.bioorg.2019.103077" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103077%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3D5%25252C6%25252C7%25252C8-Tetrahydrobenzo%25255B4%25252C5%25255Dthieno%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bfull-length%252BROR%2525CE%2525B3t%26aulast%3DLao%26aufirst%3DChuyu%26date%3D2019%26volume%3D90%26spage%3D103077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selection of published inverse agonists of RORγt.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) X-ray structure of <b>1</b> (green) binding inside RORγt LBD (gray; 2.30 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI5">5NI5</a>). Compound <b>1</b> and key residues of RORγt LBD are shown as sticks. (b) Overlay of <b>1</b> (green) and 25-hydroxycholesterol (25-HC, gray), showing the interaction of 25-HC with the water molecule (dotted sphere) and the Tyr–His lock.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Solvent analysis of RORγt LBD in complex with <b>1</b> using 3D-RISM. The arylsulfone group of <b>1</b> and key residues of RORγt LBD are shown as sticks. Solvent positions in the apo-pocket are shown as spheres (hydrophobic, unstable waters are in orange, and hydrophilic, stable ones are in cyan).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of (a) <b>1</b> and <b>8</b> (2.45 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI7">5NI7</a>) and (b) <b>8</b> and <b>10</b> (1.94 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI8">5NI8</a>) with key interactions to the RORγt LBD. Compounds <b>1</b> (green), <b>8</b> (cyan), and <b>10</b> (magenta) and key residues of RORγ LBD are shown as sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Ligand interaction near the His–Tyr lock based on the structure of <b>25</b> (1.82 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NIB">5NIB</a>). Compounds <b>10</b> (magenta), <b>25</b> (yellow), and <b>30</b> (gray, modeled on the basis of <b>8</b>) and key residues of the His–Tyr lock of RORγt LBD are shown as sticks. The ligands are only shown partially for clarity. The conserved water position is shown as a dotted sphere in red, and the position of the CF3 in <b>30</b> is shown as dotted spheres in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ligand interaction of compound <b>23</b> in RORγt LBD (2.37 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGQ">6FGQ</a>). (a) Overlay of agonists <b>10</b> (magenta) and <b>25</b> (yellow) with inverse agonist <b>23</b> (orange). Key residues of the His–Tyr lock of RORγt LBD are shown as sticks. The ligands are only shown partially for clarity. The conserved water position is shown as a dotted sphere in red. Helix 12 and part of helix 11 are disordered (indicated in the dashed circle) when compound <b>23</b> is bound. The putative steric clash between <b>23</b> and the side chain of His479 (based on <b>10</b> and <b>25</b>) is shown as a red star (∼1.4 Å in between). (b) Overlay of RORγt complexes with digoxin (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B0W">3B0W</a>, blue), <b>10</b> (magenta), and <b>23</b> (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structure overlay of RORγt in complex with compound <b>8</b> and PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G45">5G45</a> (fragment-bound). (a) Stick view. Compound <b>8</b> is shown as sticks with carbons in cyan, and the bound fragment and DMSO are shown with carbons in blue (DMSO depicted as sticks and spheres). (b) Surface view to illustrate the channel (“entrance”) to the LBD. The tethered SRC2 peptide is shown as a gray helix.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Comparison of the RORγt complex with <b>32</b> (1.84 Å, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ESN">6ESN</a>, carbons in yellow) with the observed DMSO (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G45">5G45</a>, carbons in blue) site in the X-ray screen. (a) Position of DMSO as observed in the fragment structure. (b) Binding mode of <b>32</b> depicted in the same orientation. The newly introduced carbamate group superimposes well with the DMSO position and engages in an H-bond with the backbone NH of Glu379.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Diverse Aryl-Substituted 4-Thienyl Acetamides from Intermediate <b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA, DCM; (b) EDC, 4-DMAP, DCM, 53%; (c) ArB(OH)<sub>2</sub> or Arpin, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (4:1), 80 °C.</p></p></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Aryl-Substituted 4-Thienyl Acetamides from Intermediates <b>44</b> and <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2-(Fluoropyridin-3-yl)boronic acid, PdCl<sub>2</sub>(dppf), K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (4:1), 100 °C, 64%. (b) ROH, KO<sup>t</sup>Bu, THF, 80 °C. (c) PdCl<sub>2</sub>(dppf), B<sub>2</sub>Pin<sub>2</sub>, KOAc, dioxane, 100 °C, 54%. (d) <b>46b</b>, <b>c</b>, or <b>d</b>; PdCl<sub>2</sub>(dppf); K<sub>2</sub>CO<sub>3</sub>; DME/H<sub>2</sub>O (5:1); 130 °C; microwave. (e) <b>46a</b>: 4-iodophenol, KO<sup>t</sup>Bu, THF, microwave 140 °C, 41%; <b>46c</b>: (4-trifluoromethoxy)phenyl)-methanol, NaH, DMF, 80 °C, 49%; <b>46d</b>: (4-trifluoromethoxy)phenol, NaH, DMF, 80 °C, 70%. (f) CuCN, <span class="smallcaps smallerCapital">l</span>-proline, DMF, 100 °C, 52%.</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) PdCl<sub>2</sub>(dppf), B<sub>2</sub>Pin<sub>2</sub>, KOAc, dioxane, 70 °C, 64%; (b) PdCl<sub>2</sub>(dppf), <b>46e</b>, NaHCO<sub>3</sub>, dioxane/H<sub>2</sub>O, 90 °C, 81%; (c) TBSOTf, DCM, 0 °C to RT; (d) <b>42a</b>, EDC, DMAP, DCM, RT, 93%; (e) CF<sub>3</sub>CH<sub>2</sub>OH, KO<sup>t</sup>Bu, THF, RT, 93%.</p></p></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/medium/jm-2018-007836_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Acetamides <b>32</b>, <b>35</b>, <b>38</b>, and <b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-17/acs.jmedchem.8b00783/20180907/images/large/jm-2018-007836_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00783&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>m</i>-CPBA, DCM 0 °C to RT, 88%; H<sub>2</sub>NOH·HCl, EtOH, 80 °C, quantitative. (b) Pd/C (10% Pd), H<sub>2</sub>, EtOH, RT; Boc<sub>2</sub>O, TEA, DCM, 57%; LiOH, THF, H<sub>2</sub>O, RT, 86%. (c) Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O 130 °C, microwave, 66%. (d) PdCl<sub>2</sub>(dppf), <b>46c</b>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (4:1), 100 °C, 80%. (e) TBSOTf, DCM, 0 °C to RT. (f) <b>53a</b>: <b>42b</b>, <b>49b</b>, EDC, HOBt, DIPEA, DCM, RT, 65%; <b>53b</b>: <b>42b</b>, <b>49c</b>, TBTU, Et<sub>3</sub>N EDC, DCM, RT, 59%. (g) <b>32</b>: TBSOTf, DCM, RT, then DCM, AcCl, Et<sub>3</sub>N, 51%; <b>35</b>: HCl in dioxane, then py, Ac<sub>2</sub>O, RT, 67%. (h) Chiral supercritical-fluid chromatography (SFC), 30% <i>i</i>-PrOH in CO<sub>2</sub> (120 bar): <b>38</b> (42%), <b>39</b> (44%).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 60 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism</span>. <i>Nucl. Recept. Signal.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1621%2Fnrs.07003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=19381306" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&author=A.+M.+Jetten&title=Retinoid-related+orphan+receptors+%28RORs%29%3A+critical+roles+in+development%2C+immunity%2C+circadian+rhythm%2C+and+cellular+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1621%2Fnrs.07003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1621%252Fnrs.07003%26sid%3Dliteratum%253Aachs%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DRetinoid-related%2520orphan%2520receptors%2520%2528RORs%2529%253A%2520critical%2520roles%2520in%2520development%252C%2520immunity%252C%2520circadian%2520rhythm%252C%2520and%2520cellular%2520metabolism%26jtitle%3DNucl.%2520Recept.%2520Signal.%26date%3D2009%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tato, C. M.</span></span> <span> </span><span class="NLM_article-title">Innate IL-17-producing cells: the sentinels of the immune system</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1038/nri2800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnri2800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=20559326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=479-489&author=D.+J.+Cuaauthor=C.+M.+Tato&title=Innate+IL-17-producing+cells%3A+the+sentinels+of+the+immune+system&doi=10.1038%2Fnri2800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Innate IL-17-producing cells: the sentinels of the immune system</span></div><div class="casAuthors">Cua, Daniel J.; Tato, Cristina M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">479-489</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The cytokine interleukin-17 (IL-17) has received considerable attention since the discovery of a distinct CD4+ T helper (TH) cell subset that produces it, known as the TH17 cell subset.  Despite the fact that most of the recent literature describes IL-17 as a T cell-secreted cytokine, much of the IL-17 released during an inflammatory response is produced by innate immune cells.  In this Review, we explore the many innate immune cell populations that are an early source of IL-17 in response to stress, injury or pathogens.  These early sources have been shown to have a central role in the initiation of IL-17-dependent immune responses, even before the first CD4+T cell sees its cognate antigen and initiates the TH17 cell developmental program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8LPNpjMbg57Vg90H21EOLACvtfcHk0lhMvZ6LVIRo7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKjtr0%253D&md5=f51e10df5c5d510d599e2bf88f349d55</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnri2800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2800%26sid%3Dliteratum%253Aachs%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DTato%26aufirst%3DC.%2BM.%26atitle%3DInnate%2520IL-17-producing%2520cells%253A%2520the%2520sentinels%2520of%2520the%2520immune%2520system%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D479%26epage%3D489%26doi%3D10.1038%2Fnri2800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">RORγ: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>205</i></span>,  <span class="NLM_fpage">1976</span>– <span class="NLM_lpage">1983</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1994.2902</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1006%2Fbbrc.1994.2902" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1994&pages=1976-1983&author=T.+Hiroseauthor=R.+J.+Smithauthor=A.+M.+Jetten&title=ROR%CE%B3%3A+the+third+member+of+ROR%2FRZR+orphan+receptor+subfamily+that+is+highly+expressed+in+skeletal+muscle&doi=10.1006%2Fbbrc.1994.2902"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1994.2902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1994.2902%26sid%3Dliteratum%253Aachs%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DR.%2BJ.%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DROR%25CE%25B3%253A%2520the%2520third%2520member%2520of%2520ROR%252FRZR%2520orphan%2520receptor%2520subfamily%2520that%2520is%2520highly%2520expressed%2520in%2520skeletal%2520muscle%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1994%26volume%3D205%26spage%3D1976%26epage%3D1983%26doi%3D10.1006%2Fbbrc.1994.2902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepelley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.cell.2006.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=16990136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=1121-1133&author=I.+I.+Ivanovauthor=B.+S.+McKenzieauthor=L.+Zhouauthor=C.+E.+Tadokoroauthor=A.+Lepelleyauthor=J.+J.+Lafailleauthor=D.+J.+Cuaauthor=D.+R.+Littman&title=The+orphan+nuclear+receptor+ROR%CE%B3t+directs+the+differentiation+program+of+proinflammatory+IL-17%2B+T+helper+cells&doi=10.1016%2Fj.cell.2006.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells</span></div><div class="casAuthors">Ivanov, Ivaylo I.; McKenzie, Brent S.; Zhou, Liang; Tadokoro, Carlos E.; Lepelley, Alice; Lafaille, Juan J.; Cua, Daniel J.; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1133</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease.  The authors show here that the orphan nuclear receptor RORγt is the key transcription factor that orchestrates the differentiation of this effector cell lineage.  RORγt induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naive CD4+ T helper cells and is required for their expression in response to IL-6 and TGF-β, the cytokines known to induce IL-17.  Th17 cells are constitutively present throughout the intestinal lamina propria, express RORγt, and are absent in mice deficient for RORγt or IL-6.  Mice with RORγt-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells.  Together, these studies suggest that RORγt is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYsJd6RyFqWrVg90H21EOLACvtfcHk0lhMvZ6LVIRo7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE&md5=4f5693603c30dca4f6a2d0994aeaf9b0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aufirst%3DI.%2BI.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTadokoro%26aufirst%3DC.%2BE.%26aulast%3DLepelley%26aufirst%3DA.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520orphan%2520nuclear%2520receptor%2520ROR%25CE%25B3t%2520directs%2520the%2520differentiation%2520program%2520of%2520proinflammatory%2520IL-17%252B%2520T%2520helper%2520cells%26jtitle%3DCell%26date%3D2006%26volume%3D126%26spage%3D1121%26epage%3D1133%26doi%3D10.1016%2Fj.cell.2006.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">Retinoic Acid-Related Orphan Receptors (RORs): Regulatory Functions in Immunity, Development, Circadian Rhythm, and Metabolism</span>. <i>Nucl. Receptor Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">101185</span> <span class="refDoi"> DOI: 10.11131/2015/101185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.11131%2F2015%2F101185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=26878025" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&author=D.+N.+Cookauthor=H.+S.+Kangauthor=A.+M.+Jetten&title=Retinoic+Acid-Related+Orphan+Receptors+%28RORs%29%3A+Regulatory+Functions+in+Immunity%2C+Development%2C+Circadian+Rhythm%2C+and+Metabolism&doi=10.11131%2F2015%2F101185"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.11131%2F2015%2F101185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.11131%252F2015%252F101185%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DD.%2BN.%26aulast%3DKang%26aufirst%3DH.%2BS.%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DRetinoic%2520Acid-Related%2520Orphan%2520Receptors%2520%2528RORs%2529%253A%2520Regulatory%2520Functions%2520in%2520Immunity%252C%2520Development%252C%2520Circadian%2520Rhythm%252C%2520and%2520Metabolism%26jtitle%3DNucl.%2520Receptor%2520Res.%26date%3D2015%26volume%3D2%26doi%3D10.11131%2F2015%2F101185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oukka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">IL-17 and Th17 Cells</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">517</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.021908.132710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1146%2Fannurev.immunol.021908.132710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=19132915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=485-517&author=T.+Kornauthor=E.+Bettelliauthor=M.+Oukkaauthor=V.+K.+Kuchroo&title=IL-17+and+Th17+Cells&doi=10.1146%2Fannurev.immunol.021908.132710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">IL-17 and Th17 cells</span></div><div class="casAuthors">Korn, Thomas; Bettelli, Estelle; Oukka, Mohamed; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">485-517</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  CD4+ T cells, upon activation and expansion, develop into different T helper cell subsets with different cytokine profiles and distinct effector functions.  Until recently, T cells were divided into Th1 or Th2 cells, depending on the cytokines they produce.  A third subset of IL-17-producing effector T helper cells, called Th17 cells, has now been discovered and characterized.  Here, the authors summarize the current information on the differentiation and effector functions of the Th17 lineage.  Th17 cells produce IL-17, IL-17F, and IL-22, thereby inducing a massive tissue reaction owing to the broad distribution of the IL-17 and IL-22 receptors.  Th17 cells also secrete IL-21 to communicate with the cells of the immune system.  The differentiation factors (TGF-β plus IL-6 or IL-21), the growth and stabilization factor (IL-23), and the transcription factors (STAT3, RORγt, and RORα) involved in the development of Th17 cells have just been identified.  The participation of TGF-β in the differentiation of Th17 cells places the Th17 lineage in close relation with CD4+CD25+Foxp3+ regulatory T cells (Tregs), as TGF-β also induces differentiation of native T cells into Foxp3+ Tregs in the peripheral immune compartment.  The investigation of the differentiation, effector function, and regulation of Th17 cells has opened up a new framework for understanding T cell differentiation.  Furthermore, the importance of Th17 cells is now appreciated in clearing pathogens during host defense reactions and in inducing tissue inflammation in autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAJvCEP9y1fLVg90H21EOLACvtfcHk0lis71Sdy3FZZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFSltrY%253D&md5=fffce537e2b70751fd9113e25962419e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.021908.132710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.021908.132710%26sid%3Dliteratum%253Aachs%26aulast%3DKorn%26aufirst%3DT.%26aulast%3DBettelli%26aufirst%3DE.%26aulast%3DOukka%26aufirst%3DM.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DIL-17%2520and%2520Th17%2520Cells%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D27%26spage%3D485%26epage%3D517%26doi%3D10.1146%2Fannurev.immunol.021908.132710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikejiri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyasu, S.</span></span> <span> </span><span class="NLM_article-title">Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1111/gtc.12039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1111%2Fgtc.12039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=23383714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFWgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=247-265&author=Y.+Kurebayashiauthor=S.+Nagaiauthor=A.+Ikejiriauthor=S.+Koyasu&title=Recent+advances+in+understanding+the+molecular+mechanisms+of+the+development+and+function+of+Th17+cells&doi=10.1111%2Fgtc.12039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells</span></div><div class="casAuthors">Kurebayashi, Yutaka; Nagai, Shigenori; Ikejiri, Ai; Koyasu, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">247-265</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  IL-17-producing T helper (Th17) cells comprise a distinct Th subset involved in epithelial cell- and neutrophil-mediated immune responses against extracellular microbes.  At the same time, Th17 cells play significant roles in the development of autoimmune diseases including rheumatoid arthritis and multiple sclerosis.  Since the identification of Th17 cells approx. a decade ago, the mol. mechanisms of their differentiation have been intensively studied and a no. of signaling cascades and transcription factors have been shown to be involved.  Here, we review the current knowledge regarding the function of Th17 cells in vivo as well as several key concepts for the mol. mechanisms of Th17 differentiation.  We also discuss the emerging roles of phosphoinositide 3-kinase (PI3K), mammalian target of rapamycin complex 1 (mTORC1) and hypoxia-inducible factor 1 (HIF-1) in the differentiation of Th17 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7J4hr3fa_4bVg90H21EOLACvtfcHk0lis71Sdy3FZZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFWgtb0%253D&md5=f2788bcef6e6e21ad07ecca22ab6bc2a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fgtc.12039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgtc.12039%26sid%3Dliteratum%253Aachs%26aulast%3DKurebayashi%26aufirst%3DY.%26aulast%3DNagai%26aufirst%3DS.%26aulast%3DIkejiri%26aufirst%3DA.%26aulast%3DKoyasu%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520understanding%2520the%2520molecular%2520mechanisms%2520of%2520the%2520development%2520and%2520function%2520of%2520Th17%2520cells%26jtitle%3DGenes%2520Cells%26date%3D2013%26volume%3D18%26spage%3D247%26epage%3D265%26doi%3D10.1111%2Fgtc.12039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1040</span>– <span class="NLM_lpage">1051</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2015.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.immuni.2015.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=26682981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVajtb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=1040-1051&author=D.+D.+Patelauthor=V.+K.+Kuchroo&title=Th17+Cell+Pathway+in+Human+Immunity%3A+Lessons+from+Genetics+and+Therapeutic+Interventions&doi=10.1016%2Fj.immuni.2015.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions</span></div><div class="casAuthors">Patel, Dhavalkumar D.; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1040-1051</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The T helper 17 (Th17) cell pathway has been linked by genome-wide assocn. studies to multiple autoimmune diseases.  Identification of the genetic causes of primary immunodeficiency diseases revealed that Th17 cells are also crit. in host immunity to mucocutaneous candida infections and Staphylococcus aureus.  Therapeutic interventions with inhibitors of the different components of the pathway such as interleukin-12 (IL-12), IL-23, IL-17A, and IL-17RA have variably beneficial effects in psoriasis, Crohn's disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-infectious uveitis, and multiple sclerosis.  Thus, whereas Th17 cells are protective against Candida albicans and to a lesser degree Staphylococcus aureus, they are pathogenic in many autoimmune diseases.  Here, we compare and contrast the effects of human genetic mutations of and therapeutic interventions targeted at Th17 cell mols.  We discuss that although there are similarities when Th17 cell pathway mols. are modulated, each mol. has unique non-Th17 cell features that lead to different functional outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb--L2SA4SpLVg90H21EOLACvtfcHk0lis71Sdy3FZZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVajtb7I&md5=5af767afe2a213dafa7c07f2b4271242</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2015.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2015.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DTh17%2520Cell%2520Pathway%2520in%2520Human%2520Immunity%253A%2520Lessons%2520from%2520Genetics%2520and%2520Therapeutic%2520Interventions%26jtitle%3DImmunity%26date%3D2015%26volume%3D43%26spage%3D1040%26epage%3D1051%26doi%3D10.1016%2Fj.immuni.2015.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaffen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span> <span> </span><span class="NLM_article-title">The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">600</span>, <span class="refDoi"> DOI: 10.1038/nri3707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnri3707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=25145755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSit7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=585-600&author=S.+L.+Gaffenauthor=R.+Jainauthor=A.+V.+Gargauthor=D.+J.+Cua&title=The+IL-23-IL-17+immune+axis%3A+from+mechanisms+to+therapeutic+testing&doi=10.1038%2Fnri3707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing</span></div><div class="casAuthors">Gaffen, Sarah L.; Jain, Renu; Garg, Abhishek V.; Cua, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">585-600</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the mol. mechanisms of T cell lineage commitment and function.  In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues.  We also discuss the emerging clin. data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsrf-chGl_n7Vg90H21EOLACvtfcHk0li0E-bsBJJOxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSit7%252FL&md5=3b78e054323aae062527ce32ec8e05e2</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnri3707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3707%26sid%3Dliteratum%253Aachs%26aulast%3DGaffen%26aufirst%3DS.%2BL.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DGarg%26aufirst%3DA.%2BV.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520IL-23-IL-17%2520immune%2520axis%253A%2520from%2520mechanisms%2520to%2520therapeutic%2520testing%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D14%26spage%3D585%26epage%3D600%26doi%3D10.1038%2Fnri3707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isono, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita-Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span> <span> </span><span class="NLM_article-title">Inhibiting RORγt/Th17 axis for autoimmune disorders</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1205</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.drudis.2014.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=24792721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1205-1211&author=F.+Isonoauthor=S.+Fujita-Satoauthor=S.+Ito&title=Inhibiting+ROR%CE%B3t%2FTh17+axis+for+autoimmune+disorders&doi=10.1016%2Fj.drudis.2014.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting RORγt/Th17 axis for autoimmune disorders</span></div><div class="casAuthors">Isono, Fujio; Fujita-Sato, Saori; Ito, Shuichiro</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1205-1211</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent success reported in late-stage clin. trials for the treatment of psoriasis by antibodies directed against interleukin (IL)-17 or its receptor has validated and strongly supports the development of inhibitors of the IL-17 pathway as a new therapeutic modality in chronic inflammation and autoimmunity.  These results also encourage the drug discovery of orally available small mols. that can modulate down the prodn. of IL-17 by Th17 cells (the major IL-17 producers) or the downstream signaling of the IL-17 receptor.  Here, we review these strategies with an emphasis on inhibiting the retinoic-acid-related orphan nuclear receptor RORγt, which is the master regulator of Th17 cells and a promising therapeutic target for the treatment of multiple autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQi4K-X9vSobVg90H21EOLACvtfcHk0li0E-bsBJJOxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D&md5=aaa82e8d21bcd0c879b0219a7b84e126</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DIsono%26aufirst%3DF.%26aulast%3DFujita-Sato%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DS.%26atitle%3DInhibiting%2520ROR%25CE%25B3t%252FTh17%2520axis%2520for%2520autoimmune%2520disorders%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1205%26epage%3D1211%26doi%3D10.1016%2Fj.drudis.2014.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miossec, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolls, J. K.</span></span> <span> </span><span class="NLM_article-title">Targeting IL-17 and TH17 cells in chronic inflammation</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1038/nrd3794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnrd3794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=23023676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqsb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=763-776&author=P.+Miossecauthor=J.+K.+Kolls&title=Targeting+IL-17+and+TH17+cells+in+chronic+inflammation&doi=10.1038%2Fnrd3794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IL-17 and TH17 cells in chronic inflammation</span></div><div class="casAuthors">Miossec, Pierre; Kolls, Jay K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">763-776</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The key role of interleukin-17 (IL-17) and T helper 17 (TH17) cells in tissue inflammation, autoimmunity and host defense led to the exptl. targeting of these mols. in mouse models of diseases as well as in clin. settings.  Moreover, the demonstration that IL-17 and TH17 cells contribute to local and systemic aspects of disease pathogenesis, as well as the finding that the IL-17-TH17 cell pathway is regulated by IL-23, prompted the identification of inhibitors.  These inhibitors include biotechnol. products that target IL-23 as well as the leading member of the IL-17 family, IL-17A, and one of its receptors, IL-17 receptor A.  Several clin. trials of these inhibitors are underway, and pos. results have been obtained in psoriasis, rheumatoid arthritis and ankylosing spondylitis.  This Review focuses on the current knowledge of the IL-17-TH17 cell pathway to better understand the pos. as well as potential neg. consequences of targeting them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLAiqCF66JHrVg90H21EOLACvtfcHk0li0E-bsBJJOxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqsb7L&md5=0627e4086ae6e50881cc3de52f1a2752</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd3794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3794%26sid%3Dliteratum%253Aachs%26aulast%3DMiossec%26aufirst%3DP.%26aulast%3DKolls%26aufirst%3DJ.%2BK.%26atitle%3DTargeting%2520IL-17%2520and%2520TH17%2520cells%2520in%2520chronic%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D763%26epage%3D776%26doi%3D10.1038%2Fnrd3794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suematsu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwakura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takayanagi, H.</span></span> <span> </span><span class="NLM_article-title">Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">2673</span>– <span class="NLM_lpage">2682</span>, <span class="refDoi"> DOI: 10.1084/jem.20061775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1084%2Fjem.20061775" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=2673-2682&author=K.+Satoauthor=A.+Suematsuauthor=K.+Okamotoauthor=A.+Yamaguchiauthor=Y.+Morishitaauthor=Y.+Kadonoauthor=S.+Tanakaauthor=T.+Kodamaauthor=S.+Akiraauthor=Y.+Iwakuraauthor=D.+J.+Cuaauthor=H.+Takayanagi&title=Th17+functions+as+an+osteoclastogenic+helper+T+cell+subset+that+links+T+cell+activation+and+bone+destruction&doi=10.1084%2Fjem.20061775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1084%2Fjem.20061775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20061775%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DK.%26aulast%3DSuematsu%26aufirst%3DA.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DA.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DKadono%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DIwakura%26aufirst%3DY.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DTh17%2520functions%2520as%2520an%2520osteoclastogenic%2520helper%2520T%2520cell%2520subset%2520that%2520links%2520T%2520cell%2520activation%2520and%2520bone%2520destruction%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D2673%26epage%3D2682%26doi%3D10.1084%2Fjem.20061775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beringer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miossec, P.</span></span> <span> </span><span class="NLM_article-title">IL-17 in Chronic Inflammation: From Discovery to Targeting</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2016.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.molmed.2016.01.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=230-241&author=A.+Beringerauthor=M.+Noackauthor=P.+Miossec&title=IL-17+in+Chronic+Inflammation%3A+From+Discovery+to+Targeting&doi=10.1016%2Fj.molmed.2016.01.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DBeringer%26aufirst%3DA.%26aulast%3DNoack%26aufirst%3DM.%26aulast%3DMiossec%26aufirst%3DP.%26atitle%3DIL-17%2520in%2520Chronic%2520Inflammation%253A%2520From%2520Discovery%2520to%2520Targeting%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D230%26epage%3D241%26doi%3D10.1016%2Fj.molmed.2016.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korman, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sofen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fretzin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyirady, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyring, S.</span></span> <span> </span><span class="NLM_article-title">Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis</span>. <i>J. Dermatol. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">384</span>, <span class="refDoi"> DOI: 10.1080/09546634.2016.1255306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1080%2F09546634.2016.1255306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27832717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvF2ms7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=384&author=N.+J.+Kormanauthor=H.+Sofenauthor=S.+Fretzinauthor=P.+Richauthor=Y.+Zhaoauthor=V.+Herreraauthor=J.+Nyiradyauthor=N.+Williamsauthor=M.+Mordinauthor=S.+Tyring&title=Secukinumab+provides+better+relief+from+the+impact+of+psoriasis+on+daily+activities+and+personal+relationships+than+etanercept%3A+results+of+two+phase+3+placebo-controlled+randomized+clinical+trials+in+moderate-to-severe+psoriasis&doi=10.1080%2F09546634.2016.1255306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis</span></div><div class="casAuthors">Korman, Neil J.; Sofen, Howard; Fretzin, Scott; Rich, Phoebe; Zhao, Yang; Herrera, Vivian; Nyirady, Judit; Williams, Nicole; Mordin, Margaret; Tyring, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Treatment</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">384-389</span>CODEN:
                <span class="NLM_cas:coden">JDTREY</span>;
        ISSN:<span class="NLM_cas:issn">0954-6634</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Psoriasis can greatly impact patients' lives, influencing what clothing they wear and impairing their sexual functioning.  To provide a detailed comparison of the impact of secukinumab vs. etanercept on enabling patients with psoriasis to have more normal lives with respect to daily activities (DA) (e.g. choosing clothing) and personal relationships (PR) (e.g. sexual functioning).  Baseline to Week 52 ERASURE and FIXTURE data for secukinumab 300 mg and etanercept were analyzed.  Treatment differences in mean scores on the DA and PR subscales and items from the Dermatol. Life Quality Index were compared.  The proportions of subscale and item responders (score = 0) were compared.  Subjects receiving secukinumab (n = 572) achieved greater mean improvement in DA and items (q3 and q4) than subjects receiving etanercept (n = 326; all p < .01 through Week 52).  Subjects receiving secukinumab achieved greater mean improvement in PR and items (q8 and q9) than subjects receiving etanercept (subscale: p < .05 at Weeks 8 and 12).  Response rates were significantly higher for secukinumab than for etanercept for DA (all p < .0001) and PR (all p < .05 except Weeks 4 and 36).  Secukinumab 300 mg provides greater improvements and more effective relief from psoriasis impact on DA and PR than etanercept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuYoD9EUwlWbVg90H21EOLACvtfcHk0ljaKFXIldYa2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvF2ms7jP&md5=f0ed8803c651f11e165c01a39eff9640</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1080%2F09546634.2016.1255306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09546634.2016.1255306%26sid%3Dliteratum%253Aachs%26aulast%3DKorman%26aufirst%3DN.%2BJ.%26aulast%3DSofen%26aufirst%3DH.%26aulast%3DFretzin%26aufirst%3DS.%26aulast%3DRich%26aufirst%3DP.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DHerrera%26aufirst%3DV.%26aulast%3DNyirady%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DN.%26aulast%3DMordin%26aufirst%3DM.%26aulast%3DTyring%26aufirst%3DS.%26atitle%3DSecukinumab%2520provides%2520better%2520relief%2520from%2520the%2520impact%2520of%2520psoriasis%2520on%2520daily%2520activities%2520and%2520personal%2520relationships%2520than%2520etanercept%253A%2520results%2520of%2520two%2520phase%25203%2520placebo-controlled%2520randomized%2520clinical%2520trials%2520in%2520moderate-to-severe%2520psoriasis%26jtitle%3DJ.%2520Dermatol.%2520Treat.%26date%3D2017%26volume%3D28%26spage%3D384%26doi%3D10.1080%2F09546634.2016.1255306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kopp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bangert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greisenegger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenschein, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClanahan, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marbury, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zachariae, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zandvliet, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Aarle, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalilieh, S.</span></span> <span> </span><span class="NLM_article-title">Clinical improvement in psoriasis with specific targeting of interleukin-23</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>521</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1038/nature14175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnature14175" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=521&publication_year=2015&pages=222-226&author=T.+Koppauthor=E.+Riedlauthor=C.+Bangertauthor=E.+P.+Bowmanauthor=E.+Greiseneggerauthor=A.+Horowitzauthor=H.+Kittlerauthor=W.+M.+Blumenscheinauthor=T.+K.+McClanahanauthor=T.+Marburyauthor=C.+Zachariaeauthor=D.+Xuauthor=X.+S.+Houauthor=A.+Mehtaauthor=A.+S.+Zandvlietauthor=D.+Montgomeryauthor=F.+van+Aarleauthor=S.+Khalilieh&title=Clinical+improvement+in+psoriasis+with+specific+targeting+of+interleukin-23&doi=10.1038%2Fnature14175"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature14175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14175%26sid%3Dliteratum%253Aachs%26aulast%3DKopp%26aufirst%3DT.%26aulast%3DRiedl%26aufirst%3DE.%26aulast%3DBangert%26aufirst%3DC.%26aulast%3DBowman%26aufirst%3DE.%2BP.%26aulast%3DGreisenegger%26aufirst%3DE.%26aulast%3DHorowitz%26aufirst%3DA.%26aulast%3DKittler%26aufirst%3DH.%26aulast%3DBlumenschein%26aufirst%3DW.%2BM.%26aulast%3DMcClanahan%26aufirst%3DT.%2BK.%26aulast%3DMarbury%26aufirst%3DT.%26aulast%3DZachariae%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DHou%26aufirst%3DX.%2BS.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DZandvliet%26aufirst%3DA.%2BS.%26aulast%3DMontgomery%26aufirst%3DD.%26aulast%3Dvan%2BAarle%26aufirst%3DF.%26aulast%3DKhalilieh%26aufirst%3DS.%26atitle%3DClinical%2520improvement%2520in%2520psoriasis%2520with%2520specific%2520targeting%2520of%2520interleukin-23%26jtitle%3DNature%26date%3D2015%26volume%3D521%26spage%3D222%26epage%3D226%26doi%3D10.1038%2Fnature14175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mease, P. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis</span>. <i>Curr. Opin. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1097/BOR.0000000000000147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1097%2FBOR.0000000000000147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=25599143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFCis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=127-133&author=P.+J.+Mease&title=Inhibition+of+interleukin-17%2C+interleukin-23+and+the+TH17+cell+pathway+in+the+treatment+of+psoriatic+arthritis+and+psoriasis&doi=10.1097%2FBOR.0000000000000147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis</span></div><div class="casAuthors">Mease, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Rheumatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-133</span>CODEN:
                <span class="NLM_cas:coden">CORHES</span>;
        ISSN:<span class="NLM_cas:issn">1040-8711</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: In recent years, there has been an increasing understanding of the importance of the TH17 lineage of T cells and related cytokines, including interleukin (IL)17 and IL23, not only in the biol. of innate host defense but also in the pathogenesis of inflammatory/autoimmune diseases.  These diseases include psoriasis, psoriatic arthritis, the broader category of spondyloarthritides including ankylosing spondylitis and rheumatoid arthritis.  It is postulated that in genetically predisposed individuals, external or internal stimuli such as microbial antigens, alterations in the intestinal microbiome, biomech. stress and/or immunol. dysregulation may lead to an increased expression of cytokines such as IL23, which in turn stimulate the differentiation and activation of TH17 and other immune cells, which are a part of the innate immune system that trigger adaptive immune processes and chronic inflammatory diseases.  Herein, we explore the effect of targeting this pathway therapeutically.  Recent findings: New drugs that are designed to inhibit steps in this pathway, the IL12/IL23 inhibitor, ustekinumab, the IL17A inhibitors secukinumab and ixekizumab, the IL17A receptor inhibitor, brodalumab, and the IL23 inhibitors guselkumab and tildrakizumab, have demonstrated significant effectiveness in treating these diseases, particularly psoriasis, psoriatic arthritis and ankylosing spondylitis.  Summary: This article reviews the relevant biol., efficacy and safety of new medications targeting the TH17 pathway, including inhibition of IL17 and IL23, particularly in psoriasis and psoriatic arthritis.  Esp. for patients who have not gained benefit from, lost effectiveness to or could not use antitumor necrosis factor (TNF) medications for safety or tolerability reasons, having effective medicines with an alternative mechanism of action will improve our ability to diminish disease activity impact on patient lives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryNc3Fy2wnNrVg90H21EOLACvtfcHk0ljaKFXIldYa2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFCis7g%253D&md5=452435fc597207937abb44f188614662</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1097%2FBOR.0000000000000147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FBOR.0000000000000147%26sid%3Dliteratum%253Aachs%26aulast%3DMease%26aufirst%3DP.%2BJ.%26atitle%3DInhibition%2520of%2520interleukin-17%252C%2520interleukin-23%2520and%2520the%2520TH17%2520cell%2520pathway%2520in%2520the%2520treatment%2520of%2520psoriatic%2520arthritis%2520and%2520psoriasis%26jtitle%3DCurr.%2520Opin.%2520Rheumatol.%26date%3D2015%26volume%3D27%26spage%3D127%26epage%3D133%26doi%3D10.1097%2FBOR.0000000000000147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumbley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundasen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojetin, D. J.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptors and their selective pharmacologic modulators</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">778</span>, <span class="refDoi"> DOI: 10.1124/pr.112.006833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1124%2Fpr.112.006833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=23457206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslCisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=710-778&author=T.+P.+Burrisauthor=L.+A.+Soltauthor=Y.+Wangauthor=C.+Crumbleyauthor=S.+Banerjeeauthor=K.+Griffettauthor=T.+Lundasenauthor=T.+Hughesauthor=D.+J.+Kojetin&title=Nuclear+receptors+and+their+selective+pharmacologic+modulators&doi=10.1124%2Fpr.112.006833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptors and their selective pharmacologic modulators</span></div><div class="casAuthors">Burris, Thomas P.; Solt, Laura A.; Wang, Yongjun; Crumbley, Christine; Banerjee, Subhashis; Griffett, Kristine; Lundasen, Thomas; Hughes, Travis; Kojetin, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">710-778, 69 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors are ligand-activated transcription factors and include the receptors for steroid hormones, lipophilic vitamins, sterols, and bile acids.  These receptors serve as targets for development of myriad drugs that target a range of disorders.  Classically defined ligands that bind to the ligand-binding domain of nuclear receptors, whether they are endogenous or synthetic, either activate receptor activity (agonists) or block activation (antagonists) and due to the ability to alter activity of the receptors are often termed receptor "modulators".  The complex pharmacol. of nuclear receptors has provided a class of ligands distinct from these simple modulators where ligands display agonist/partial agonist/antagonist function in a tissue or gene selective manner.  This class of ligands is defined as selective modulators.  Here, we review the development and pharmacol. of a range of selective nuclear receptor modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodFD-Tf1vBUrVg90H21EOLACvtfcHk0lgFLJsLg2CEPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslCisrY%253D&md5=33c34757a837d2a80674fbe5c1660fe2</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fpr.112.006833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.112.006833%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCrumbley%26aufirst%3DC.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DGriffett%26aufirst%3DK.%26aulast%3DLundasen%26aufirst%3DT.%26aulast%3DHughes%26aufirst%3DT.%26aulast%3DKojetin%26aufirst%3DD.%2BJ.%26atitle%3DNuclear%2520receptors%2520and%2520their%2520selective%2520pharmacologic%2520modulators%26jtitle%3DPharmacol.%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D710%26epage%3D778%26doi%3D10.1124%2Fpr.112.006833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savkur, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">The coactivator LXXLL nuclear receptor recognition motif</span>. <i>J. Pept. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1111/j.1399-3011.2004.00126.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1111%2Fj.1399-3011.2004.00126.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=15049832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtlKlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2004&pages=207-212&author=R.+S.+Savkurauthor=T.+P.+Burris&title=The+coactivator+LXXLL+nuclear+receptor+recognition+motif&doi=10.1111%2Fj.1399-3011.2004.00126.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The coactivator LXXLL nuclear receptor recognition motif</span></div><div class="casAuthors">Savkur, R. S.; Burris, T. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-212</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors require coactivator binding in order to activate transcription of their cognate target genes.  Ligands regulate nuclear receptor (NR)-mediated recruitment of coactivators by binding to the ligand-binding domain of the receptor and inducing a conformational change allowing for recognition of a specific motif contained within the coactivator protein.  This motif is known as the NR box or LXXLL (where L is leucine and X is any amino acid) domain.  Here, we review the discovery of the domain as well as its characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-3lqTiOQ-E7Vg90H21EOLACvtfcHk0lgFLJsLg2CEPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtlKlsrk%253D&md5=31d0ef26857300ea80b32378bb2b2771</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.2004.00126.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.2004.00126.x%26sid%3Dliteratum%253Aachs%26aulast%3DSavkur%26aufirst%3DR.%2BS.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DThe%2520coactivator%2520LXXLL%2520nuclear%2520receptor%2520recognition%2520motif%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D2004%26volume%3D63%26spage%3D207%26epage%3D212%26doi%3D10.1111%2Fj.1399-3011.2004.00126.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gronemeyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, V.</span></span> <span> </span><span class="NLM_article-title">Principles for modulation of the nuclear receptor superfamily</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">950</span>– <span class="NLM_lpage">964</span>, <span class="refDoi"> DOI: 10.1038/nrd1551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnrd1551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=15520817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=950-964&author=H.+Gronemeyerauthor=J.+A.+Gustafssonauthor=V.+Laudet&title=Principles+for+modulation+of+the+nuclear+receptor+superfamily&doi=10.1038%2Fnrd1551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Principles for modulation of the nuclear receptor superfamily</span></div><div class="casAuthors">Gronemeyer, Hinrich; Gustafsson, Jan-A.; Laudet, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">950-964</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors are major targets for drug discovery and have key roles in development and homeostasis, as well as in many diseases such as obesity, diabetes and cancer.  This review provides a general overview of the mechanism of action of nuclear receptors and explores the various factors that are instrumental in modulating their pharmacol.  In most cases, the response of a given receptor to a particular ligand in a specific tissue will be dictated by the set of proteins with which the receptor is able to interact.  One of the most promising aspects of nuclear receptor pharmacol. is that it is now possible to develop ligands with a large spectrum of full, partial or inverse agonist or antagonist activities, but also compds., called selective nuclear receptor modulators, that activate only a subset of the functions induced by the cognate ligand or that act in a cell-type-selective manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSWL9yf1CceLVg90H21EOLACvtfcHk0lgFLJsLg2CEPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFemtrY%253D&md5=aedb60785c235bf44cb5f0ea34236090</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd1551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1551%26sid%3Dliteratum%253Aachs%26aulast%3DGronemeyer%26aufirst%3DH.%26aulast%3DGustafsson%26aufirst%3DJ.%2BA.%26aulast%3DLaudet%26aufirst%3DV.%26atitle%3DPrinciples%2520for%2520modulation%2520of%2520the%2520nuclear%2520receptor%2520superfamily%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D950%26epage%3D964%26doi%3D10.1038%2Fnrd1551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helvering, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumbley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stayrook, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">Modulation of Retinoic Acid Receptor-related Orphan Receptor α and γ Activity by 7-Oxygenated Sterol Ligands</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">5013</span>– <span class="NLM_lpage">5025</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.080614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1074%2Fjbc.M109.080614" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=5013-5025&author=Y.+Wangauthor=N.+Kumarauthor=L.+A.+Soltauthor=T.+I.+Richardsonauthor=L.+M.+Helveringauthor=C.+Crumbleyauthor=R.+D.+Garcia-Ordonezauthor=K.+R.+Stayrookauthor=X.+Zhangauthor=S.+Novickauthor=M.+J.+Chalmersauthor=P.+R.+Griffinauthor=T.+P.+Burris&title=Modulation+of+Retinoic+Acid+Receptor-related+Orphan+Receptor+%CE%B1+and+%CE%B3+Activity+by+7-Oxygenated+Sterol+Ligands&doi=10.1074%2Fjbc.M109.080614"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.080614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.080614%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DRichardson%26aufirst%3DT.%2BI.%26aulast%3DHelvering%26aufirst%3DL.%2BM.%26aulast%3DCrumbley%26aufirst%3DC.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%2BD.%26aulast%3DStayrook%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DNovick%26aufirst%3DS.%26aulast%3DChalmers%26aufirst%3DM.%2BJ.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DModulation%2520of%2520Retinoic%2520Acid%2520Receptor-related%2520Orphan%2520Receptor%2520%25CE%25B1%2520and%2520%25CE%25B3%2520Activity%2520by%25207-Oxygenated%2520Sterol%2520Ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D5013%26epage%3D5025%26doi%3D10.1074%2Fjbc.M109.080614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soroosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandridge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tootoonchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenkrants, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milla, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span> <span> </span><span class="NLM_article-title">Oxysterols are agonist ligands of RORgt and drive Th17 cell differentiation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12163</span>– <span class="NLM_lpage">12168</span>, <span class="refDoi"> DOI: 10.1073/pnas.1322807111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1073%2Fpnas.1322807111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12163-12168&author=P.+Sorooshauthor=J.+Wuauthor=X.+Xueauthor=J.+Songauthor=S.+W.+Suttonauthor=M.+Sabladauthor=J.+Yuauthor=M.+I.+Nelenauthor=X.+Liuauthor=G.+Castroauthor=R.+Lunaauthor=S.+Crawfordauthor=H.+Banieauthor=R.+A.+Dandridgeauthor=X.+Dengauthor=A.+Bittnerauthor=C.+Kueiauthor=M.+Tootoonchiauthor=N.+Rozenkrantsauthor=K.+Hermanauthor=J.+Gaoauthor=X.+V.+Yangauthor=K.+Sachenauthor=K.+Ngoauthor=W.+P.+Fung-Leungauthor=S.+Nguyenauthor=A.+de+Leon-Tabaldoauthor=J.+Blevittauthor=Y.+Zhangauthor=M.+D.+Cummingsauthor=T.+Raoauthor=N.+S.+Maniauthor=C.+Liuauthor=M.+McKinnonauthor=M.+E.+Millaauthor=A.+M.+Fourieauthor=S.+Sun&title=Oxysterols+are+agonist+ligands+of+RORgt+and+drive+Th17+cell+differentiation&doi=10.1073%2Fpnas.1322807111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1322807111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1322807111%26sid%3Dliteratum%253Aachs%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DLuna%26aufirst%3DR.%26aulast%3DCrawford%26aufirst%3DS.%26aulast%3DBanie%26aufirst%3DH.%26aulast%3DDandridge%26aufirst%3DR.%2BA.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DBittner%26aufirst%3DA.%26aulast%3DKuei%26aufirst%3DC.%26aulast%3DTootoonchi%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DHerman%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%2BV.%26aulast%3DSachen%26aufirst%3DK.%26aulast%3DNgo%26aufirst%3DK.%26aulast%3DFung-Leung%26aufirst%3DW.%2BP.%26aulast%3DNguyen%26aufirst%3DS.%26aulast%3Dde%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DBlevitt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DRao%26aufirst%3DT.%26aulast%3DMani%26aufirst%3DN.%2BS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DMilla%26aufirst%3DM.%2BE.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DSun%26aufirst%3DS.%26atitle%3DOxysterols%2520are%2520agonist%2520ligands%2520of%2520RORgt%2520and%2520drive%2520Th17%2520cell%2520differentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D12163%26epage%3D12168%26doi%3D10.1073%2Fpnas.1322807111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huh, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, M. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krout, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malapaka, R. R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciofani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuesta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santori, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gin, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>472</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1038/nature09978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnature09978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=21441909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2011&pages=486-490&author=J.+R.+Huhauthor=M.+W.+L.+Leungauthor=P.+Huangauthor=D.+A.+Ryanauthor=M.+R.+Kroutauthor=R.+R.+V.+Malapakaauthor=J.+Chowauthor=N.+Manelauthor=M.+Ciofaniauthor=S.+V.+Kimauthor=A.+Cuestaauthor=F.+R.+Santoriauthor=J.+J.+Lafailleauthor=H.+E.+Xuauthor=D.+Y.+Ginauthor=F.+Rastinejadauthor=D.+R.+Littman&title=Digoxin+and+its+derivatives+suppress+TH17+cell+differentiation+by+antagonizing+ROR%CE%B3t+activity&doi=10.1038%2Fnature09978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity</span></div><div class="casAuthors">Huh, Jun R.; Leung, Monica W. L.; Huang, Pengxiang; Ryan, Daniel A.; Krout, Michael R.; Malapaka, Raghu R. V.; Chow, Jonathan; Manel, Nicolas; Ciofani, Maria; Kim, Sangwon V.; Cuesta, Adolfo; Santori, Fabio R.; Lafaille, Juan J.; Xu, H. Eric; Gin, David Y.; Rastinejad, Fraydoon; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">472</span>
        (<span class="NLM_cas:issue">7344</span>),
    <span class="NLM_cas:pages">486-490</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CD4+ T helper lymphocytes that express interleukin-17 (TH17 cells) have crit. roles in mouse models of autoimmunity, and there is mounting evidence that they also influence inflammatory processes in humans.  Genome-wide assocn. studies in humans have linked genes involved in TH17 cell differentiation and function with susceptibility to Crohn's disease, rheumatoid arthritis and psoriasis.  Thus, the pathway towards differentiation of TH17 cells and, perhaps, of related innate lymphoid cells with similar effector functions, is an attractive target for therapeutic applications.  Mouse and human TH17 cells are distinguished by expression of the retinoic acid receptor-related orphan nuclear receptor RORγt, which is required for induction of IL-17 transcription and for the manifestation of TH17-dependent autoimmune disease in mice.  By performing a chem. screen with an insect cell-based reporter system, we identified the cardiac glycoside digoxin as a specific inhibitor of RORγt transcriptional activity.  Digoxin inhibited murine TH17 cell differentiation without affecting differentiation of other T cell lineages and was effective in delaying the onset and reducing the severity of autoimmune disease in mice.  At high concns., digoxin is toxic for human cells, but non-toxic synthetic derivs. 20,22-dihydrodigoxin-21,23-diol and digoxin-21-salicylidene specifically inhibited induction of IL-17 in human CD4+ T cells.  Using these small-mol. compds., we demonstrate that RORγt is important for the maintenance of IL-17 expression in mouse and human effector T cells.  These data indicate that derivs. of digoxin can be used as chem. templates for the development of RORγt-targeted therapeutic agents that attenuate inflammatory lymphocyte function and autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZeBtm9HrHi7Vg90H21EOLACvtfcHk0ljSt1XcTSC77A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOisr8%253D&md5=d25efc57bc2849ed23456c95c59cc006</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnature09978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09978%26sid%3Dliteratum%253Aachs%26aulast%3DHuh%26aufirst%3DJ.%2BR.%26aulast%3DLeung%26aufirst%3DM.%2BW.%2BL.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DRyan%26aufirst%3DD.%2BA.%26aulast%3DKrout%26aufirst%3DM.%2BR.%26aulast%3DMalapaka%26aufirst%3DR.%2BR.%2BV.%26aulast%3DChow%26aufirst%3DJ.%26aulast%3DManel%26aufirst%3DN.%26aulast%3DCiofani%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.%2BV.%26aulast%3DCuesta%26aufirst%3DA.%26aulast%3DSantori%26aufirst%3DF.%2BR.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DGin%26aufirst%3DD.%2BY.%26aulast%3DRastinejad%26aufirst%3DF.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DDigoxin%2520and%2520its%2520derivatives%2520suppress%2520TH17%2520cell%2520differentiation%2520by%2520antagonizing%2520ROR%25CE%25B3t%2520activity%26jtitle%3DNature%26date%3D2011%26volume%3D472%26spage%3D486%26epage%3D490%26doi%3D10.1038%2Fnature09978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendling, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toogood, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G. D.</span></span> <span> </span><span class="NLM_article-title">Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fnchembio.1714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=25558972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=141-147&author=X.+Huauthor=Y.+Wangauthor=L.-Y.+Haoauthor=X.+Liuauthor=C.+A.+Leschauthor=B.+M.+Sanchezauthor=J.+M.+Wendlingauthor=R.+W.+Morganauthor=T.+D.+Aicherauthor=L.+L.+Carterauthor=P.+L.+Toogoodauthor=G.+D.+Glick&title=Sterol+metabolism+controls+TH17+differentiation+by+generating+endogenous+ROR%CE%B3+agonists&doi=10.1038%2Fnchembio.1714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists</span></div><div class="casAuthors">Hu, Xiao; Wang, Yahong; Hao, Ling-Yang; Liu, Xikui; Lesch, Chuck A.; Sanchez, Brian M.; Wendling, Jay M.; Morgan, Rodney W.; Aicher, Tom D.; Carter, Laura L.; Toogood, Peter L.; Glick, Gary D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-147</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptor γ (RORγt) controls the differentiation of naive CD4+ T cells into the TH17 lineage, which are crit. cells in the pathogenesis of autoimmune diseases.  Here the authors report that during TH17 differentiation, cholesterol biosynthesis and uptake programs are induced, whereas their metab. and efflux programs are suppressed.  These changes result in the accumulation of the cholesterol precursor, desmosterol, which functions as a potent endogenous RORγ agonist.  Generation of cholesterol precursors is essential for TH17 differentiation as blocking cholesterol synthesis with chem. inhibitors at steps before the formation of active precursors reduces differentiation.  Upon activation, metabolic changes also lead to prodn. of specific sterol-sulfate conjugates that favor activation of RORγ over the TH17-inhibiting sterol receptor LXR.  Thus, TH17 differentiation is orchestrated by coordinated sterol synthesis, mobilization and metab. to selectively activate RORγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKonRBn05nmbVg90H21EOLACvtfcHk0lgL8sHiG39uJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislOltQ%253D%253D&md5=e82af9d561a1e4683a86b815cb734971</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1714%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DL.-Y.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLesch%26aufirst%3DC.%2BA.%26aulast%3DSanchez%26aufirst%3DB.%2BM.%26aulast%3DWendling%26aufirst%3DJ.%2BM.%26aulast%3DMorgan%26aufirst%3DR.%2BW.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DGlick%26aufirst%3DG.%2BD.%26atitle%3DSterol%2520metabolism%2520controls%2520TH17%2520differentiation%2520by%2520generating%2520endogenous%2520ROR%25CE%25B3%2520agonists%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D141%26epage%3D147%26doi%3D10.1038%2Fnchembio.1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martynowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORγ</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1210/me.2009-0507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1210%2Fme.2009-0507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=20203100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=923-929&author=L.+Jinauthor=D.+Martynowskiauthor=S.+Zhengauthor=T.+Wadaauthor=W.+Xieauthor=Y.+Li&title=Structural+basis+for+hydroxycholesterols+as+natural+ligands+of+orphan+nuclear+receptor+ROR%CE%B3&doi=10.1210%2Fme.2009-0507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORγ</span></div><div class="casAuthors">Jin, Lihua; Martynowski, Dariusz; Zheng, Songyang; Wada, Taira; Xie, Wen; Li, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">923-929</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The retinoic acid-related orphan receptor γ (RORγ) has important roles in development and metabolic homeostasis.  Although the biol. functions of RORγ have been studied extensively, no ligands for RORγ have been identified, and no structure of RORγ has been reported.  In this study, we showed that hydroxycholesterols promote the recruitment of coactivators by RORγ using biochem. assays.  We also report the crystal structures of the RORγ ligand-binding domain bound with hydroxycholesterols.  The structures reveal the binding modes of various hydroxycholesterols in the RORγ pocket, with the receptors all adopting the canonical active conformation.  Mutations that disrupt the binding of hydroxycholesterols abolish the constitutive activity of RORγ.  Our observations suggest an important role for the endogenous hydroxycholesterols in modulating RORγ-dependent biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-ndP3ZSYebVg90H21EOLACvtfcHk0lgL8sHiG39uJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D&md5=1651fa21702f2a06451377fa11aa80bc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0507%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMartynowski%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520for%2520hydroxycholesterols%2520as%2520natural%2520ligands%2520of%2520orphan%2520nuclear%2520receptor%2520ROR%25CE%25B3%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D923%26epage%3D929%26doi%3D10.1210%2Fme.2009-0507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita-Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isono, F.</span></span> <span> </span><span class="NLM_article-title">Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 production</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">31409</span>– <span class="NLM_lpage">31417</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.254003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1074%2Fjbc.M111.254003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=31409-31417&author=S.+Fujita-Satoauthor=S.+Itoauthor=T.+Isobeauthor=T.+Ohyamaauthor=K.+Wakabayashiauthor=K.+Morishitaauthor=O.+Andoauthor=F.+Isono&title=Structural+basis+of+digoxin+that+antagonizes+RORgamma+t+receptor+activity+and+suppresses+Th17+cell+differentiation+and+interleukin+%28IL%29-17+production&doi=10.1074%2Fjbc.M111.254003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.254003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.254003%26sid%3Dliteratum%253Aachs%26aulast%3DFujita-Sato%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DOhyama%26aufirst%3DT.%26aulast%3DWakabayashi%26aufirst%3DK.%26aulast%3DMorishita%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DO.%26aulast%3DIsono%26aufirst%3DF.%26atitle%3DStructural%2520basis%2520of%2520digoxin%2520that%2520antagonizes%2520RORgamma%2520t%2520receptor%2520activity%2520and%2520suppresses%2520Th17%2520cell%2520differentiation%2520and%2520interleukin%2520%2528IL%2529-17%2520production%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D31409%26epage%3D31417%26doi%3D10.1074%2Fjbc.M111.254003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5871</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1021/jm401901d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401901d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5871-5892&author=B.+P.+Fauberauthor=S.+Magnuson&title=Modulators+of+the+Nuclear+Receptor+Retinoic+Acid+Receptor-Related+Orphan+Receptor-%CE%B3+%28ROR%CE%B3+or+RORc%29&doi=10.1021%2Fjm401901d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)</span></div><div class="casAuthors">Fauber, Benjamin P.; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5871-5892</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the biol. surrounding the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORγ or RORc) continues to evolve, significant effort has been invested in discovering modulators of this potentially important target for the treatment of metabolic and immunol. diseases.  Several major pharmaceutical and biotechnol. companies have disclosed RORc inhibitors or partnered with other players in the field.  In this perspective, we discuss both the biol. and the underlying structural biol. of RORc, and summarize the RORc modulators disclosed in the scientific and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhzxefrY4hLVg90H21EOLACvtfcHk0lgL8sHiG39uJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D&md5=42b350bff7776d4b5689275eab214d86</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm401901d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401901d%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DModulators%2520of%2520the%2520Nuclear%2520Receptor%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor-%25CE%25B3%2520%2528ROR%25CE%25B3%2520or%2520RORc%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5871%26epage%3D5892%26doi%3D10.1021%2Fjm401901d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyda, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Synthetic modulators of the retinoic acid receptor-related orphan receptors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">764</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1039/c3md00005b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1039%2Fc3md00005b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVygsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=764-776&author=T.+M.+Kameneckaauthor=B.+Lydaauthor=M.+R.+Changauthor=P.+R.+Griffin&title=Synthetic+modulators+of+the+retinoic+acid+receptor-related+orphan+receptors&doi=10.1039%2Fc3md00005b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic modulators of the retinoic acid receptor-related orphan receptors</span></div><div class="casAuthors">Kamenecka, Theodore M.; Lyda, Brent; Chang, Mi Ra; Griffin, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">764-776</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NR) are ligand-regulated transcription factors that control the expression of target genes involved in a range of physiol. processes such as development, metab., and immunity.  The retinoic acid receptor-related orphan receptors alpha, beta, and gamma (RORA, RORB, and RORC) comprise a distinct subfamily of nuclear receptors and are considered orphan' receptors, as they have no known generally agreed upon endogenous ligands, although these receptors do bind to and are modulated by oxysterols.  Several recent reports have highlighted the potential role for RORs in human disease, and more importantly, studies have demonstrated that these receptors can be modulated by exogenous synthetic ligands.  The identification of potent and selective ROR ligands will allow for a better understanding of the roles of the ROR receptors in human disease, and potentially pave the way for development of novel therapeutics.  Here we review the current status of synthetic ligand development from both the primary and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOh7XjR1TYObVg90H21EOLACvtfcHk0lhc49LUZaOqHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVygsL0%253D&md5=1985ee3df0c0476b65bcd68f7e9bc126</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fc3md00005b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00005b%26sid%3Dliteratum%253Aachs%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DLyda%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DSynthetic%2520modulators%2520of%2520the%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptors%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D764%26epage%3D776%26doi%3D10.1039%2Fc3md00005b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cyr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">Recent progress on nuclear receptor RORγ modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4387</span>– <span class="NLM_lpage">4393</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2016.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27542308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4387-4393&author=P.+Cyrauthor=S.+M.+Bronnerauthor=J.+J.+Crawford&title=Recent+progress+on+nuclear+receptor+ROR%CE%B3+modulators&doi=10.1016%2Fj.bmcl.2016.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress on nuclear receptor RORγ modulators</span></div><div class="casAuthors">Cyr, Patrick; Bronner, Sarah M.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4387-4393</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The retinoic acid receptor-related orphan receptor RORγ plays key roles in the development and differentiation of TH17 cells, and thus in IL-17 expression, thymocyte development and regulation of metab.  With the recent progression into phase 2 clin. trials of both oral and topically administered inverse agonists, and with others close behind, there is significant interest in the discovery of RORγ modulators.  This digest covers key developments around RORγ agonists, antagonists and inverse agonists; orthosteric and allosteric binders; and aims to summarize the available information concerning the potential utility of RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD6nrse0GiBLVg90H21EOLACvtfcHk0lhc49LUZaOqHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL&md5=688885fc5c71ce01b86df6c9703b51ec</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DCyr%26aufirst%3DP.%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DRecent%2520progress%2520on%2520nuclear%2520receptor%2520ROR%25CE%25B3%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4387%26epage%3D4393%26doi%3D10.1016%2Fj.bmcl.2016.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">ROR nuclear receptors: structures, related diseases, and drug discovery</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1038/aps.2014.120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Faps.2014.120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=25500868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVGgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=71-87&author=Y.+Zhangauthor=X.-y.+Luoauthor=D.-h.+Wuauthor=Y.+Xu&title=ROR+nuclear+receptors%3A+structures%2C+related+diseases%2C+and+drug+discovery&doi=10.1038%2Faps.2014.120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">ROR nuclear receptors: structures, related diseases, and drug discovery</span></div><div class="casAuthors">Zhang, Yan; Luo, Xiao-yu; Wu, Dong-hai; Xu, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-87</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NRs) are ligand-regulated transcription factors that regulate metab., development and immunity.  The NR superfamily is one of the major classes of drug targets for human diseases.  Retinoic acid receptor-related orphan receptor (ROR) α, β and γ belong to the NR superfamily, and these receptors are still considered as 'orphan' receptors because the identification of their endogenous ligands has been controversial.  Recent studies have demonstrated that these receptors are regulated by synthetic ligands, thus emerge as important drug targets for the treatment of multiple sclerosis, rheumatoid arthritis, psoriasis, etc.  Studying the structural basis and ligand development of RORs will pave the way for a better understanding of the roles of these receptors in human diseases.  Here, we review the structural basis, disease relevance, strategies for ligand identification, and current status of development of therapeutic ligands for RORs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoupXZKlp8kzbVg90H21EOLACvtfcHk0lhc49LUZaOqHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVGgtw%253D%253D&md5=5f5c6e553f7860890bb9f3d9d42be14b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Faps.2014.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2014.120%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DX.-y.%26aulast%3DWu%26aufirst%3DD.-h.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DROR%2520nuclear%2520receptors%253A%2520structures%252C%2520related%2520diseases%252C%2520and%2520drug%2520discovery%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2015%26volume%3D36%26spage%3D71%26epage%3D87%26doi%3D10.1038%2Faps.2014.120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zbieg, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">RORγ antagonists and inverse agonists: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1236918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1080%2F13543776.2017.1236918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27629281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=101-112&author=S.+M.+Bronnerauthor=J.+R.+Zbiegauthor=J.+J.+Crawford&title=ROR%CE%B3+antagonists+and+inverse+agonists%3A+a+patent+review&doi=10.1080%2F13543776.2017.1236918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">RORγ antagonists and inverse agonists: a patent review</span></div><div class="casAuthors">Bronner, Sarah M.; Zbieg, Jason R.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The transcription factor RORγ plays a crit. role in the expression of pro-inflammatory cytokine interleukin IL-17 and is therefore an attractive target for the treatment of inflammatory diseases.  Interest in this mol. target has been heightened by the advancement of orally and topically administered RORγ modulators into clin. trials.  The present review seeks to summarize published patent applications from assignee companies that have disclosed Investigational New Drug (IND) filings for small mol. RORγ/RORγt antagonists and inverse agonists.  The field of RORγ research is extremely competitive, with the majority of companies targeting psoriasis as the primary disease indication.  Vitae Pharmaceuticals is currently the most advanced, with a potential first-in-class oral RORγ-modulator for the treatment of psoriasis.  Future efforts will likely expand into potential applications of RORγ-modulators in the lesser explored immune-related areas of rheumatoid arthritis, type 1 diabetes, lupus, and irritable bowel disorder, as well as cancer immunotherapy and castration-resistant prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj8lMzWsYVA7Vg90H21EOLACvtfcHk0lhc49LUZaOqHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP&md5=d80db6c4c948bc12c5d0ce4b41edd2fb</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1236918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1236918%26sid%3Dliteratum%253Aachs%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DZbieg%26aufirst%3DJ.%2BR.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DROR%25CE%25B3%2520antagonists%2520and%2520inverse%2520agonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D101%26epage%3D112%26doi%3D10.1080%2F13543776.2017.1236918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonemori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujitani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmc.2017.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=29262987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=483-500&author=J.+Shiraiauthor=Y.+Tomataauthor=M.+Konoauthor=A.+Ochidaauthor=Y.+Fukaseauthor=A.+Satoauthor=S.+Masadaauthor=T.+Kawamotoauthor=K.+Yonemoriauthor=R.+Koyamaauthor=H.+Nakagawaauthor=M.+Nakayamaauthor=K.+Ugaauthor=A.+Shibataauthor=K.+Kogaauthor=T.+Okuiauthor=M.+Shirasakiauthor=R.+Skeneauthor=B.+Sangauthor=I.+Hoffmanauthor=W.+Laneauthor=Y.+Fujitaniauthor=M.+Yamasakiauthor=S.+Yamamoto&title=Discovery+of+orally+efficacious+ROR%CE%B3t+inverse+agonists%2C+part+1%3A+Identification+of+novel+phenylglycinamides+as+lead+scaffolds&doi=10.1016%2Fj.bmc.2017.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds</span></div><div class="casAuthors">Shirai, Junya; Tomata, Yoshihide; Kono, Mitsunori; Ochida, Atsuko; Fukase, Yoshiyuki; Sato, Ayumu; Masada, Shinichi; Kawamoto, Tetsuji; Yonemori, Kazuko; Koyama, Ryoukichi; Nakagawa, Hideyuki; Nakayama, Masaharu; Uga, Keiko; Shibata, Akira; Koga, Keiko; Okui, Toshitake; Shirasaki, Mikio; Skene, Robert; Sang, Bi Ching; Hoffman, Isaac; Lane, Wes; Fujitani, Yasushi; Yamasaki, Masashi; Yamamoto, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">483-500</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel phenylglycinamides as retinoic acid receptor-related orphan receptor-gamma t (RORγt) inverse agonists were discovered through optimization of a high-throughput screen hit 1.  (R)-N-(2-((3,5-Difluoro-4-(trimethylsilyl)phenyl) amino)-1-(4-methoxyphenyl)-2-oxoethyl)-3-hydroxy-N-methylisoxazole-5-carboxamide (22) was identified as one of the best of these compds.  It displayed higher subtype selectivity and specificity over other nuclear receptors and demonstrated in vivo potency to suppress the transcriptional activity of RORγt in a mouse PD (pharmacodynamic) model upon oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIW-zVUDTjKLVg90H21EOLACvtfcHk0lhssxSNoUbtaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLbJ&md5=649c3527a6f7e383456dd59551e35628</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DTomata%26aufirst%3DY.%26aulast%3DKono%26aufirst%3DM.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DMasada%26aufirst%3DS.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DYonemori%26aufirst%3DK.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DKoga%26aufirst%3DK.%26aulast%3DOkui%26aufirst%3DT.%26aulast%3DShirasaki%26aufirst%3DM.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DSang%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DI.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DFujitani%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520orally%2520efficacious%2520ROR%25CE%25B3t%2520inverse%2520agonists%252C%2520part%25201%253A%2520Identification%2520of%2520novel%2520phenylglycinamides%2520as%2520lead%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D483%26epage%3D500%26doi%3D10.1016%2Fj.bmc.2017.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yukawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujitani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmc.2017.12.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=470-482&author=M.+Konoauthor=T.+Odaauthor=M.+Tawadaauthor=T.+Imadaauthor=Y.+Bannoauthor=N.+Tayaauthor=T.+Kawamotoauthor=H.+Tokuharaauthor=Y.+Tomataauthor=N.+Ishiiauthor=A.+Ochidaauthor=Y.+Fukaseauthor=T.+Yukawaauthor=S.+Fukumotoauthor=H.+Watanabeauthor=K.+Ugaauthor=A.+Shibataauthor=H.+Nakagawaauthor=M.+Shirasakiauthor=Y.+Fujitaniauthor=M.+Yamasakiauthor=J.+Shiraiauthor=S.+Yamamoto&title=Discovery+of+orally+efficacious+ROR%CE%B3t+inverse+agonists.+Part+2%3A+Design%2C+synthesis%2C+and+biological+evaluation+of+novel+tetrahydroisoquinoline+derivatives&doi=10.1016%2Fj.bmc.2017.12.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DOda%26aufirst%3DT.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DImada%26aufirst%3DT.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DTaya%26aufirst%3DN.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DTokuhara%26aufirst%3DH.%26aulast%3DTomata%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DYukawa%26aufirst%3DT.%26aulast%3DFukumoto%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DShirasaki%26aufirst%3DM.%26aulast%3DFujitani%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520orally%2520efficacious%2520ROR%25CE%25B3t%2520inverse%2520agonists.%2520Part%25202%253A%2520Design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520tetrahydroisoquinoline%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D470%26epage%3D482%26doi%3D10.1016%2Fj.bmc.2017.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karmakar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemagiri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raut, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pudzianowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borowski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arienzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galella, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somerville, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, T. G. M.</span></span> <span> </span><span class="NLM_article-title">Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2017.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=29233651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCqtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=85-93&author=H.+Gongauthor=D.+S.+Weinsteinauthor=Z.+Luauthor=J.+J.+W.+Duanauthor=S.+Stachuraauthor=L.+Haqueauthor=A.+Karmakarauthor=H.+Hemagiriauthor=D.+K.+Rautauthor=A.+K.+Guptaauthor=J.+Khanauthor=D.+Camacauthor=J.+S.+Sackauthor=A.+Pudzianowskiauthor=D.-R.+Wuauthor=M.+Yardeauthor=D.-R.+Shenauthor=V.+Borowskiauthor=J.+H.+Xieauthor=H.+Sunauthor=C.+D%E2%80%99Arienzoauthor=M.+Dabrosauthor=M.+A.+Galellaauthor=F.+Wangauthor=C.+A.+Weigeltauthor=Q.+Zhaoauthor=W.+Fosterauthor=J.+E.+Somervilleauthor=L.+M.+Salter-Cidauthor=J.+C.+Barrishauthor=P.+H.+Carterauthor=T.+G.+M.+Dhar&title=Identification+of+bicyclic+hexafluoroisopropyl+alcohol+sulfonamides+as+retinoic+acid+receptor-related+orphan+receptor+gamma+%28ROR%CE%B3%2FRORc%29+inverse+agonists.+Employing+structure-based+drug+design+to+improve+pregnane+X+receptor+%28PXR%29+selectivity&doi=10.1016%2Fj.bmcl.2017.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity</span></div><div class="casAuthors">Gong, Hua; Weinstein, David S.; Lu, Zhonghui; Duan, James J.-W.; Stachura, Sylwia; Haque, Lauren; Karmakar, Ananta; Hemagiri, Hemalatha; Raut, Dhanya Kumar; Gupta, Arun Kumar; Khan, Javed; Camac, Dan; Sack, John S.; Pudzianowski, Andrew; Wu, Dauh-Rurng; Yarde, Melissa; Shen, Ding-Ren; Borowski, Virna; Xie, Jenny H.; Sun, Huadong; D'Arienzo, Celia; Dabros, Marta; Galella, Michael A.; Wang, Faye; Weigelt, Carolyn A.; Zhao, Qihong; Foster, William; Somerville, John E.; Salter-Cid, Luisa M.; Barrish, Joel C.; Carter, Percy H.; Dhar, T. G. Murali</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-93</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We disclose the optimization of a high throughput screening hit to yield benzothiazine and tetrahydroquinoline sulfonamides as potent RORγt inverse agonists.  However, a majority of these compds. showed potent activity against pregnane X receptor (PXR) and modest activity against liver X receptor α (LXRα).  Structure-based drug design (SBDD) led to the identification of benzothiazine and tetrahydroquinoline sulfonamide analogs which completely dialed out LXRα activity and were less potent at PXR.  Pharmacodynamic (PD) data for compd. 35 in an IL-23 induced IL-17 mouse model is discussed along with the implications of a high Ymax in the PXR assay for long term preclin. pharmacokinetic (PK) studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosFyMm8wpiSbVg90H21EOLACvtfcHk0lhjJY_aqOZ_Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCqtr%252FJ&md5=be0dfef2d7494dca1979711a03ac7878</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DH.%26aulast%3DWeinstein%26aufirst%3DD.%2BS.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DDuan%26aufirst%3DJ.%2BJ.%2BW.%26aulast%3DStachura%26aufirst%3DS.%26aulast%3DHaque%26aufirst%3DL.%26aulast%3DKarmakar%26aufirst%3DA.%26aulast%3DHemagiri%26aufirst%3DH.%26aulast%3DRaut%26aufirst%3DD.%2BK.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DPudzianowski%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DD.-R.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DD.-R.%26aulast%3DBorowski%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%26aulast%3DDabros%26aufirst%3DM.%26aulast%3DGalella%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DFoster%26aufirst%3DW.%26aulast%3DSomerville%26aufirst%3DJ.%2BE.%26aulast%3DSalter-Cid%26aufirst%3DL.%2BM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DDhar%26aufirst%3DT.%2BG.%2BM.%26atitle%3DIdentification%2520of%2520bicyclic%2520hexafluoroisopropyl%2520alcohol%2520sulfonamides%2520as%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520gamma%2520%2528ROR%25CE%25B3%252FRORc%2529%2520inverse%2520agonists.%2520Employing%2520structure-based%2520drug%2520design%2520to%2520improve%2520pregnane%2520X%2520receptor%2520%2528PXR%2529%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D85%26epage%3D93%26doi%3D10.1016%2Fj.bmcl.2017.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kummer, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutter, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharoof, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalk-Hihi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span> <span> </span><span class="NLM_article-title">Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2047</span>– <span class="NLM_lpage">2057</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2017.02.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=28318945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2047-2057&author=D.+A.+Kummerauthor=M.+D.+Cummingsauthor=M.+Abadauthor=J.+Barbayauthor=G.+Castroauthor=R.+Wolinauthor=K.+D.+Kreutterauthor=U.+Maharoofauthor=C.+Milliganauthor=R.+Nishimuraauthor=J.+Pierceauthor=C.+Schalk-Hihiauthor=J.+Spurlinoauthor=M.+Urbanskiauthor=H.+Venkatesanauthor=A.+Wangauthor=C.+Woodsauthor=X.+Xueauthor=J.+P.+Edwardsauthor=A.+M.+Fourieauthor=K.+Leonard&title=Identification+and+structure+activity+relationships+of+quinoline+tertiary+alcohol+modulators+of+ROR%CE%B3t&doi=10.1016%2Fj.bmcl.2017.02.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt</span></div><div class="casAuthors">Kummer, David A.; Cummings, Maxwell D.; Abad, Marta; Barbay, Joseph; Castro, Glenda; Wolin, Ronald; Kreutter, Kevin D.; Maharoof, Umar; Milligan, Cynthia; Nishimura, Rachel; Pierce, Joan; Schalk-Hihi, Celine; Spurlino, John; Urbanski, Maud; Venkatesan, Hariharan; Wang, Aihua; Woods, Craig; Xue, Xiaohua; Edwards, James P.; Fourie, Anne M.; Leonard, Kristi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2047-2057</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A high-throughput screen of the ligand binding domain of the nuclear receptor retinoic acid-related orphan receptor gamma t (RORγt) employing a thermal shift assay yielded a quinoline tertiary alc. hit.  Optimization of the 2-, 3- and 4-positions of the quinoline core using structure-activity relationships and structure-based drug design methods led to the discovery of a series of modulators with improved RORγt inhibitory potency and inverse agonism properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpK1Jvozgl87Vg90H21EOLACvtfcHk0lhjJY_aqOZ_Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKrt7Y%253D&md5=29a4b89fa5d539dbac771a720feeb6ee</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.044%26sid%3Dliteratum%253Aachs%26aulast%3DKummer%26aufirst%3DD.%2BA.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DAbad%26aufirst%3DM.%26aulast%3DBarbay%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DWolin%26aufirst%3DR.%26aulast%3DKreutter%26aufirst%3DK.%2BD.%26aulast%3DMaharoof%26aufirst%3DU.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DNishimura%26aufirst%3DR.%26aulast%3DPierce%26aufirst%3DJ.%26aulast%3DSchalk-Hihi%26aufirst%3DC.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DUrbanski%26aufirst%3DM.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DWoods%26aufirst%3DC.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DEdwards%26aufirst%3DJ.%2BP.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DLeonard%26aufirst%3DK.%26atitle%3DIdentification%2520and%2520structure%2520activity%2520relationships%2520of%2520quinoline%2520tertiary%2520alcohol%2520modulators%2520of%2520ROR%25CE%25B3t%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2047%26epage%3D2057%26doi%3D10.1016%2Fj.bmcl.2017.02.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutter, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummer, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharoof, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalk-Hihi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanis, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span> <span> </span><span class="NLM_article-title">6-Substituted quinolines as RORγt inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5277</span>– <span class="NLM_lpage">5283</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2017.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=29079472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslejsbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5277-5283&author=J.+K.+Barbayauthor=M.+D.+Cummingsauthor=M.+Abadauthor=G.+Castroauthor=K.+D.+Kreutterauthor=D.+A.+Kummerauthor=U.+Maharoofauthor=C.+Milliganauthor=R.+Nishimuraauthor=J.+Pierceauthor=C.+Schalk-Hihiauthor=J.+Spurlinoauthor=V.+M.+Tanisauthor=M.+Urbanskiauthor=H.+Venkatesanauthor=A.+Wangauthor=C.+Woodsauthor=R.+Wolinauthor=X.+Xueauthor=J.+P.+Edwardsauthor=A.+M.+Fourieauthor=K.+Leonard&title=6-Substituted+quinolines+as+ROR%CE%B3t+inverse+agonists&doi=10.1016%2Fj.bmcl.2017.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">6-Substituted quinolines as RORγt inverse agonists</span></div><div class="casAuthors">Barbay, J. Kent; Cummings, Maxwell D.; Abad, Marta; Castro, Glenda; Kreutter, Kevin D.; Kummer, David A.; Maharoof, Umar; Milligan, Cynthia; Nishimura, Rachel; Pierce, Joan; Schalk-Hihi, Celine; Spurlino, John; Tanis, Virginia M.; Urbanski, Maud; Venkatesan, Hariharan; Wang, Aihua; Woods, Craig; Wolin, Ronald; Xue, Xiaohua; Edwards, James P.; Fourie, Anne M.; Leonard, Kristi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5277-5283</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We identified 6-substituted quinolines as modulators of the retinoic acid receptor-related orphan receptor gamma t (RORγt).  The synthesis of this class of RORγt modulators is reported, and optimization of the substituents at the quinoline 6-position that produced compds. with high affinity for the receptor is detailed.  This effort identified mols. that act as potent, full inverse agonists in a RORγt-driven cell-based reporter assay.  The X-ray crystal structures of two full inverse agonists, I and II, from this chem. series bound to the RORγt ligand binding domain are disclosed, and we highlight the interaction of a hydrogen-bond acceptor on the 6-position substituent of the inverse agonist with Glu379:NH as a conserved binding contact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmNK7flW-DSbVg90H21EOLACvtfcHk0lgw3vFplfHKzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslejsbrO&md5=7df780bf52c1750414412d1c0067e280</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DAbad%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DKreutter%26aufirst%3DK.%2BD.%26aulast%3DKummer%26aufirst%3DD.%2BA.%26aulast%3DMaharoof%26aufirst%3DU.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DNishimura%26aufirst%3DR.%26aulast%3DPierce%26aufirst%3DJ.%26aulast%3DSchalk-Hihi%26aufirst%3DC.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DTanis%26aufirst%3DV.%2BM.%26aulast%3DUrbanski%26aufirst%3DM.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DWoods%26aufirst%3DC.%26aulast%3DWolin%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DEdwards%26aufirst%3DJ.%2BP.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DLeonard%26aufirst%3DK.%26atitle%3D6-Substituted%2520quinolines%2520as%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5277%26epage%3D5283%26doi%3D10.1016%2Fj.bmcl.2017.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soroosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna-Roman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenkrants, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria-Babi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlueter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budelsky, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic modulation of RORgt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">37977</span>, <span class="refDoi"> DOI: 10.1038/srep37977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Fsrep37977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27905482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWnsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=37977&author=X.+Xueauthor=P.+Sorooshauthor=A.+De+Leon-Tabaldoauthor=R.+Luna-Romanauthor=M.+Sabladauthor=N.+Rozenkrantsauthor=J.+Yuauthor=G.+Castroauthor=H.+Banieauthor=W.+P.+Fung-Leungauthor=L.+Santamaria-Babiauthor=T.+Schlueterauthor=M.+Albersauthor=K.+Leonardauthor=A.+L.+Budelskyauthor=A.+M.+Fourie&title=Pharmacologic+modulation+of+RORgt+translates+to+efficacy+in+preclinical+and+translational+models+of+psoriasis+and+inflammatory+arthritis&doi=10.1038%2Fsrep37977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis</span></div><div class="casAuthors">Xue, Xiaohua; Soroosh, Pejman; De Leon-Tabaldo, Aimee; Luna-Roman, Rosa; Sablad, Marciano; Rozenkrants, Natasha; Yu, Jingxue; Castro, Glenda; Banie, Homayon; Fung-Leung, Wai-Ping; Santamaria-Babi, Luis; Schlueter, Thomas; Albers, Michael; Leonard, Kristi; Budelsky, Alison L.; Fourie, Anne M.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37977</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The IL-23/IL-17 pathway is implicated in autoimmune diseases, particularly psoriasis, where biologics targeting IL-23 and IL-17 have shown significant clin. efficacy.  Retinoid-related orphan nuclear receptor gamma t (RORγt) is required for Th17 differentiation and IL-17 prodn. in adaptive and innate immune cells.  We identified JNJ-54271074, a potent and highly-selective RORγt inverse agonist, which dose-dependently inhibited RORγt-driven transcription, decreased co-activator binding and promoted interaction with co-repressor protein.  This compd. selectively blocked Th17 differentiation, significantly reduced IL-17A prodn. from memory T cells, and decreased IL-17A- and IL-22-producing human and murine γδ and NKT cells.  In a murine collagen-induced arthritis model, JNJ-54271074 dose-dependently suppressed joint inflammation.  Furthermore, JNJ-54271074 suppressed IL-17A prodn. in human PBMC from rheumatoid arthritis patients.  RORγt-deficient mice showed decreased IL-23-induced psoriasis-like skin inflammation and cytokine gene expression, consistent with dose-dependent inhibition in wild-type mice through oral dosing of JNJ-54271074.  In a translational model of human psoriatic epidermal cells and skin-homing T cells, JNJ-54271074 selectively inhibited streptococcus ext.-induced IL-17A and IL-17F.  JNJ-54271074 is thus a potent, selective RORγt modulator with therapeutic potential in IL-23/IL-17 mediated autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6V70xff8x77Vg90H21EOLACvtfcHk0lgw3vFplfHKzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWnsr3F&md5=2dea294b5db93b110af4818dbfcb589b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsrep37977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep37977%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DDe%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DLuna-Roman%26aufirst%3DR.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DBanie%26aufirst%3DH.%26aulast%3DFung-Leung%26aufirst%3DW.%2BP.%26aulast%3DSantamaria-Babi%26aufirst%3DL.%26aulast%3DSchlueter%26aufirst%3DT.%26aulast%3DAlbers%26aufirst%3DM.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DBudelsky%26aufirst%3DA.%2BL.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26atitle%3DPharmacologic%2520modulation%2520of%2520RORgt%2520translates%2520to%2520efficacy%2520in%2520preclinical%2520and%2520translational%2520models%2520of%2520psoriasis%2520and%2520inflammatory%2520arthritis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D37977%26doi%3D10.1038%2Fsrep37977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.-l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-l.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1516</span>– <span class="NLM_lpage">1524</span>, <span class="refDoi"> DOI: 10.1038/aps.2016.32</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1038%2Faps.2016.32" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2016&pages=1516-1524&author=X.-S.+Wuauthor=R.+Wangauthor=Y.-l.+Xingauthor=X.-q.+Xueauthor=Y.+Zhangauthor=Y.-z.+Luauthor=Y.+Songauthor=X.-Y.+Luoauthor=C.+Wuauthor=Y.-l.+Zhouauthor=J.-q.+Jiangauthor=Y.+Xu&title=Discovery+and+structural+optimization+of+4-%284-%28benzyloxy%29phenyl%29-3%2C4-dihydropyrimidin-2%281H%29-ones+as+RORc+inverse+agonists&doi=10.1038%2Faps.2016.32"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Faps.2016.32&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2016.32%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.-S.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DXing%26aufirst%3DY.-l.%26aulast%3DXue%26aufirst%3DX.-q.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.-z.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DX.-Y.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DY.-l.%26aulast%3DJiang%26aufirst%3DJ.-q.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520structural%2520optimization%2520of%25204-%25284-%2528benzyloxy%2529phenyl%2529-3%252C4-dihydropyrimidin-2%25281H%2529-ones%2520as%2520RORc%2520inverse%2520agonists%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2016%26volume%3D37%26spage%3D1516%26epage%3D1524%26doi%3D10.1038%2Faps.2016.32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rene, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4455</span>– <span class="NLM_lpage">4461</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.07.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2016.07.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27524313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCit7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4455-4461&author=O.+Reneauthor=B.+P.+Fauberauthor=A.+Barnardauthor=K.+Chapmanauthor=Y.+Dengauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=A.+R.+Johnsonauthor=H.+Laauthor=M.+Normanauthor=G.+Salmonauthor=S.+Summerhillauthor=H.+Wong&title=Discovery+of+oxa-sultams+as+RORc+inverse+agonists+showing+reduced+lipophilicity%2C+improved+selectivity+and+favorable+ADME+properties&doi=10.1016%2Fj.bmcl.2016.07.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME properties</span></div><div class="casAuthors">Rene, Olivier; Fauber, Benjamin P.; Barnard, Adrian; Chapman, Kerry; Deng, Yuzhong; Eidenschenk, Celine; Everett, Christine; Gobbi, Alberto; Johnson, Adam R.; La, Hank; Norman, Maxine; Salmon, Gary; Summerhill, Susan; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4455-4461</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Modification of the δ-sultam ring of RORc inverse agonist 2 led to the discovery of more polar oxa-sultam 65.  The less lipophilic inverse agonist (65) displayed high potency in a biochem. assay, which translated into inhibition of IL-17 prodn. in human peripheral blood mononuclear cells.  The successful redn. of lipophilicity of this new analog gave rise to addnl. improvements in ROR selectivity and aq. kinetic soly., as well as redn. in plasma protein binding, while maintaining high cellular permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptgLNGbT0tzrVg90H21EOLACvtfcHk0lgP0zWLpY1bLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCit7nO&md5=59c6fb759488c507052efaffafc9a17b</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.07.081%26sid%3Dliteratum%253Aachs%26aulast%3DRene%26aufirst%3DO.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DBarnard%26aufirst%3DA.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DSalmon%26aufirst%3DG.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520oxa-sultams%2520as%2520RORc%2520inverse%2520agonists%2520showing%2520reduced%2520lipophilicity%252C%2520improved%2520selectivity%2520and%2520favorable%2520ADME%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4455%26epage%3D4461%26doi%3D10.1016%2Fj.bmcl.2016.07.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aagaard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPheat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirholt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grindebacke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span> <span> </span><span class="NLM_article-title">Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1002%2Fcmdc.201500432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=26553345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=207-216&author=R.+I.+Olssonauthor=Y.+Xueauthor=S.+von+Bergauthor=A.+Aagaardauthor=J.+McPheatauthor=E.+L.+Hanssonauthor=J.+Bernstroemauthor=P.+Hanssonauthor=J.+Jirholtauthor=H.+Grindebackeauthor=A.+Lefflerauthor=R.+Chenauthor=Y.+Xiongauthor=H.+Geauthor=T.+G.+Hanssonauthor=F.+Narjes&title=Benzoxazepines+Achieve+Potent+Suppression+of+IL-17+Release+in+Human+T-Helper+17+%28TH17%29+Cells+through+an+Induced-Fit+Binding+Mode+to+the+Nuclear+Receptor+ROR%CE%B3&doi=10.1002%2Fcmdc.201500432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ</span></div><div class="casAuthors">Olsson, Roine I.; Xue, Yafeng; von Berg, Stefan; Aagaard, Anna; McPheat, Jane; Hansson, Eva L.; Bernstroem, Jenny; Hansson, Pia; Jirholt, Johan; Grindebacke, Hanna; Leffler, Agnes; Chen, Rongfeng; Xiong, Yao; Ge, Hongbin; Hansson, Thomas G.; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">RORγt, an isoform of the retinoic acid-related orphan receptor gamma (RORc, RORγ), has been identified as the master regulator of T-helper 17 (TH17) cell function and development, making it an attractive target for the treatment of autoimmune diseases.  Validation for this target comes from antibodies targeting interleukin-17 (IL-17), the signature cytokine produced by TH17 cells, which have shown impressive results in clin. trials.  Through focused screening of our compd. collection, we identified a series of N-sulfonylated benzoxazepines, which displayed micromolar affinity for the RORγ ligand-binding domain (LBD) in a radioligand binding assay.  Optimization of these initial hits resulted in potent binders, which dose-dependently decreased the ability of the RORγ-LBD to interact with a peptide derived from steroid receptor coactivator 1, and inhibited the release of IL-17 secretion from isolated and cultured human TH17 cells with nanomolar potency.  A cocrystal structure of inverse agonist 15 (2-chloro-6-fluoro-N-(4-{[3-(trifluoromethyl)phenyl]sulfonyl}-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)benzamide) bound to the RORγ-LBD illustrated that both hydrophobic interactions, leading to an induced fit around the substituted benzamide moiety of 15, as well as a hydrogen bond from the amide NH to His479 seemed to be important for the mechanism of action.  This structure is compared with the structure of agonist 25 (N-(2-fluorophenyl)-4-[(4-fluorophenyl)sulfonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-6-amine ) and structures of other known RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorSpjXrs3zSrVg90H21EOLACvtfcHk0lgP0zWLpY1bLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N&md5=ed6fa69d887818da7acd4f9abbd2ff93</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500432%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DR.%2BI.%26aulast%3DXue%26aufirst%3DY.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DAagaard%26aufirst%3DA.%26aulast%3DMcPheat%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DE.%2BL.%26aulast%3DBernstroem%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJirholt%26aufirst%3DJ.%26aulast%3DGrindebacke%26aufirst%3DH.%26aulast%3DLeffler%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DH.%26aulast%3DHansson%26aufirst%3DT.%2BG.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DBenzoxazepines%2520Achieve%2520Potent%2520Suppression%2520of%2520IL-17%2520Release%2520in%2520Human%2520T-Helper%252017%2520%2528TH17%2529%2520Cells%2520through%2520an%2520Induced-Fit%2520Binding%2520Mode%2520to%2520the%2520Nuclear%2520Receptor%2520ROR%25CE%25B3%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D207%26epage%3D216%26doi%3D10.1002%2Fcmdc.201500432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obika, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asahina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aratsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steensma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiozaki, M.</span></span> <span> </span><span class="NLM_article-title">SAR Exploration Guided by LE and Fsp3: Discovery of a Selective and Orally Efficacious RORγ Inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00253</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00253" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKlt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=23-27&author=K.+Hirataauthor=M.+Kotokuauthor=N.+Sekiauthor=T.+Maebaauthor=K.+Maedaauthor=S.+Hirashimaauthor=T.+Sakaiauthor=S.+Obikaauthor=A.+Horiauthor=Y.+Haseauthor=T.+Yamaguchiauthor=Y.+Katsudaauthor=T.+Hataauthor=N.+Miyagawaauthor=K.+Aritaauthor=Y.+Nomuraauthor=K.+Asahinaauthor=Y.+Aratsuauthor=M.+Kamadaauthor=T.+Adachiauthor=M.+Noguchiauthor=S.+Doiauthor=P.+Croweauthor=E.+Bradleyauthor=R.+Steensmaauthor=H.+Taoauthor=M.+Fennauthor=R.+Babineauthor=X.+Liauthor=S.+Thacherauthor=H.+Hashimotoauthor=M.+Shiozaki&title=SAR+Exploration+Guided+by+LE+and+Fsp3%3A+Discovery+of+a+Selective+and+Orally+Efficacious+ROR%CE%B3+Inhibitor&doi=10.1021%2Facsmedchemlett.5b00253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">SAR Exploration Guided by LE and Fsp3: Discovery of a Selective and Orally Efficacious RORγ Inhibitor</span></div><div class="casAuthors">Hirata, Kazuyuki; Kotoku, Masayuki; Seki, Noriyoshi; Maeba, Takaki; Maeda, Katsuya; Hirashima, Shintaro; Sakai, Takayuki; Obika, Shingo; Hori, Akimi; Hase, Yasunori; Yamaguchi, Takayuki; Katsuda, Yoshiaki; Hata, Takahiro; Miyagawa, Naoki; Arita, Kojo; Nomura, Yukihiro; Asahina, Kota; Aratsu, Yusuke; Kamada, Masafumi; Adachi, Tsuyoshi; Noguchi, Masato; Doi, Satoki; Crowe, Paul; Bradley, Erin; Steensma, Ruo; Tao, Haiyan; Fenn, Morgan; Babine, Robert; Li, Xiaolin; Thacher, Scott; Hashimoto, Hiromasa; Shiozaki, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of RORγ inhibitors was identified starting with the HTS hit compd. 2-(5-(2,3-dihydro-1H-inden-2-yl)-4-ethyl-4-H-1,2,4-triazol-3-ylthio)-N-(naphthalen-1-yl)acetamide.  After SAR investigation based on a prospective consideration of two drug-likeness metrics, ligand efficiency (LE) and fraction of Sp3 carbon atoms (Fsp3), significant improvement of metabolic stability as well as redn. of CYP inhibition was obsd., which finally led to discovery of a selective and orally efficacious RORγ inhibitor (3R,4R)-1-acetyl-4-(4-cyclopropyl-5-(cis-3-isobutylcyclobutyl)-4H-1,2,4-triazol-3-yl)-M-(2,4-dimethylphenyl) pyrrolidine-3-carboxamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojA7KFHVtsOrVg90H21EOLACvtfcHk0lgP0zWLpY1bLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKlt77P&md5=fc2736f8baafee2084bb3adce7bb1a2e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00253%26sid%3Dliteratum%253Aachs%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DKotoku%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DMaeba%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DObika%26aufirst%3DS.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DKatsuda%26aufirst%3DY.%26aulast%3DHata%26aufirst%3DT.%26aulast%3DMiyagawa%26aufirst%3DN.%26aulast%3DArita%26aufirst%3DK.%26aulast%3DNomura%26aufirst%3DY.%26aulast%3DAsahina%26aufirst%3DK.%26aulast%3DAratsu%26aufirst%3DY.%26aulast%3DKamada%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DCrowe%26aufirst%3DP.%26aulast%3DBradley%26aufirst%3DE.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DFenn%26aufirst%3DM.%26aulast%3DBabine%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DThacher%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DShiozaki%26aufirst%3DM.%26atitle%3DSAR%2520Exploration%2520Guided%2520by%2520LE%2520and%2520Fsp3%253A%2520Discovery%2520of%2520a%2520Selective%2520and%2520Orally%2520Efficacious%2520ROR%25CE%25B3%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D23%26epage%3D27%26doi%3D10.1021%2Facsmedchemlett.5b00253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rene, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-{4-[3-Fluoro-4-((3S,6R)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5308</span>– <span class="NLM_lpage">5322</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVansL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5308-5322&author=B.+P.+Fauberauthor=O.+Reneauthor=Y.+Dengauthor=J.+DeVossauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Ganguliauthor=A.+Gobbiauthor=J.+Hawkinsauthor=A.+R.+Johnsonauthor=H.+Laauthor=J.+Leschauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=S.+Summerhillauthor=H.+Wong&title=Discovery+of+1-%7B4-%5B3-Fluoro-4-%28%283S%2C6R%29-3-methyl-1%2C1-dioxo-6-phenyl-%5B1%2C2%5Dthiazinan-2-ylmethyl%29-phenyl%5D-piperazin-1-yl%7D-ethanone+%28GNE-3500%29%3A+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+Retinoic+Acid+Receptor-Related+Orphan+Receptor+C+%28RORc+or+ROR%CE%B3%29+Inverse+Agonist&doi=10.1021%2Facs.jmedchem.5b00597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1-{4-[3-Fluoro-4-((3S,6R)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist</span></div><div class="casAuthors">Fauber, Benjamin P.; Rene, Olivier; Deng, Yuzhong; DeVoss, Jason; Eidenschenk, Celine; Everett, Christine; Ganguli, Arunima; Gobbi, Alberto; Hawkins, Julie; Johnson, Adam R.; La, Hank; Lesch, Justin; Lockey, Peter; Norman, Maxine; Ouyang, Wenjun; Summerhill, Susan; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5308-5322</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptor C (RORc, RORγ, or NR1F3) is a nuclear receptor that plays a major role in the prodn. of interleukin (IL)-17.  Considerable efforts have been directed toward the discovery of selective RORc inverse agonists as potential treatments of inflammatory diseases such as psoriasis and rheumatoid arthritis.  Using the previously reported tertiary sulfonamide as a starting point, the authors engineered structural modifications that significantly improved human and rat metabolic stabilities while maintaining a potent and highly selective RORc inverse agonist profile.  The most advanced δ-sultam compd. I possessed favorable RORc cellular potency with 75-fold selectivity for RORc over other ROR family members and >200-fold selectivity over 25 addnl. nuclear receptors in a cell assay panel.  The favorable potency, selectivity, in vitro ADME properties, in vivo PK, and dose-dependent inhibition of IL-17 in a PK/PD model support the evaluation of I in preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgSG0WeUAvc7Vg90H21EOLACvtfcHk0ljgk8vWey0piw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVansL3M&md5=86f291aa61281c4ec98a34cdd31963e0</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00597%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DRene%26aufirst%3DO.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGanguli%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLesch%26aufirst%3DJ.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%25201-%257B4-%255B3-Fluoro-4-%2528%25283S%252C6R%2529-3-methyl-1%252C1-dioxo-6-phenyl-%255B1%252C2%255Dthiazinan-2-ylmethyl%2529-phenyl%255D-piperazin-1-yl%257D-ethanone%2520%2528GNE-3500%2529%253A%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Bioavailable%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520C%2520%2528RORc%2520or%2520ROR%25CE%25B3%2529%2520Inverse%2520Agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5308%26epage%3D5322%26doi%3D10.1021%2Facs.jmedchem.5b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00122</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00122" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=787-792&author=Y.+Wangauthor=W.+Caiauthor=Y.+Chengauthor=T.+Yangauthor=Q.+Liuauthor=G.+Zhangauthor=Q.+Mengauthor=F.+Hanauthor=Y.+Huangauthor=L.+Zhouauthor=Z.+Xiangauthor=Y.-G.+Zhaoauthor=Y.+Xuauthor=Z.+Chengauthor=S.+Luauthor=Q.+Wuauthor=J.-N.+Xiangauthor=J.+D.+Elliottauthor=S.+Leungauthor=F.+Renauthor=X.+Lin&title=Discovery+of+Biaryl+Amides+as+Potent%2C+Orally+Bioavailable%2C+and+CNS+Penetrant+ROR%CE%B3t+Inhibitors&doi=10.1021%2Facsmedchemlett.5b00122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors</span></div><div class="casAuthors">Wang, Yonghui; Cai, Wei; Cheng, Yaobang; Yang, Ting; Liu, Qian; Zhang, Guifeng; Meng, Qinghua; Han, Fangbin; Huang, Yafei; Zhou, Ling; Xiang, Zhijun; Zhao, Yong-Gang; Xu, Yan; Cheng, Ziqiang; Lu, Sijie; Wu, Qianqian; Xiang, Jia-Ning; Elliott, John D.; Leung, Stewart; Ren, Feng; Lin, Xichen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">787-792</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of biaryl amides was identified as RORγt inhibitors through core replacement of a starting hit 1.  Structure-activity relation exploration on the biaryl moiety led to discovery of potent RORγt inhibitors with good oral bioavailability and CNS penetration.  Compds. 9a and 9g demonstrated excellent in vivo efficacy in EAE mice dose dependently with once daily oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRg-_IJY0l47Vg90H21EOLACvtfcHk0ljgk8vWey0piw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGmtb8%253D&md5=0011aa5b6e6952ef2f7cfced6ee1b7fc</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00122%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DY.-G.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520Biaryl%2520Amides%2520as%2520Potent%252C%2520Orally%2520Bioavailable%252C%2520and%2520CNS%2520Penetrant%2520ROR%25CE%25B3t%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D787%26epage%3D792%26doi%3D10.1021%2Facsmedchemlett.5b00122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yosef, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundrud, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretschmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahl, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2014.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.immuni.2014.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=24745332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVKltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=477-489&author=S.+Xiaoauthor=N.+Yosefauthor=J.+Yangauthor=Y.+Wangauthor=L.+Zhouauthor=C.+Zhuauthor=C.+Wuauthor=E.+Balogluauthor=D.+Schmidtauthor=R.+Rameshauthor=M.+Loberaauthor=M.+S.+Sundrudauthor=P.-Y.+Tsaiauthor=Z.+Xiangauthor=J.+Wangauthor=Y.+Xuauthor=X.+Linauthor=K.+Kretschmerauthor=P.+B.+Rahlauthor=R.+A.+Youngauthor=Z.+Zhongauthor=D.+A.+Haflerauthor=A.+Regevauthor=S.+Ghoshauthor=A.+Marsonauthor=V.+K.+Kuchroo&title=Small-Molecule+ROR%CE%B3t+Antagonists+Inhibit+T+Helper+17+Cell+Transcriptional+Network+by+Divergent+Mechanisms&doi=10.1016%2Fj.immuni.2014.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms</span></div><div class="casAuthors">Xiao, Sheng; Yosef, Nir; Yang, Jianfei; Wang, Yonghui; Zhou, Ling; Zhu, Chen; Wu, Chuan; Baloglu, Erkan; Schmidt, Darby; Ramesh, Radha; Lobera, Mercedes; Sundrud, Mark S.; Tsai, Pei-Yun; Xiang, Zhijun; Wang, Jinsong; Xu, Yan; Lin, Xichen; Kretschmer, Karsten; Rahl, Peter B.; Young, Richard A.; Zhong, Zhong; Hafler, David A.; Regev, Aviv; Ghosh, Shomir; Marson, Alexander; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-489</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We identified three retinoid-related orphan receptor gamma t (RORγt)-specific inhibitors that suppress T helper 17 (Th17) cell responses, including Th17-cell-mediated autoimmune disease.  We systemically characterized RORγt binding in the presence and absence of drugs with corresponding whole-genome transcriptome sequencing.  RORγt acts as a direct activator of Th17 cell signature genes and a direct repressor of signature genes from other T cell lineages; its strongest transcriptional effects are on cis-regulatory sites contg. the RORα binding motif.  RORγt is central in a densely interconnected regulatory network that shapes the balance of T cell differentiation.  Here, the three inhibitors modulated the RORγt-dependent transcriptional network to varying extents and through distinct mechanisms.  Whereas one inhibitor displaced RORγt from its target loci, the other two inhibitors affected transcription predominantly without removing DNA binding.  Our work illustrates the power of a system-scale anal. of transcriptional regulation to characterize potential therapeutic compds. that inhibit pathogenic Th17 cells and suppress autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo23p8R83CDDbVg90H21EOLACvtfcHk0lietJOhtwEjJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVKltr0%253D&md5=940074c565211bc00832179574e5231a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2014.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DYosef%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBaloglu%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DSundrud%26aufirst%3DM.%2BS.%26aulast%3DTsai%26aufirst%3DP.-Y.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKretschmer%26aufirst%3DK.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DHafler%26aufirst%3DD.%2BA.%26aulast%3DRegev%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DMarson%26aufirst%3DA.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DSmall-Molecule%2520ROR%25CE%25B3t%2520Antagonists%2520Inhibit%2520T%2520Helper%252017%2520Cell%2520Transcriptional%2520Network%2520by%2520Divergent%2520Mechanisms%26jtitle%3DImmunity%26date%3D2014%26volume%3D40%26spage%3D477%26epage%3D489%26doi%3D10.1016%2Fj.immuni.2014.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gege, C.</span></span> <span> </span><span class="NLM_article-title">Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">744</span>, <span class="refDoi"> DOI: 10.1517/13543776.2016.1153066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1517%2F13543776.2016.1153066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=26895086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslKht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=737-744&author=C.+Gege&title=Retinoid-related+orphan+receptor+gamma+t+%28ROR%CE%B3t%29+inhibitors+from+Vitae+Pharmaceuticals+%28WO2015116904%29+and+structure+proposal+for+their+Phase+I+candidate+VTP-43742&doi=10.1517%2F13543776.2016.1153066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742</span></div><div class="casAuthors">Gege, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-744</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan nuclear receptor gamma t (RORγt or RORC2) is a key transcription factor for the differentiation of naive proinflammatory CD4+ T cells and the prodn. of T helper-17 (TH17) cells.  Inhibiting RORγt activity is thought to be beneficial in targeting a variety of inflammatory and autoimmune disorders, however current candidates remain to be validated in the clinic.  Recently Vitae Pharmaceuticals successfully finished its Phase 1 single ascending dose clin. study with their proprietary RORγt inverse agonist.  On the basis of the reported promising results, Vitae Pharmaceuticals could currently be considered as having the leading clin. candidate in the RORγt inverse agonist category.  This prompts the interest on the exact chem. structure of their clin. candidate.  The first relevant patent application (WO2014179564) from Vitae Pharmaceuticals describes RORγt inverse agonists with a 5,6-dihydro-4H-pyrrolo[3,4-d]thiazole core, while in the second and latest patent application (WO2015116904) this element has changed towards a 6,7-dihydro-5H-pyrrolo[3,4-b]pyridine core.  By combining information from Vitae's patent applications and trustworthy online information, the potential elucidation of the chem. structure of clin. candidate is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGookgjg34nmU7Vg90H21EOLACvtfcHk0lietJOhtwEjJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslKht74%253D&md5=f0a556f34d0cd87ee97e630bac6a16cf</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1153066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1153066%26sid%3Dliteratum%253Aachs%26aulast%3DGege%26aufirst%3DC.%26atitle%3DRetinoid-related%2520orphan%2520receptor%2520gamma%2520t%2520%2528ROR%25CE%25B3t%2529%2520inhibitors%2520from%2520Vitae%2520Pharmaceuticals%2520%2528WO2015116904%2529%2520and%2520structure%2520proposal%2520for%2520their%2520Phase%2520I%2520candidate%2520VTP-43742%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D737%26epage%3D744%26doi%3D10.1517%2F13543776.2016.1153066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Mackensen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemetzki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freudenberg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigger-Alberti, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span> <span> </span><span class="NLM_article-title">A Phase I Randomised Controlled Trial to Evaluate Safety and Clinical Effect of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test</span>. <i>Br. J. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">1427</span>, <span class="refDoi"> DOI: 10.1111/bjd.16131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1111%2Fbjd.16131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=29150844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A280%3ADC%252BC1M3isFWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2018&pages=1427&author=E.+G.+Kangauthor=S.+Wuauthor=A.+Guptaauthor=Y.+L.+von+Mackensenauthor=H.+Siemetzkiauthor=J.+M.+Freudenbergauthor=W.+Wigger-Albertiauthor=Y.+Yamaguchi&title=A+Phase+I+Randomised+Controlled+Trial+to+Evaluate+Safety+and+Clinical+Effect+of+Topically+Applied+GSK2981278+Ointment+in+a+Psoriasis+Plaque+Test&doi=10.1111%2Fbjd.16131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test</span></div><div class="casAuthors">Kang E G; Wu S; Gupta A; Freudenberg J M; Yamaguchi Y; von Mackensen Y-L; Siemetzki H; Wigger-Alberti W</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1427-1429</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2LnZBzvo4YtFxYDaSSP8XfW6udTcc2ea5YedqdkPuOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3isFWltg%253D%253D&md5=c480c28f5973de8ccba8f8e290d8e8ab</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fbjd.16131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbjd.16131%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DE.%2BG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3Dvon%2BMackensen%26aufirst%3DY.%2BL.%26aulast%3DSiemetzki%26aufirst%3DH.%26aulast%3DFreudenberg%26aufirst%3DJ.%2BM.%26aulast%3DWigger-Alberti%26aufirst%3DW.%26aulast%3DYamaguchi%26aufirst%3DY.%26atitle%3DA%2520Phase%2520I%2520Randomised%2520Controlled%2520Trial%2520to%2520Evaluate%2520Safety%2520and%2520Clinical%2520Effect%2520of%2520Topically%2520Applied%2520GSK2981278%2520Ointment%2520in%2520a%2520Psoriasis%2520Plaque%2520Test%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2018%26volume%3D178%26spage%3D1427%26doi%3D10.1111%2Fbjd.16131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span> <i>VTP-43742 demonstrated statistically
significant efficacy and was
well tolerated. Company plans to move VTP-43742 forward into 16-week
study. Conference call to discuss results at 5:00 p.m. ET, March 16,
2016. James Krueger, M.D., Ph.D., Head of the Laboratory for Investigative
Dermatology at Rockefeller University, to join call</i>; Press
Release for <span class="NLM_publisher-name">Vitae Pharmaceuticals</span>, March 16, <span class="NLM_year">2016</span>. Available at <a href="http://ir.vitaepharma.com/phoenix.zhtml?c=219654&amp;p=irol-newsArticle&amp;ID=2149044" class="extLink">http://ir.vitaepharma.com/phoenix.zhtml?c=219654&p=irol-newsArticle&ID=2149044</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+VTP-43742+demonstrated+statistically%0Asignificant+efficacy+and+was%0Awell+tolerated.+Company+plans+to+move+VTP-43742+forward+into+16-week%0Astudy.+Conference+call+to+discuss+results+at+5%3A00+p.m.+ET%2C+March+16%2C%0A2016.+James+Krueger%2C+M.D.%2C+Ph.D.%2C+Head+of+the+Laboratory+for+Investigative%0ADermatology+at+Rockefeller+University%2C+to+join+call%3B+Press%0ARelease+for+Vitae+Pharmaceuticals%2C+March+16%2C+2016.+Available+at+http%3A%2F%2Fir.vitaepharma.com%2Fphoenix.zhtml%3Fc%3D219654%26p%3Dirol-newsArticle%26ID%3D2149044."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DVTP-43742%2520demonstrated%2520statistically%250Asignificant%2520efficacy%2520and%2520was%250Awell%2520tolerated.%2520Company%2520plans%2520to%2520move%2520VTP-43742%2520forward%2520into%252016-week%250Astudy.%2520Conference%2520call%2520to%2520discuss%2520results%2520at%25205%253A00%2520p.m.%2520ET%252C%2520March%252016%252C%250A2016.%2520James%2520Krueger%252C%2520M.D.%252C%2520Ph.D.%252C%2520Head%2520of%2520the%2520Laboratory%2520for%2520Investigative%250ADermatology%2520at%2520Rockefeller%2520University%252C%2520to%2520join%2520call%26pub%3DVitae%2520Pharmaceuticals%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillertz, P.</span></span> <span> </span><span class="NLM_article-title">Fragment Screening of RORγt Using Cocktail Crystallography: Identification of Simultaneous Binding of Multiple Fragments</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1881</span>– <span class="NLM_lpage">1885</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1002%2Fcmdc.201600242" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1881-1885&author=Y.+Xueauthor=H.+Guoauthor=P.+Hillertz&title=Fragment+Screening+of+ROR%CE%B3t+Using+Cocktail+Crystallography%3A+Identification+of+Simultaneous+Binding+of+Multiple+Fragments&doi=10.1002%2Fcmdc.201600242"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600242%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DHillertz%26aufirst%3DP.%26atitle%3DFragment%2520Screening%2520of%2520ROR%25CE%25B3t%2520Using%2520Cocktail%2520Crystallography%253A%2520Identification%2520of%2520Simultaneous%2520Binding%2520of%2520Multiple%2520Fragments%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1881%26epage%3D1885%26doi%3D10.1002%2Fcmdc.201600242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Cai, W.</span>; <span class="NLM_string-name">Liu, Q.</span>; <span class="NLM_string-name">Xiang, J.-N.</span></span> <span> </span><span class="NLM_article-title">Preparation of thiazole derivatives as modulators of retinoid-related orphan receptor gamma</span>. <span class="NLM_patent">WO 2012027965</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=Y.+Wang&author=W.+Cai&author=Q.+Liu&author=J.-N.+Xiang&title=Preparation+of+thiazole+derivatives+as+modulators+of+retinoid-related+orphan+receptor+gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520thiazole%2520derivatives%2520as%2520modulators%2520of%2520retinoid-related%2520orphan%2520receptor%2520gamma%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huxdorf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">702</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmc.2013.12.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=692-702&author=Y.+Wangauthor=W.+Caiauthor=G.+Zhangauthor=T.+Yangauthor=Q.+Liuauthor=Y.+Chengauthor=L.+Zhouauthor=Y.+Maauthor=Z.+Chengauthor=S.+Luauthor=Y.-G.+Zhaoauthor=W.+Zhangauthor=Z.+Xiangauthor=S.+Wangauthor=L.+Yangauthor=Q.+Wuauthor=L.+A.+Orband-Millerauthor=Y.+Xuauthor=J.+Zhangauthor=R.+Gaoauthor=M.+Huxdorfauthor=J.-N.+Xiangauthor=Z.+Zhongauthor=J.+D.+Elliottauthor=S.+Leungauthor=X.+Lin&title=Discovery+of+novel+N-%285-%28arylcarbonyl%29thiazol-2-yl%29amides+and+N-%285-%28arylcarbonyl%29thiophen-2-yl%29amides+as+potent+ROR%CE%B3t+inhibitors&doi=10.1016%2Fj.bmc.2013.12.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.-G.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DR.%26aulast%3DHuxdorf%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%2520N-%25285-%2528arylcarbonyl%2529thiazol-2-yl%2529amides%2520and%2520N-%25285-%2528arylcarbonyl%2529thiophen-2-yl%2529amides%2520as%2520potent%2520ROR%25CE%25B3t%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D692%26epage%3D702%26doi%3D10.1016%2Fj.bmc.2013.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5293</span>– <span class="NLM_lpage">5302</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmc.2015.07.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5293-5302&author=Y.+Wangauthor=T.+Yangauthor=Q.+Liuauthor=Y.+Maauthor=L.+Yangauthor=L.+Zhouauthor=Z.+Xiangauthor=Z.+Chengauthor=S.+Luauthor=L.+A.+Orband-Millerauthor=W.+Zhangauthor=Q.+Wuauthor=K.+Zhangauthor=Y.+Liauthor=J.-N.+Xiangauthor=J.+D.+Elliottauthor=S.+Leungauthor=F.+Renauthor=X.+Lin&title=Discovery+of+N-%284-aryl-5-aryloxy-thiazol-2-yl%29-amides+as+potent+ROR%CE%B3t+inverse+agonists&doi=10.1016%2Fj.bmc.2015.07.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.068%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520N-%25284-aryl-5-aryloxy-thiazol-2-yl%2529-amides%2520as%2520potent%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5293%26epage%3D5302%26doi%3D10.1016%2Fj.bmc.2015.07.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izaac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Be, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arista, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span> <span> </span><span class="NLM_article-title">Structural States of RORγt: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1014</span>– <span class="NLM_lpage">1021</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1002%2Fcmdc.201700278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=28590087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFamsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1014-1021&author=J.+Kallenauthor=A.+Izaacauthor=C.+Beauthor=L.+Aristaauthor=D.+Orainauthor=K.+Kaupmannauthor=C.+Guntermannauthor=K.+Hoegenauerauthor=S.+Hintermann&title=Structural+States+of+ROR%CE%B3t%3A+X-ray+Elucidation+of+Molecular+Mechanisms+and+Binding+Interactions+for+Natural+and+Synthetic+Compounds&doi=10.1002%2Fcmdc.201700278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structural States of RORγt: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds</span></div><div class="casAuthors">Kallen, Joerg; Izaac, Aude; Be, Celine; Arista, Luca; Orain, David; Kaupmann, Klemens; Guntermann, Christine; Hoegenauer, Klemens; Hintermann, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1014-1021</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The T-cell-specific retinoic acid receptor (RAR)-related orphan receptor-γ (RORγt) is a key transcription factor for the prodn. of pro-inflammatory Th17 cytokines, which are implicated in the pathogenesis of autoimmune diseases.  Over the years, several structurally diverse RORγt inverse agonists have been reported, but combining high potency and good physicochem. properties has remained a challenging task.  We recently reported a new series of inverse agonists based on an imidazopyridine core with good physicochem. properties and excellent selectivity.  Herein we report eight new X-ray crystal structures for different classes of natural and synthetic compds., including examples selected from the patent literature.  Anal. of their resp. binding modes revealed insight into the mol. mechanisms that lead to agonism, antagonism, or inverse agonism.  We report new mol. mechanisms for RORγt agonism and propose a sepn. of the inverse agonists into two classes: those that act via steric clash and those that act via other mechanisms (for the latter, co-crystn. with a co-activator peptide and helix 12 in the agonist position is still possible).  For the non-steric clash inverse agonists, we propose a new mechanism ("water trapping") which can be combined with other mechanisms (e.g., close contacts with H479).  In addn., we compare the interactions made for selected compds. in the "back pocket" near S404 and in the "sulfate pocket" near R364 and R367.  Taken together, these new mechanistic insights should prove useful for the design and optimization of further RORγt modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2bJdGLB1okrVg90H21EOLACvtfcHk0ljqfoceXuaU4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFamsrvK&md5=c49d7d9710f6c4f7baed7e7b207a0bf7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700278%26sid%3Dliteratum%253Aachs%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DIzaac%26aufirst%3DA.%26aulast%3DBe%26aufirst%3DC.%26aulast%3DArista%26aufirst%3DL.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DHintermann%26aufirst%3DS.%26atitle%3DStructural%2520States%2520of%2520ROR%25CE%25B3t%253A%2520X-ray%2520Elucidation%2520of%2520Molecular%2520Mechanisms%2520and%2520Binding%2520Interactions%2520for%2520Natural%2520and%2520Synthetic%2520Compounds%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D1014%26epage%3D1021%26doi%3D10.1002%2Fcmdc.201700278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span> <span> </span><span class="NLM_article-title">From RORγt agonists to two types of RORgt inverse agonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00476</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00476" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=120-124&author=Y.+Wangauthor=W.+Caiauthor=T.+Tangauthor=Q.+Liuauthor=T.+Yangauthor=L.+Yangauthor=Y.+Maauthor=G.+Zhangauthor=Y.+Huangauthor=S.+Songauthor=L.+A.+Orband-Millerauthor=Q.+Wuauthor=L.+Zhouauthor=Z.+Xiangauthor=J.-N.+Xiangauthor=S.+Leungauthor=L.+Shaoauthor=X.+Linauthor=M.+Loberaauthor=F.+Ren&title=From+ROR%CE%B3t+agonists+to+two+types+of+RORgt+inverse+agonists&doi=10.1021%2Facsmedchemlett.7b00476"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00476%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DS.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DF.%26atitle%3DFrom%2520ROR%25CE%25B3t%2520agonists%2520to%2520two%2520types%2520of%2520RORgt%2520inverse%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D120%26epage%3D124%26doi%3D10.1021%2Facsmedchemlett.7b00476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beno, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4383</span>– <span class="NLM_lpage">4438</span>, <span class="refDoi"> DOI: 10.1021/jm501853m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501853m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4383-4438&author=B.+R.+Benoauthor=K.+S.+Yeungauthor=M.+D.+Bartbergerauthor=L.+D.+Penningtonauthor=N.+A.+Meanwell&title=A+Survey+of+the+Role+of+Noncovalent+Sulfur+Interactions+in+Drug+Design&doi=10.1021%2Fjm501853m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design</span></div><div class="casAuthors">Beno, Brett R.; Yeung, Kap-Sun; Bartberger, Michael D.; Pennington, Lewis D.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4383-4438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Electron deficient, bivalent sulfur atoms have two areas of pos. electrostatic potential, a consequence of the low-lying σ* orbitals of the C-S bond that are available for interaction with electron donors including oxygen and nitrogen atoms and, possibly, π-systems.  Intramol. interactions are by far the most common manifestation of this effect, which offers a means of modulating the conformational preferences of a mol.  Although a well-documented phenomenon, a priori applications in drug design are relatively sparse and this interaction, which is often isosteric with an intramol. hydrogen-bonding interaction, appears to be underappreciated by the medicinal chem. community.  In this Perspective, we discuss the theor. basis for sulfur σ* orbital interactions and illustrate their importance in the context of drug design and org. synthesis.  The role of sulfur interactions in protein structure and function is discussed and although relatively rare, intermol. interactions between ligand C-S σ* orbitals and proteins are illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYKXRsl4BQYrVg90H21EOLACvtfcHk0ljqfoceXuaU4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D&md5=d12f53eb3271c161cfc833fb9f7c02b3</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm501853m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501853m%26sid%3Dliteratum%253Aachs%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DYeung%26aufirst%3DK.%2BS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DA%2520Survey%2520of%2520the%2520Role%2520of%2520Noncovalent%2520Sulfur%2520Interactions%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4383%26epage%3D4438%26doi%3D10.1021%2Fjm501853m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sirvent, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lücking, U.</span></span> <span> </span><span class="NLM_article-title">Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1002%2Fcmdc.201700044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=28221724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXks1Sltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=487-501&author=J.+A.+Sirventauthor=U.+L%C3%BCcking&title=Novel+Pieces+for+the+Emerging+Picture+of+Sulfoximines+in+Drug+Discovery%3A+Synthesis+and+Evaluation+of+Sulfoximine+Analogues+of+Marketed+Drugs+and+Advanced+Clinical+Candidates&doi=10.1002%2Fcmdc.201700044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates</span></div><div class="casAuthors">Sirvent, Juan Alberto; Luecking, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">487-501</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sulfoximines have gained considerable recognition as an important structural motif in drug discovery of late.  In particular, the clin. kinase inhibitors for the treatment of cancer, roniciclib (pan-CDK inhibitor), BAY 1143572 (P-TEFb inhibitor), and AZD 6738 (ATR inhibitor), have recently drawn considerable attention.  While the interest in this underrepresented functional group in drug discovery is clearly on the rise, there remains an incomplete understanding of the medicinal-chem.-relevant properties of sulfoximines.  Herein we report the synthesis and in vitro characterization of a variety of sulfoximine analogs of marketed drugs and advanced clin. candidates to gain a better understanding of this neglected functional group and its potential in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-5kfVM3I45LVg90H21EOLACvtfcHk0lhP6mE_Cui6mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXks1Sltbo%253D&md5=5b4589d7af32c8984d4fd3027c31c168</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700044%26sid%3Dliteratum%253Aachs%26aulast%3DSirvent%26aufirst%3DJ.%2BA.%26aulast%3DL%25C3%25BCcking%26aufirst%3DU.%26atitle%3DNovel%2520Pieces%2520for%2520the%2520Emerging%2520Picture%2520of%2520Sulfoximines%2520in%2520Drug%2520Discovery%253A%2520Synthesis%2520and%2520Evaluation%2520of%2520Sulfoximine%2520Analogues%2520of%2520Marketed%2520Drugs%2520and%2520Advanced%2520Clinical%2520Candidates%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D487%26epage%3D501%26doi%3D10.1002%2Fcmdc.201700044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Truchon, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettitt, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labute, P.</span></span> <span> </span><span class="NLM_article-title">A Cavity Corrected 3D-RISM Functional for Accurate Solvation Free Energies</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">934</span>– <span class="NLM_lpage">941</span>, <span class="refDoi"> DOI: 10.1021/ct4009359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct4009359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFSgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=934-941&author=J.-F.+Truchonauthor=B.+M.+Pettittauthor=P.+Labute&title=A+Cavity+Corrected+3D-RISM+Functional+for+Accurate+Solvation+Free+Energies&doi=10.1021%2Fct4009359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">A Cavity Corrected 3D-RISM Functional for Accurate Solvation Free Energies</span></div><div class="casAuthors">Truchon, Jean-Francois; Pettitt, B. Montgomery; Labute, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">934-941</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We show that an Ng bridge function modified version of the three-dimensional ref. interaction site model (3D-RISM-NgB) solvation free energy method can accurately predict the hydration free energy (HFE) of a set of 504 org. mols.  To achieve this, a single unique const. parameter was adjusted to the computed HFE of single atom Lennard-Jones solutes.  It is shown that 3D-RISM is relatively accurate at predicting the electrostatic component of the HFE without correction but requires a modification of the nonpolar contribution that originates in the formation of the cavity created by the solute in water.  We use a free energy functional with the Ng scaling of the direct correlation function.  This produces a rapid, reliable small mol. HFE calcn. for applications in drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolHuFo-mVCArVg90H21EOLACvtfcHk0lhP6mE_Cui6mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFSgtQ%253D%253D&md5=85963a9a895e6f79ab54692b95eaa0cc</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fct4009359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct4009359%26sid%3Dliteratum%253Aachs%26aulast%3DTruchon%26aufirst%3DJ.-F.%26aulast%3DPettitt%26aufirst%3DB.%2BM.%26aulast%3DLabute%26aufirst%3DP.%26atitle%3DA%2520Cavity%2520Corrected%25203D-RISM%2520Functional%2520for%2520Accurate%2520Solvation%2520Free%2520Energies%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2014%26volume%3D10%26spage%3D934%26epage%3D941%26doi%3D10.1021%2Fct4009359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredlund, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winiwarter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgendorf, C.</span></span> <span> </span><span class="NLM_article-title">In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.6b01059</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.6b01059" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC2sXks1GgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=1601-1609&author=L.+Fredlundauthor=S.+Winiwarterauthor=C.+Hilgendorf&title=In+Vitro+Intrinsic+Permeability%3A+A+Transporter-Independent+Measure+of+Caco-2+Cell+Permeability+in+Drug+Design+and+Development&doi=10.1021%2Facs.molpharmaceut.6b01059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development</span></div><div class="casAuthors">Fredlund, Linda; Winiwarter, Susanne; Hilgendorf, Constanze</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1601-1609</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In vitro permeability data have a central place in absorption risk assessments in drug discovery and development.  For compds. where active efflux impacts permeability in vitro, the inherent passive membrane permeability ("intrinsic permeability") gives a concn.-independent measure of the compd.'s permeability.  This work describes the validation of an in vitro intrinsic permeability assay and application of the data in a predictive in silico model.  Apparent intrinsic permeability (Papp) across Caco-2 cell monolayers is detd. in the presence of an optimized cocktail of chem. inhibitors toward the three major efflux transporters ABCB1, ABCC2, and ABCG2.  The intrinsic Papp value gives an est. of passive permeability, which is independent of transporter expression levels and not limited by soly. or cell toxicity.  An in silico model has been established to predict the Caco-2 intrinsic permeability and shown to consistently identify highly permeable compds.  The new intrinsic permeability assay is useful for early absorption ests. and suitable for absorption risk assessment in DMPK and pharmaceutical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzz4IoZ6pXJbVg90H21EOLACvtfcHk0lhP6mE_Cui6mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXks1GgsLw%253D&md5=2e3af857e97f2ce5ce9743294c50d3b9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.6b01059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.6b01059%26sid%3Dliteratum%253Aachs%26aulast%3DFredlund%26aufirst%3DL.%26aulast%3DWiniwarter%26aufirst%3DS.%26aulast%3DHilgendorf%26aufirst%3DC.%26atitle%3DIn%2520Vitro%2520Intrinsic%2520Permeability%253A%2520A%2520Transporter-Independent%2520Measure%2520of%2520Caco-2%2520Cell%2520Permeability%2520in%2520Drug%2520Design%2520and%2520Development%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2017%26volume%3D14%26spage%3D1601%26epage%3D1609%26doi%3D10.1021%2Facs.molpharmaceut.6b01059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doebelin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patouret, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmarajan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuruvilla, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span> <span> </span><span class="NLM_article-title">N-Arylsulfonyl Indolines as Retinoic Acid Receptor-Related Orphan Receptor γ (RORγ) Agonists</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2607</span>– <span class="NLM_lpage">2620</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1002%2Fcmdc.201600491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=27879053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFSlsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2607-2620&author=C.+Doebelinauthor=R.+Patouretauthor=R.+D.+Garcia-Ordonezauthor=M.+R.+Changauthor=V.+Dharmarajanauthor=D.+S.+Kuruvillaauthor=S.+J.+Novickauthor=L.+Linauthor=M.+D.+Cameronauthor=P.+R.+Griffinauthor=T.+M.+Kamenecka&title=N-Arylsulfonyl+Indolines+as+Retinoic+Acid+Receptor-Related+Orphan+Receptor+%CE%B3+%28ROR%CE%B3%29+Agonists&doi=10.1002%2Fcmdc.201600491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">N-Arylsulfonyl Indolines as Retinoic Acid Receptor-Related Orphan Receptor γ (RORγ) Agonists</span></div><div class="casAuthors">Doebelin, Christelle; Patouret, Remi; Garcia-Ordonez, Ruben D.; Chang, Mi Ra; Dharmarajan, Venkatasubramanian; Kuruvilla, Dana S.; Novick, Scott J.; Lin, Li; Cameron, Michael D.; Griffin, Patrick R.; Kamenecka, Theodore M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2607-2620</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The nuclear retinoic acid receptor-related orphan receptor γ (RORγ; NR1F3) is a key regulator of inflammatory gene programs involved in T helper 17 (TH17) cell proliferation.  As such, synthetic small-mol. repressors (inverse agonists) targeting RORγ have been extensively studied for their potential as therapeutic agents for various autoimmune diseases.  Alternatively, enhancing TH17 cell proliferation through activation (agonism) of RORγ may boost an immune response, thereby offering a potentially new approach in cancer immunotherapy.  Herein the authors describe the development of N-arylsulfonyl indolines as RORγ agonists.  Structure-activity studies reveal a crit. linker region in these mols. as the major determinant for agonism.  Hydrogen/deuterium exchange coupled to mass spectrometry (HDX-MS) anal. of RORγ-ligand complexes help rationalize the obsd. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFUjlrkpRAz7Vg90H21EOLACvtfcHk0lgq604SYvQOQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFSlsbzP&md5=1dfb3c08077c18e8cda3e6a287bb8194</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600491%26sid%3Dliteratum%253Aachs%26aulast%3DDoebelin%26aufirst%3DC.%26aulast%3DPatouret%26aufirst%3DR.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%2BD.%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DDharmarajan%26aufirst%3DV.%26aulast%3DKuruvilla%26aufirst%3DD.%2BS.%26aulast%3DNovick%26aufirst%3DS.%2BJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26atitle%3DN-Arylsulfonyl%2520Indolines%2520as%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520%25CE%25B3%2520%2528ROR%25CE%25B3%2529%2520Agonists%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2607%26epage%3D2620%26doi%3D10.1002%2Fcmdc.201600491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rene, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boenig, G. d. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1021/ml500420y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500420y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=276-281&author=O.+Reneauthor=B.+P.+Fauberauthor=G.+d.+L.+Boenigauthor=B.+Burtonauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=S.+G.+Hymowitzauthor=A.+R.+Johnsonauthor=J.+R.+Kieferauthor=M.+Liimattaauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=H.+A.+Wallweberauthor=H.+Wong&title=Minor+Structural+Change+to+Tertiary+Sulfonamide+RORc+Ligands+Led+to+Opposite+Mechanisms+of+Action&doi=10.1021%2Fml500420y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fml500420y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500420y%26sid%3Dliteratum%253Aachs%26aulast%3DRene%26aufirst%3DO.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DBoenig%26aufirst%3DG.%2Bd.%2BL.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DWallweber%26aufirst%3DH.%2BA.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DMinor%2520Structural%2520Change%2520to%2520Tertiary%2520Sulfonamide%2520RORc%2520Ligands%2520Led%2520to%2520Opposite%2520Mechanisms%2520of%2520Action%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D276%26epage%3D281%26doi%3D10.1021%2Fml500420y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huxdorf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1021/ml4003875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=65-68&author=T.+Yangauthor=Q.+Liuauthor=Y.+Chengauthor=W.+Caiauthor=Y.+Maauthor=L.+Yangauthor=Q.+Wuauthor=L.+A.+Orband-Millerauthor=L.+Zhouauthor=Z.+Xiangauthor=M.+Huxdorfauthor=W.+Zhangauthor=J.+Zhangauthor=J.-N.+Xiangauthor=S.+Leungauthor=Y.+Qiuauthor=Z.+Zhongauthor=J.+D.+Elliottauthor=X.+Linauthor=Y.+Wang&title=Discovery+of+Tertiary+Amine+and+Indole+Derivatives+as+Potent+ROR%CE%B3t+Inverse+Agonists&doi=10.1021%2Fml4003875"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fml4003875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003875%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DHuxdorf%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520Tertiary%2520Amine%2520and%2520Indole%2520Derivatives%2520as%2520Potent%2520ROR%25CE%25B3t%2520Inverse%2520Agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D65%26epage%3D68%26doi%3D10.1021%2Fml4003875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Vloten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontenot, J. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of biaryls as RORγ inverse agonists by using structure-based design</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2459</span>– <span class="NLM_lpage">2463</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;key=10.1016%2Fj.bmcl.2016.03.109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2459-2463&author=I.+J.+Enyedyauthor=N.+A.+Powellauthor=J.+Caravellaauthor=K.+van+Vlotenauthor=J.+Chaoauthor=D.+Banerjeeauthor=D.+Marcotteauthor=L.+Silvianauthor=A.+McKenzieauthor=V.+S.+Hongauthor=J.+D.+Fontenot&title=Discovery+of+biaryls+as+ROR%CE%B3+inverse+agonists+by+using+structure-based+design&doi=10.1016%2Fj.bmcl.2016.03.109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.109%26sid%3Dliteratum%253Aachs%26aulast%3DEnyedy%26aufirst%3DI.%2BJ.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DCaravella%26aufirst%3DJ.%26aulast%3Dvan%2BVloten%26aufirst%3DK.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DBanerjee%26aufirst%3DD.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DSilvian%26aufirst%3DL.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DV.%2BS.%26aulast%3DFontenot%26aufirst%3DJ.%2BD.%26atitle%3DDiscovery%2520of%2520biaryls%2520as%2520ROR%25CE%25B3%2520inverse%2520agonists%2520by%2520using%2520structure-based%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2459%26epage%3D2463%26doi%3D10.1016%2Fj.bmcl.2016.03.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI5','PDB','5NI5'); return false;">PDB: 5NI5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI7','PDB','5NI7'); return false;">PDB: 5NI7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI8','PDB','5NI8'); return false;">PDB: 5NI8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NIB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NIB','PDB','5NIB'); return false;">PDB: 5NIB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGQ','PDB','6FGQ'); return false;">PDB: 6FGQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B0W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B0W','PDB','3B0W'); return false;">PDB: 3B0W</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G45" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5G45','PDB','5G45'); return false;">PDB: 5G45</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ESN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ESN','PDB','6ESN'); return false;">PDB: 6ESN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i62"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00783">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_42065"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00783">10.1021/acs.jmedchem.8b00783</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular-formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_001.csv">CSV</a>)</p></li><li><p class="inline">Synthetic routes and characterization for final compounds <b>5</b>, <b>6</b>, <b>8</b>–<b>11</b>, <b>13</b>–<b>21</b>, <b>23</b>–<b>25</b>, <b>31</b>, <b>34</b>, <b>36</b>, and <b>37</b> and their intermediates; protein-production protocols; assay procedures; and information on the X-ray crystallographic analysis (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_001.csv">jm8b00783_si_001.csv (2.69 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00783/suppl_file/jm8b00783_si_002.pdf">jm8b00783_si_002.pdf (0.99 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors are deposited in the Protein Data Bank and will be released upon publication. PDB IDs have been provided in figure legends (<b>1</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI5">5NI5</a>; <b>8</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI7">5NI7</a>; <b>10</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NI8">5NI8</a>; <b>23</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FGQ">6FGQ</a>; <b>25</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NIB">5NIB</a>; <b>32</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6ESN">6ESN</a>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00783&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00783%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00783" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679935b76ffa32a9","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
